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Abstract 
Mechanisms of Axonal Pathology in the Context of Traumatic Brain Injury 
Raha M. Dastgheyb 
Kenneth Barbee, Ph.D 
 
 
Traumatic Brain Injury (TBI) affects approximately 270,000 people a year and costs 
the U.S. more than $48 billion annually. Around 70,000 people die each year from head 
injuries, but many of those who survive are left with long-term disabilities as a result of 
their injuries. While there have been many promising therapeutic treatments for TBI, 
clinical trials have not been successful. In vitro studies can provide insight into the cellular 
mechanisms leading to neuronal death and degeneration after TBI and aid in developing 
more effective treatments. 
The goal of this work was to investigate the mechanisms and pathways by which 
damage to neurons progresses in the context of Traumatic Brain Injuries by characterizing 
the behavior and response of cells to individual components of the proposed TBI 
mechanisms – specifically; membrane damage, increases in intracellular calcium, 
mitochondrial damage, and oxidative stress and lipid peroxidation. A clear understanding 
of the injury mechanisms and pathways is a requirement for the development of 
successful therapeutic interventions after injury. 
The mechanisms for cell death and dysfunction after TBI are hypothesized to be 
initiated by damage to the plasma membrane, which results in a loss of ionic homeostasis. 
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Calcium flows into the cell and causes an activation of various proteases that disrupt the 
cytoskeleton and cause deficits in axonal transport. Mitochondria, the primary source of 
cellular energy, also work in the cell as calcium buffers, but become dysfunctional when 
they cannot accommodate the excess calcium and result in the release of stored calcium. 
Damage to mitochondria results in an inability to produce ATP, whereby the cell starves, 
ATP-driven motors will be arrested, and ATP-driven ion pumps can no longer work to 
restore ion homeostasis. Damage to the mitochondria can also result in the opening of 
the mitochondrial permeability pore (MPP) and an increase in oxidative stress. Free 
radicals can further damage the mitochondria and the plasma membrane, and thus 
propagate and prolong cellular dysfunction. Damage to the mitochondria and the opening 
of the MPP also serves to release sequestered calcium from the mitochondria into the 
cytoplasm. These insults culminate in axonal “beads” and neuronal dysfunction and 
death.  
 
 
 
 
 
 
Chapter 1: Background 
1.1 Epidemiology 
Traumatic Brain Injury (TBI) is one of the most common causes of disability and 
death in adults (Langlois, Rutland-Brown et al. 2006). It is predicted that by the year 2020 
TBI will be the third leading cause of death and disability in the world (Murray and Lopez 
1997). Among patients who die from TBI, about 90% die within 48 hours, usually due to 
an uncontrolled rise in intracranial pressure (Sahuquillo and Arikan 2006). 
 Survivors are often left with long term effects including sleep disturbances, 
persistent headaches, depression, and cognitive defects (Feigin, Barker-Collo et al. 2010). 
Survivors of mild TBI can suffer from diverse and sometimes disabling symptoms such as 
chronic headaches, dizziness, and vertigo, difficulty concentrating, problems 
communicating, depression, irritability, and impulsiveness(DeKosky, Ikonomovic et al. 
2010). In addition to the social and health related consequences, TBI represents a 
significant socioeconomic burden(Marshall 2000) . The annual costs for TBI-related 
treatment in the United States was around $56 billion in 1999(Maas, Marmarou et al. 
2007).  Total direct and indirect costs to society have been estimated to exceed $60 billion 
annually (Gean and Fischbein 2010). Any successful treatment for TBI would also aid in 
relieving some of these socioeconomic burdens.  
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While there have been many promising therapeutic treatments for TBI in the 
laboratory, clinical trials have not been successful (Schouten 2007, Vink and Nimmo 
2009).  There are many possible reasons for the failure seen in clinical trials, including 
drug delivery, timing, dosing issues, and limitations due to side effects. A better 
understanding of the injury mechanisms and pathways may aid in the development of 
successful therapeutic interventions.  
1.2 Biomechanics of TBI 
TBI is initiated by a transfer of kinetic energy to the head(Geddes and Cargill 2001) 
and can be either focal (from a direct blow or penetrating object) or diffuse (resulting 
from dramatic accelerations and decelerations of the head)(Waxweiler, Thurman et al. 
1995) . Mechanisms of brain injury may include direct brain contusion from skull 
deformation, brain contusion from movements of the brain against the interior of the 
skull, or subdural hematomas typically from the tearing of the parasagittal bridging veins 
(Viano, King et al. 1989).  Diffuse injuries result from non-contact rotational forces to the 
brain(Meaney, Smith et al. 1995). Diffuse brain injury can occur without direct impact, 
but it is dependent on inertial forces such as those from automobile accidents or falls and 
assaults(Smith, Meaney et al. 2003). 
The brain is normally protected from physical injury by the skull(LaPlaca, Prado et 
al. 2009).  Loosely coupled to the skull, the brain has its own inertia, so its movement lags 
behind that of the skull during incidences of sudden acceleration or deceleration. The 
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resulting relative displacement causes shear deformations, stretches the blood vessels in 
the brain, and strains the brain tissue(Viano, King et al. 1989).  
Neurons have viscoelastic properties, which may make them more vulnerable to 
acceleration-dependent injury. When exposed to the rapid deformations associated with 
brain injury they become brittle(Smith, Meaney et al. 2003) and more prone to injury.  
Human cadaver studies have shown that the level of injury depends on both the 
acceleration of the head as well as the duration of acceleration (Gurdjian, Roberts et al. 
1966). In addition, the orientation and direction of acceleration are also important 
(Anderson, Wisner et al. 1997), with angular accelerations being particularly harmful 
(Ommaya and Gennarelli 1974). Injury can result in the destruction of neural circuits by 
the primary mechanical forces, or following secondary damage, leading to obvious 
functional deficits and impairments. 
Primary injuries due to the mechanical forces can include immediate cell death, 
hemorrhaging, and hematomas, as well as diffuse swelling that results in an increase in 
intracranial pressure (ICP) (Maas, Stocchetti et al. 2008) as well as sub-lethal damage to 
cells.  The possible therapeutic interventions to alleviate these primary effects are limited 
as the damage occurs over a small time window and there are no known treatments save 
for surgical interventions for increases in ICP.   Brain damage is not limited to the primary 
insult, as a cascade of events follow, termed “secondary damage”(Gean and Fischbein 
2010). Work in animal models has shown that axons are not always directly severed or 
disconnected unless the level of injury is very severe. Rather, for mild injuries, there are 
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sub-lethal mechanical injuries that lead axons to undergo a sequence of changes that 
result in secondary injury.  
1.3 Experimental Models of TBI 
 There are many different models of TBI, both in vivo and in vitro. There is no single 
model that perfectly replicates what happens in human TBI, or that allows observations 
of the entire injury pathway. This highlights the importance of being able to isolate and 
study pieces of the injury pathway in order to fully understand the mechanisms leading 
to neurodegeneration and neuronal death.  
1.3.1 In Vivo 
 In vivo models of brain injury allow the replication of all cellular mechanisms in a 
whole, living animal and allow for the observation of overall effects after injury.  However, 
they do not allow for time progression studies or live cellular imaging. The primary in vivo 
models of TBI are the weight drop model, fluid percussion model, and the cortical 
contusion injury model (Albert-Weissenberger and Siren 2010) often in rodents.  Each 
model has its own strengths and weaknesses which must be considered when choosing 
or evaluating an injury model.  
 The weight-drop model (Feeney, Boyeson et al. 1981, Marmarou, Foda et al. 1994, 
Shohami, Beit-Yannai et al. 1997) is an impact acceleration model that consists of a weight 
falling freely from a designated height onto an animal’s skull. While commonly used, this 
model has a high mortality rate and is not often reproducible.  As with all current in vivo 
models, it does not allow for easy evaluation of the time progression of injury. The cortical 
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contusion injury (CCI) model (Dixon, Clifton et al. 1991, Sutton, Lescaudron et al. 1993, 
Huh, Raghupathi et al. 2003) consists of a pneumatic piston which strikes the exposed 
dura of the rat. This method requires a craniotomy to expose the dura, which may 
compensate for any intracranial pressure increases that may occur as a result of injury. 
The fluid percussion model (McIntosh, Noble et al. 1987) may be a more diffuse model of 
injury than the CCI. It consists of a pendulum that strikes the piston of a reservoir of fluid 
that generates a pressure pulse to the dura. This method also requires a craniotomy that 
may compensate for increases in intracranial pressure.  
In vivo models are more comprehensive than in vitro models of injury in that they 
can better replicate the anatomy and progression of injury with all cell types and systems 
in the body. While most in vivo injury models are rodent based, which stray from human 
anatomy, there are non-primate models of rotational acceleration that follow human 
injury more closely.   In vivo models represent a more accurate time course of injury, but 
they are also limited in that they are more complex and have minimal opportunities for 
observing the progression of injury. When it comes to evaluating therapeutics in vivo 
models provide a better opportunity for understanding drug metabolism and delivery as 
well as systemic side-effects. 
1.3.2 In Vitro 
The primary in vitro models of TBI attempt to replicate the biomechanics of TBI by 
inducing either shear or stretch forces on cultured neurons. These models often offer 
several advantages over animal models but are not capable of completely replicating all 
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the pathological effects of TBI. Importantly, in vitro models provide many opportunities 
for live imaging studies.  
The stretch (Ellis, McKinney et al. 1995, Cargill and Thibault 1996, Morrison, 
Saatman et al. 1998, Smith, Wolf et al. 1999, Geddes and Cargill 2001, Pfister, Weihs et 
al. 2003, Lusardi, Rangan et al. 2004) model of TBI involves culturing cells on a deformable 
substrate that can then be stretched either uniaxially or biaxially, thereby transferring 
strain to the attached cells. The shear (LaPlaca, Lee et al. 1997, Kilinc, Gallo et al. 2007) 
model of TBI involves applying a fluid shear stress over cultured neurons. Both of these 
models have been shown to replicate many of the pathologies seen in TBI.   
In vitro models may not involve the complexity of in vivo models, but in some cases 
this may be an advantage. In vitro models bypass the problem of drug delivery, where in 
in vivo models it may be difficult to determine if the lack of an effect is due to the 
ineffectiveness of the drug or to failure of delivery to the intended site, especially in 
studies of the brain where the blood brain barrier poses a formidable obstacle. The 
primary advantage of in vitro models is the opportunity to make real time measurements 
of cellular responses.  
1.4 Secondary Injuries 
Secondary injuries are those that occur after the initial injury. They can take 
several hours to days to develop, which suggests a window of opportunity for therapeutic 
intervention (Povlishock and Katz 2005) to prevent, attenuate, or delay the resulting 
neurological deficits (Vink and Nimmo 2009).  Secondary damage can include 
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morphological changes, calcium-mediated damage, mitochondrial dysfunction, and 
increased oxidative stress(Maas, Stocchetti et al. 2008) . Reports for the time span over 
which this occurs differ based on the injury model and subject. In animals secondary injury 
can progress over a period of 2-6 hours, though in humans it can take 12 hours or longer 
(Christman, Grady et al. 1994) providing a greater window of opportunity for intervention.   
1.4.1 Beading 
Beading is a well-documented phenomenon in neurons that indicates injury 
severity (Takeuchi, Mizuno et al. 2005). It is the term for focal enlargements in axonal 
width (Ochs, Pourmand et al. 1996) considered to be the morphological hallmark of DAI.  
It has gone by other names too, including “axonal varicosities”(Rand and Courville 1946, 
Coleman 2005), “axonal swellings”  or “blebs”(Pullarkat, Dommersnes et al. 2006).   
Axonal beading has been identified in human white matter after DAI (Adams 1982, 
Gentleman, Roberts et al. 1995).  The presence of axonal beads is often used to ascertain 
that an injury has occurred, and to validate experimental injury models.  Beading has been 
shown after stretch injury(Lusardi, Rangan et al. 2004) as well as shear injury in 
vitro(Kilinc, Gallo et al. 2007). 
Beading morphology has been associated with disruptions in axonal transport 
(Smith, Wolf et al. 1999, Coleman 2005) including a misalignment of the cytoskeleton 
(Povlishock, Becker et al. 1983, Povlishock and Christman 1995, Gaetz 2004).  
Ultrastructural analysis at beading sites has revealed an aggregation of organelles (Stone, 
Singleton et al. 2001, Gaetz 2004)  along with axolemmal and cytoskeletal defects. In in 
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vitro experiments, beading can be used as a morphological indicator of the extent of 
neuronal injury. 
The mechanisms behind bead formation are not well understood. The beading 
morphology may be a consequence of osmotic imbalance(Budde and Frank 2010), but 
this does not explain why the swelling is focal. Cytoskeletal degradation, which is 
colocalized with beads, has been proposed as a cause of axonal beading(Monnerie, Tang-
Schomer et al. 2010) but has not been confirmed. Transport problems have also been 
hypothesized as an initiator of beading. Pilling et al. have proposed that stationary 
organelles cause “traffic jams” that grown into axonal swellings through the simple 
blockage of organelle passage(Pilling, Horiuchi et al. 2006), and have suggested that this 
may be caused by defects in transport motor function. However, organelles and 
cytoskeletal alterations may not be required for bead formation as beading can also occur 
with pure lipid bilayer tubes(Markin, Tanelian et al. 1999). 
 
1.4.2 Membrane Damage 
The cell membrane plays a very important role in providing a diffusion barrier 
against ion transport, to prevent ions from diffusing in the direction of their concentration 
gradient. Membrane damage is often identified either by the release of intracellular 
contents or the cellular uptake of membrane impermeable markers such as dextrans. 
Damage to the plasma membrane has been shown in both in vivo and in vitro models of 
TBI (Pettus, Christman et al. 1994, Povlishock and Christman 1995, Pettus and Povlishock 
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1996, Povlishock and Pettus 1996, LaPlaca, Lee et al. 1997, Okonkwo, Pettus et al. 1998, 
Borgens 2001, Geddes, Cargill et al. 2003, Geddes, LaPlaca et al. 2003, Stone, Okonkwo et 
al. 2004, Geddes-Klein, Schiffman et al. 2006, Kilinc, Gallo et al. 2008). This damage can 
be transient, permanent, or delayed (Farkas, Lifshitz et al. 2006).  The plasma membrane 
may become damaged in a way that does not necessarily kill cells immediately, but results 
in delayed cell death or dysfunction. It has been hypothesized that mechanical damage 
to the cell membrane (termed “mechanoporation”) is the originating event that leads to 
all following secondary damage (Borgens 2001, Kilinc, Gallo et al. 2008, Kilinc, Gallo et al. 
2009).  
There is also evidence that membrane damage can exist and be exacerbated 
beyond the original insult (Lafrenaye, McGinn et al. 2012). This suggests the presence of 
a positive feedback loop that leads to increased membrane permeability and further 
neuronal degeneration.   If true, this could possibly be manipulated as a point of 
therapeutic intervention. 
1.4.3 Calcium 
The concentration of free calcium in neurons has been shown to increase after 
brain injury (Shapira, Yadid et al. 1989, Cargill and Thibault 1996, Zhou, Xiang et al. 2001) 
and is thought to be linked to many of the neurodegenerative processes that occur 
following injury. Calcium is a very important ion in cells, and exhibits a large difference in 
concentration between the outside (1.2mM) and the inside (100nM) of the cell 
(Gleichmann and Mattson 2011). It is a second messenger that transfers signals locally 
and globally within the neuron. Calcium has been shown to play an important role in many 
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aspects of the cell, including neurite outgrowth, synaptogenesis, synaptic transmission, 
plasticity, and cell survival and degeneration.    
Intracellular calcium has been shown to increase within 1 hour following in vivo 
TBI in a variety of experimental models (Shapira, Yadid et al. 1989, Fineman, Hovda et al. 
1993, Maxwell, McCreath et al. 1995).  Using ion-selective microelectrodes, Nilsson et al. 
measured interstitial calcium concentrations in the cortex after cerebral contusion injury 
in rats and found that there was a dramatic decrease in calcium from a baseline of 1.1mM 
to between 0.1 and 0.3mM implying massive calcium entry into cells in the direction of 
the concentration gradient(Nilsson, Hillered et al. 1993).   In a rat model of DAI the 
concentration of free calcium in neurons was increased at 30 minutes after injury(Zhou, 
Xiang et al. 2001). In in vitro stretch models, there is an immediate rise in calcium followed 
by a graduate recovery period, with calcium magnitudes being dependent on the degree 
of strain(Geddes-Klein, Schiffman et al. 2006). 
Elevated intracellular calcium has been linked to a wide array of cellular 
dysfunction(Trump and Berezesky 1995). An increase in intracellular calcium 
concentration is well known to initiate degenerative processes in multiple cell types(Stys, 
Ransom et al. 1990). Persistence of high cytosolic calcium may also be responsible for 
mitochondrial damage (Pettus, Christman et al. 1994, Lifshitz, Friberg et al. 2003), energy 
depletion, and signaling for necrotic and apoptotic cell death (Rink, Fung et al. 1995).  
While it is agreed that there is an increase in intracellular calcium after injury, 
there is no clear consensus on the source of the calcium. Calcium may enter the cell from 
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the extracellular space through nonselective pores or through channels (LoPachin and 
Lehning 1997, Wolf, Stys et al. 2001). Glutamate receptor activation has also been 
implicated as a route for calcium entry (Arundine and Tymianski 2004). The N-methyl-D-
aspartate (NMDA) receptor is the glutamate receptor most often studied in terms of 
excitotoxicity after TBI. Substantial sources of intra-axonal calcium might also include the 
mitochondria(Thayer and Miller 1990, Nicholls, Vesce et al. 2003), which are capable of 
storing and releasing intracellular calcium(Parekh 2008).  
Paradoxically, calcium may also play a protective role by activating vesicle proteins 
that promote membrane fusion to seal the cell membrane (Fishman, Tewari et al. 1990, 
Terasaki, Miyake et al. 1997, Fishman and Bittner 2003). By some accounts membrane 
resealing cannot occur in the absence of extracellular calcium(Steinhardt, Bi et al. 1994). 
These observations indicate that calcium may play a dual role in TBI.  
1.4.4 Protease Activation 
Calcium has been implicated in activating certain proteases that contribute to 
neuronal degeneration, specifically calpains and caspases (Brana, Benham et al. 1999, 
Buki, Okonkwo et al. 1999, Pike, Zhao et al. 2000, Newcomb-Fernandez, Zhao et al. 2001).  
Calpains are calcium-activated proteases that can degrade several cytoskeletal proteins 
including spectrin and tubulin (Johnson, Litersky et al. 1991, Saatman, Abai et al. 2003, 
Gaetz 2004).  There are two major calpains: µ-calpain and m-calpain, which refer to their 
micromolar or millimolar requirement for calcium activation.  
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There have been many studies demonstrating the activation of calpain-mediated 
degradation of the cytoskeleton with regards to sites of axonal damage (Saatman, Murai 
et al. 1996, Posmantur, Kampfl et al. 1997, Buki, Okonkwo et al. 1999). In in vivo models 
of TBI, calpains have been shown to be activated as early as 15 minutes after 
injury(Kampfl, Posmantur et al. 1996). Adult male rates receiving lateral fluid percussion 
injury showed calpain-mediated spectrin breakdown at 90 minutes in axons(Saatman, 
Bozyczko-Coyne et al. 1996) .  Axonal calpain activation has also been observed in 
repetitive mild brain injury in rats (Huh, Widing et al. 2007).  In vitro models of TBI have 
also shown calpain activity that has been linked to beading (Kilinc, Gallo et al. 2009). 
Caspase activation has also been noted after TBI in rats (Clark, Kochanek et al. 2000), 
where a caspase inhibitor was able to reduce cellular injury in a cortical contusion model 
but did not show significant improvements on functional outcome.  
Calpain activation has also been noted in other diseases. It has been observed in 
Parkinson’s disease, where experimental models have shown that calpain inhibition is 
able to attenuate cell death (Chen, Yap et al. 2006) . Calpain activation has also been 
noted in the brain of Alzheimer’s patients (Saito, Elce et al. 1993). 
1.4.5 Impaired Axonal Transport 
Deficits in axonal transport have been shown in TBI as well as in many other 
neurological disorders.  To move cargo along the axon there is a requirement for “motors” 
to move the cargo and “rails” to transport them on (Roy, Zhang et al. 2005). In axons the 
“rails” consist mainly of microtubules, which run in a longitudinal direction(Hirokawa and 
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Takemura 2005) .  Transport failure can occur when there is a defect in any one of these 
components.  
Microtubules are a major component of the axonal cytoskeleton. Impaired axonal 
transport, marked by a breakdown of the cytoskeleton, has been shown in a variety of in 
vivo(Pettus, Christman et al. 1994, Maxwell 1996, Maxwell and Graham 1997, Stone, 
Singleton et al. 2001)  and in vitro (Kilinc, Gallo et al. 2008, Tang-Schomer, Johnson et al. 
2012) models. The loss of microtubules is not limited to the primary injury and can extend 
over a number of hours (Maxwell 1996, Pettus and Povlishock 1996, Maxwell and Graham 
1997). It has been linked to focal disruption of axonal transport along with the 
accumulation of organelles such as mitochondria(Maxwell 1996, Maxwell and Graham 
1997) and has been implicated in beading(Pettus, Christman et al. 1994) .  
1.4.6 Mitochondria 
The main function of mitochondria is to produce high energy intermediates (NADH 
and ATP) through the tri-carboxylic (TCA) cycle, also known as the Krebs cycle, and 
oxidative phosphorylation. Mitochondrial health has crucial links to TBI recovery, and 
patients with only marginal mitochondrial impairment have been shown to demonstrate 
a good outcome compared to those with profound mitochondrial impairment, who often 
have a poor prognosis (Signoretti, Marmarou et al. 2008).  Mitochondria are actively 
transported on the axonal cytoskeleton to areas of high metabolic demand by the motors 
kinesin and dynein (Ligon and Steward 2000, Hollenbeck and Saxton 2005).This means 
that defects in mitochondria transport can lead to an altered distribution of mitochondria 
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along the axon, resulting in an inability to meet local energy demands or participate in 
calcium buffering.  
Mitochondrial dysfunction and accumulation at sites of impaired axonal transport 
have been noted in in vivo (Pettus, Christman et al. 1994) and in vitro (Ellis, McKinney et 
al. 1995) models of TBI. Mitochondria function as calcium buffers and are the main 
cellular source of reactive oxygen species (ROS)(Rizzuto, Bernardi et al. 2000).  In vitro, 
neuronal stretch produces mitochondrial dysfunction and ROS formation (Arundine, Aarts 
et al. 2004). 
Mitochondria also play an important role in calcium regulation. Axonal 
mitochondria do not normally accumulate calcium(Scarpa, Malmstrom et al. 1976), but 
when intracellular calcium is increased above 5 µM, the calcium can be sequestered in 
the mitochondria (Blaustein 1988). However, large increases in intracellular calcium due 
to extracellular influx have been closely associated with mitochondrial dysfunction (Nasr, 
Gursahani et al. 2003). 
Mitochondria are primarily responsible for the cellular production of reactive 
oxygen species (ROS). During electron transfer in the inner mitochondrial membrane 
there is spontaneous leakage of electrons that lead to ROS production.  Excessive calcium 
accumulation can also potentiate mitochondrial ROS production (Dykens 1994, Adam-Vizi 
2005) and result in the release of apoptogenic factors such as cytochrome c into the 
cytosol (Liu, Kim et al. 1996, Fiskum 2000).  The release of cytochrome c has been 
associated with in vivo brain injury (Buki, Okonkwo et al. 2000, Fiskum 2000).  
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An increase in mitochondrial calcium may induce a phenomenon known as the 
mitochondrial permeability transition (MPT), characterized by a pore in the inner 
mitochondrial membrane (Gunter and Pfeiffer 1990).  The MPT is promoted by excess 
calcium and inhibited by cyclosporin A (CsA) (Kim, He et al. 2003). The opening of the 
mitochondrial permeability pore results in the ability of solutes with a molecular mass of 
up to 1500 Da to nonselectively pass through the inner mitochondrial membrane leading 
to depolarization of the mitochondria, uncoupling of oxidative phosphorylation, ATP 
depletion, and mitochondrial swelling (Kim, He et al. 2003).  Mitochondrial dysfunction 
and the MPT have been implicated in brain injury (Okonkwo, Buki et al. 1999, Scheff and 
Sullivan 1999, Sullivan, Rabchevsky et al. 2000, Alessandri, Rice et al. 2002). 
1.4.7 Oxidative Stress 
Free radical production has been widely implicated in the pathology of TBI (Hall, 
Andrus et al. 1996, Shohami, Beit-Yannai et al. 1997, Arundine, Aarts et al. 2004). The 
primary ROS generated by mitochondria is superoxide (O2-), which is a result of leakage 
from the electron transport chain(Kowaltowski, de Souza-Pinto et al. 2009) where 
electrons spontaneously leak and react with available O2 (Won, Kim et al. 2002). 
Superoxide is transformed into hydrogen peroxide (H2O2) through the activity of Mn-SOD 
as well as Cu-SOD and Zn-SOD.  Hydrogen peroxide is diffusible through the membrane 
and can be removed by an endogenous antioxidant system within the cell. If hydrogen 
peroxide is not removed, it can generate the hydroxyl radical (.OH) through the metal-
catalyzed Fenton reaction. It can also react with nitric oxide (NO) to produce peroxynitrite 
(ONOO-). Excess calcium in the mitochondria can interrupt the electron transport chain 
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and collapse mitochondrial membrane potential which allows for the accumulation of 
free electrons which can react with oxygen and produce more superoxide.  
1.4.8 Lipid Peroxidation 
ROS, while generally damaging to the cell, may also contribute to neuronal 
degeneration through lipid peroxidation. The neurons are particularly sensitive to this 
type of damage because of the enrichment of polyunsaturated fatty acids.  Lipid 
peroxidation is the reaction between free radicals and polyunsaturated fatty acids which 
results in peroxyl radical formation and conformational changes in the membrane, 
leading to a loss of membrane integrity (Girotti 1985, Hall, Braughler et al. 1992).  
ROS induction of lipid peroxidation has been implicated in secondary damage after 
TBI (Braughler and Hall 1992, Hall, Braughler et al. 1992).  Increased levels of lipid 
peroxidation, as measured by quantifying malondialdehyde(Ohkawa, Ohishi et al. 1979), 
have been shown 1-24 hours after diffuse head injury(Marmarou, Foda et al. 1994, 
Hsiang, Yeung et al. 1997, Vagnozzi, Marmarou et al. 1999) and 36 hours after weight-
drop injury (Inci, Ozcan et al. 1998). Measurements using electron spin resonance have 
indicated lipid peroxidation 6 hours after TBI (Nishio, Yunoki et al. 1997). Using other 
methods, lipid peroxidation has been indicated in TBI at 24 hours after weight-drop injury 
(Promyslov and Demchuk 1995) . These studies provide compelling evidence that lipid 
peroxidation is present after TBI and may be contributing to secondary damage (Lewen, 
Matz et al. 2000).    
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1.5 Other Neurological Disorders 
Understanding the mechanisms underlying secondary pathologies may be 
important not only for unlocking management techniques for TBI, but also for other 
neurological disorders which may not only have similar pathways, but may also be linked. 
There has been much discussion about a link between TBI and Alzheimer’s disease 
(Heyman, Wilkinson et al. 1984, DeKosky, Ikonomovic et al. 2010).  Significant amyloid 
plaques, a hallmark of Alzheimer’s, have been reported in TBI patients who died 6-18 days 
following injury (Roberts, Gentleman et al. 1991).  Alzheimer’s also exhibits some of the 
same pathologies seen in TBI, such as axonal swelling and transport deficits (Stokin, Lillo 
et al. 2005). 
A history of repetitive closed head injury has been described to lead to Chronic 
Traumatic Encephalopathy (CTE), which is a progressive taupathy with a distinct clinical 
neuropathological profile that becomes symptomatic many years after an individual has 
experienced repeated concussive or subconcussive blows to the head. Characteristic 
features include tau immunoreactive neurofibrillary tangles and astrocytic tangles 
(Gavett, Stern et al. 2010). Patients with a history of head injury have also been associated 
with an increased risk for Parkinson’s disease (Goldman, Tanner et al. 2006) . In addition, 
a study of Italian soccer players has shown that they have an unusually high risk of 
Amyotrophic Lateral Sclerosis, possibly linked to repeated head trauma. The correlation 
between head injury and neurological disorders emphasizes the importance of 
understanding the mechanism of pathology after head injury.  
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1.6 Hypothesis and Motivation 
 
Figure 1. Hypothesized pathways of cellular death and dysfunction after TBI. Highlighted regions represent components targeted 
in specific aims 
 
The overall hypothesis (Figure 1) is that cell death and dysfunction after TBI are 
initiated by damage to the plasma membrane. A major consequence of membrane 
disruption is the loss of ionic homeostasis, resulting in a flux of ions in the direction of 
their concentration gradient. Thus, cell metabolism and energy demand are increased as 
ATP-driven ion pumps work to restore the ion gradients.  Calcium, which flows into the 
cell because of the large inward gradient, can cause an activation of various proteases 
that disrupt the cytoskeleton and cause deficits in axonal transport. Mitochondria, the 
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primary source of cellular energy, also work in the cell as calcium buffers, but become 
dysfunctional when they cannot accommodate the excess calcium. Damage to 
mitochondria results in an inability to produce ATP, whereby the cell starves, ATP-driven 
motors are arrested, and ATP-driven ion pumps can no longer work to restore the ion 
gradient. Damage to the mitochondria can also result in the opening of the mitochondrial 
permeability pore (MPP) and an increase in oxidative stress. Free radicals can further 
damage the mitochondria and the plasma membrane, and thus propagate and prolong 
cellular dysfunction.  Damage to the mitochondria and the opening of the MPP also serves 
to release sequestered calcium from the mitochondria into the cytoplasm. These insults 
culminate in axonal “beads” and neuronal dysfunction and death.  
The proposed specific aims are designed to isolate main components in the 
proposed pathway to validate or revise the injury sequence after TBI.  Understanding the 
relationship between the initial injury and the subsequent pathology is vital to the 
development of clinically relevant therapeutic interventions.  
1.7 Specific Aims 
Specific Aim 1: Determine the role of membrane disruption in axonal pathology. In this 
aim, the membrane-permeabilizing agents, saponin and melittin were used to determine 
the progression of injury in neurons after membrane disruption. EGTA was used to 
chelate extracellular calcium with models of membrane disruption to investigate the role 
that calcium influx plays after membrane disruption.  Calcium Ionophore A23187 was 
used to induce increased intracellular calcium without preceding membrane damage.  
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The hypotheses were that membrane damage and calcium influx would result in a 
pathology that mimics in vivo and in vitro models of TBI, including axonal beading, 
increased intracellular calcium, mitochondrial dysfunction, and microtubule disruption, 
and that chelating extracellular calcium would prevent axonal beading.   
Specific Aim 2: Determine the contribution of mitochondria to membrane damage-
induced axonal pathology. In this aim, carbonyl cyanide 3-chlorophenyl hydrazine (CCCP) 
was used to target mitochondria in order to investigate the isolated component of 
mitochondrial damage.  Intracellular chelation of calcium by BAPTA was used to 
investigate the interplay between calcium and mitochondria. To investigate the role that 
oxidative stress plays with disrupted mitochondria, antioxidants glutathione (GSH) and 
catalase were tested with CCCP, as well as with other isolated perturbations of the 
proposed pathway. The role of the MPP was explored by preventing its opening with 
Cyclosporin A (CsA) after various insults. The hypotheses were that isolated mitochondrial 
injury will result in a pathology that mimic components of the TBI pathway. Increasing 
oxidative stress would also mimic TBI pathology and antioxidant use would mitigate 
axonal beading. Chelating intracellular calcium was hypothesized to be neuroprotective 
and reduce axonal beading, as was the use of CsA to prevent the opening of the MPP.  
Specific Aim 3: Determine the role of secondary membrane damage in axonal pathology. 
In this aim, the development of secondary membrane disruption after isolated insults in 
the cell injury pathway was investigated by measuring changes in membrane 
permeability. Poloxamer 188 (P188) was used in conjunction with these isolated insults 
to test for the therapeutic potential of membrane sealing. Injured cells were tested for 
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lipid peroxidation. The hypotheses were that secondary steps in the pathway in the 
absence of preceding membrane damage would lead to secondary membrane damage 
that can be mitigated by P188. It was also hypothesized that lipid peroxidation 
measurements will reveal that lipid peroxidation is responsible for secondary membrane 
damage.  
1.8 Organization of Thesis 
This thesis is organized in six chapters with a separate chapter for each aim, 
preceded by a general introduction (present) and a chapter on general methods (Chapter 
2) that were used repeatedly. Any reagents or techniques specific to an aim are described 
in a separate methods section for each aim. Each chapter describing aims (Chapters 3 – 
5) includes a background and materials section followed by results and discussion. 
Chapter 3 discusses the role of membrane disruption in axonal pathology, Chapter 4 
investigates the contribution of mitochondria to membrane damage-induced axonal 
pathology and Chapter 5 explores the role of secondary membrane damage in axonal 
pathology. Chapter 6 is a final discussion with recommendations for future work. These 
chapters are followed by appendices with Matlab code and detailed methods for 
analyzing axonal beading and focal disruptions in microtubules.  
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Chapter 2: Materials and Methods 
2.1 Cell Culture 
All of the experiments in this thesis were conductedusing chick forebrain neurons. 
These cells were chosen for culture because of their technical conveniences and because 
of their similarity to the commonly used rat hippocampal neurons, a common source for 
neuronal culture. Chick forebrain neurons are able to grow at low density, which allows 
for the analysis of isolated neurons. 
Chick forebrain neurons were dissected using a protocol modified from 
Heidemann(Heidemann, Reynolds et al. 2003). Fertilized chicken eggs were received from 
Charles River Laboratories and incubated in humidified chambers to allow for embryo 
growth. Dissections were performed after 8 days of incubation. The outer surface of the 
egg was sterilized with 70% ethanol and the top portion of the egg was cracked open and 
the outer membrane detached so that the embryo could be removed to a petri dish and 
decapitated quickly.  The two forebrain hemispheres were identified and the outer 
transparent tissue later was removed starting at the central fissure of the forebrain. 
Traces of blood vessels and meninges were removed, and the hemispheres are 
mechanically minced.   After a brief centrifugation in PBS to clean the tissue, the pieces 
were incubated for 8 minutes at 37C in Phosphate-buffered saline without calcium and 
magnesium (CMF-PBS) to help break up the tissues. This step was followed by more 
centrifugation to remove the supernatant, followed by enzymatic treatment with trypsin 
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to digest extracellular components. The cells were incubated for 8 minutes at 37C in the 
presence of trypsin, centrifuged, and mechanically triturated again in Hepes-buffered 
Ham’s F12 media (F12HS10) with 10% serum to deactivate the trypsin and further break 
up the cells. One more centrifugation step removed the trypsin and F12HS10, at which 
point the cells were counted and plated at a concentration 200-300 cells/mm on flamed 
glass coverslips that had been coated overnight with 0.01 mg/ml poly-DL-lysine The 
plating media was Medium 199 (M199) supplemented with penicillin- streptomycin and 
10% fetal bovine serum (FBS). The following day (DIV1) the cells were fed with M199, and 
the media was partially changed at DIV3. Experiments were conducted after 4-6 days in 
culture in Ham’s F12 Medium supplemented with penicillin-streptomycin and 10mM 
Hepes (F12H). 
For live imaging experiments, cells were plated on video dishes that were created 
by drilling a 1.5 cm diameter hole in the bottom of a 60mm diameter petri dish and 
affixing glass coverslips to the bottom of the hole using aquarium sealant and cured at 
room temperature(Gallo 2004). Dishes were then treated as regular coverslips for 
standard culture and were coated with 0.1 mg/ml poly-dl-lysine in borate buffer overnight 
before a suspension of cells was added. The use of a glass coverslip on the bottom of the 
dish allowed for oil immersion microscopy, and the creation of the well facilitated keeping 
cells alive in a small volume of media.  
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2.2 Measurement of Axonal Beading 
For beading experiments, images were taken after treatment and fixation. Phase 
microscopy was used to obtain images of single neurons with discernable axons that did 
not have connections with other cells. ImageJ was used to measure the length of each 
axon, and the counting tool was used to manually select the number of beads in each 
axon. Beading intensity was measured by normalizing the number of beads per axon by 
the length of the axon in microns.  
Axonal Beading was used as a measure of neuronal health in lieu of other methods 
because it is a morphological measurement based on phase images that potentially allows 
for the observation of the degradation of a single neuron through time. The use of 
live/dead assays merely allows for a binary measurement of health: alive or dead. 
Furthermore, most live/dead assays are based on measurements of membrane 
permeability. They make the assumption that cells with permeable membranes are no 
longer alive. Here, we are making the case that increased cell membrane permeability is 
only the beginning of a cell death pathway and that it can be treated, so these 
measurements were not sufficient. 
For speed and ease of analysis, as well as for comparisons to other labs who use 
similar methods, the experiments shown here quantify only the number of beads 
normalized by the length of the axon. However, this may not be the best method of 
quantification as the size and location of the beads may also be important. To allow for 
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the quantification of these measurements, an automated and interactive method for the 
quantification of beading was developed and is presented in Appendix A.  
2.3 Mitochondrial Morphology 
Mitochondria were visualized using the mitochondrial dye Mitotracker Green,  a 
fluorescent dye that accumulates in the mitochondria due to the membrane potential 
(Presley, Fuller et al. 2003) .Cells were incubated in 50nM Mitotracker Green for 30 
minutes and were imaged before and at the end of treatment. Mitochondrial morphology 
was quantified using ImageJ (Figure 2). Images were background-subtracted and the cell 
body removed. Mitochondria were then segmented using a fluorescence intensity 
threshold. If multiple mitochondria appeared to be overlapping they were not included in 
the segmentation. ImageJ’s multi-measure tool was used to select the segments and 
quantify morphology based on a fit ellipse, measuring the major and minor length. The 
major axis length was used as a measure of the length of the mitochondria.  
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The shape descriptor of roundness was also measured. Roundess was calculated 
in ImageJ using Equation 1.  A value of 1 indicates a perfect circle. Values approaching 0 
indicate an increasingly elongated shape. 
𝑹𝒐𝒖𝒏𝒅𝒏𝒆𝒔𝒔 = 𝟒 ×
𝑨𝒓𝒆𝒂
𝝅 × (𝑴𝒂𝒋𝒐𝒓 𝑨𝒙𝒊𝒔)𝟐
 
Equation 1. Calculation of Roundness 
 
These measurement were made for each discernable mitochondria in two images 
for each neuron, before and after treatment. At each time point the measurements for 
roundness and length were averaged and the percent changes was calculated for the 
second time point. The average measurements for each axon were used because of the 
Figure 2. Process of Quantifying Mitochondrial 
Shape.A) Neuron with mitochondria stained 
using Mitotracker Green. B) Background 
subtraction using a 50 pixel rolling ball radius. 
C) Thresholding using fluorescence intensity. D) 
Mitochondria segmented and ready to be 
quantified using an ellipsoid fit.  
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difficulty in tracking each individual mitochondrion over long periods of time without 
more frequent images, which would have contributed to mitochondrial dysfunction. 
2.4 Microtubule Analysis 
Quantifying cytoskeletal disruption involved two general steps: (1) fluorescent 
staining and imaging of microtubules and (2) quantification of focal disruptions in 
microtubules. 
2.4.1 Visualization of the Cytoskeleton 
To visualize their breakdown, microtubules must be fixed and stained while 
removing free tubulin monomers. To do this, a combined fixation and extraction method 
was used (Gallo and Letourneau 1999)   Experimental cultures were fixed in PHEM buffer 
with 1% Triton X-100 and 0.05% gluteraldehyde for 15 minutes. They were then treated 
with 2 mg/ml of sodium borohydride to quench autofluorescence and stained with FITC-
conjugated DM1A anti-tubulin (1:100) to stain tubulin.   
2.4.2 Quantifying focal disruptions 
 An automated program was written and developed in Matlab to allow for the 
quantification of focal disruptions in microtubules. A detailed explanation of the program 
and methods is given in Appendix B. Briefly, the images were loaded into Image J and 
manually rotated and segmented with the user interface already available in Image J. The 
segmented image was then loaded into Matlab where the plot profile was created by 
finding the average intensity along the axon.  These values were then filtered in a separate 
Matlab program to identify focal disruptions in microtubule intensity.  
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2.5  Measurement of Membrane Permeability 
Membrane permeability was measured as the loss of an intracellular dye, 
CellTrace™ Calcein Red-Orange, AM (MW = 789.55, excitation/emission maxima 577/590 
nm). Calcein Red-Orange is an acetoxymethyl (AM) ester derivative. Modification of 
carboxylic acids with AM ester groups results in an uncharged molecule that can 
permeate cell membranes. Once inside the cell, the lipophilic blocking groups are cleaved 
by nonspecific esterases, resulting in a charged form that is well retained by live cells with 
intact membranes.  
Cultured neurons were incubated in a final concentration of 5 µM of Calcein Red-
Orange for 30 minutes at 37°C to load the cell intracellularly with the dye. After incubation 
cultures were rinsed 3 times with the experimental media, F12H. Imaging was done on a 
temperature-controlled wide-field fluorescence microscope with an automated 
motorized stage with a 60x oil immersion objective.  Fluorescence images were taken in 
live cells before and after treatment.  ImageJ was used to quantify the total axonal 
fluorescence for each neuron before and after treatment. These numbers were used to 
calculate the percent decrease in calcein fluorescence, which is used as a measure of 
membrane permeability.    
Factors other than membrane damage that could result in a change in axonal 
fluorescence include photobleaching, additional esterase cleavage of the dye, and a 
change in focus of the microscope.  It is assumed that photobleaching and dye conversion 
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occur at similar rates for both controls and treated cells. Any axons with obvious changes 
in focus were not included in measurements.  
2.6  Calcium Quantification 
Calcium measurements were achieved in live cells using the calcium dye Fluo-3 
AM. Fluo-3 (769.54) is a fluorescent calcium indicator that exhibits an increase in 
fluorescence when bound to calcium and can be used to image the spatial and temporal 
dynamics of intracellular calcium. An increase in Fluo-3 fluorescence is indicative of an 
increase in cytosolic calcium concentrations. Traditionally, an increase in Fluo-3 
fluorescence would be interpreted as a decrease in cytosolic calcium concentrations. 
However, in these experiments there is a presumed loss of plasma membrane integrity, 
so a decrease in Fluo-3 fluorescence could also be interpreted as a loss of the intracellular 
dye. To control for this, the ratio of the cytosolic dye Calcein red/orange was also used 
with the assumption that the two dyes with similar molecular weights would escape from 
the cell at the same rate.  
Immediately prior to experimentation, cells were incubated in F12H with 5uM 
Fluo-3 AM and 5 µM of Calcein Red-Orange for 30 minutes at 37°C to load the cell 
intracellularly with the dyes. After incubation cultures were rinsed 3 times with the 
experimental media, F12H. Imaging was done on a temperature-controlled wide-field 
fluorescence microscope with an automated motorized stage with a 60x oil immersion 
objective.  Fluorescence images were taken in live cells before and after treatment.  
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ImageJ was used to quantify the total axonal fluorescence for each neuron before and 
after treatment.  
Factors other than membrane damage that could result in a change in axonal 
fluorescence include photobleaching, additional esterase cleavage of the dye, and a 
change in focus of the microscope.  It is assumed that photobleaching and dye conversion 
occur at similar rates for both controls and treated cells. One major benefit for the 
ratiometric measurements used here is that any change in focus would affect the view of 
both dyes, so the ratiometric measurement helps to minimize these artifacts.  
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Chapter 3: The Role of Membrane Damage in Axonal Pathology 
3.1 Background 
3.1.1 Axonal Pathology 
Collective data has revealed that there are several areas of impairment in TBI. In 
vivo models have demonstrated that after injury there is a loss of integrity in the plasma 
membrane(Pettus, Christman et al. 1994, Pettus and Povlishock 1996, Okonkwo, Pettus 
et al. 1998, Stone, Okonkwo et al. 2004), an increase in intracellular calcium(Shapira, 
Yadid et al. 1989, Fineman, Hovda et al. 1993, Zhou, Xiang et al. 2001), a breakdown of 
intracellular transport (indicated by focal disruptions in the axonal cytoskeleton and an 
accumulation of organelles) (Pettus, Christman et al. 1994, Maxwell 1996, Maxwell and 
Graham 1997, Stone, Okonkwo et al. 2004, Dikranian, Cohen et al. 2008), an increase in 
oxidative stress(Smith and Hall 1996), mitochondrial damage(Maxwell, McCreath et al. 
1995, Dikranian, Cohen et al. 2008), and the formation of axonal beads(Maxwell 1996, 
Dikranian, Cohen et al. 2008). In many cases the connection and progression between 
these areas of impairment is unclear. Understanding the pathway that leads to the 
progression of these axonal pathologies will be an important step to unlocking 
therapeutic strategies. 
3.1.2 Membrane Damage 
The cell membrane plays a very important role in providing a diffusion barrier 
against ion transport, to prevent ions from diffusing in the direction of their concentration 
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gradient. Membrane damage is often identified either by the release of intracellular 
contents or the cellular uptake of membrane impermeable markers such as dextrans. 
Damage to the plasma membrane has been shown in both in vivo and in vitro models of 
TBI (Pettus, Christman et al. 1994, Povlishock and Christman 1995, Pettus and Povlishock 
1996, LaPlaca, Lee et al. 1997, Okonkwo, Pettus et al. 1998, Borgens 2001, Geddes, Cargill 
et al. 2003, Geddes, LaPlaca et al. 2003, Stone, Okonkwo et al. 2004, Geddes-Klein, 
Schiffman et al. 2006, Kilinc, Gallo et al. 2008).  The mechanism and structure of 
membrane damage is not well understood, but has been investigated using various types 
of markers. Lucifer Yellow (MW 457)has been shown to enter cells in a rat controlled 
cortical impact model, as has a 3000 MW dextran(Lessing 2008). Dextrans with a 
molecular weight of around 10,000 have been shown to enter neurons in rat fluid 
percussion models (Singleton and Povlishock 2004, Kelley, Farkas et al. 2006) as well as 
rat impact acceleration models (Stone, Okonkwo et al. 2004, Farkas, Lifshitz et al. 2006) . 
Dextrans as large as 40,000 Da have been shown to enter cells in rat fluid percussion 
models (Pettus and Povlishock 1996, Singleton and Povlishock 2004)  and impact 
acceleration models (Stone, Okonkwo et al. 2004) . Horseradish Peroxidase, also with a 
molecular weight of around 40,000, has been shown to enter cells in a cat fluid percussion 
model (Pettus, Christman et al. 1994) and a rat fluid percussion model(Singleton and 
Povlishock 2004) as well as an impact acceleration model in rats (Koob, Duerstock et al. 
2005) . All of these studies indicate damage to the plasma membrane that can vary based 
on the model and location of injury.  This damage can be transient, permanent, or delayed 
(Farkas, Lifshitz et al. 2006).   
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The plasma membrane may become damaged in a way that does not necessarily 
kill cells immediately, but results in delayed cell death or dysfunction. It has been 
hypothesized that mechanical damage to the cell membrane (termed 
“mechanoporation”) is the originating event that leads to all following secondary damage 
(Borgens 2001, Kilinc, Gallo et al. 2008, Kilinc, Gallo et al. 2009). There is also evidence 
that membrane damage can exist and be exacerbated beyond the original insult 
(Lafrenaye, McGinn et al. 2012), suggesting the presence of a feedback loop that leads to  
increased membrane permeability.  Damage to the plasma membrane results in a loss of 
ionic homeostasis as ions move in the direction of their concentration gradient. In 
neurons, this involves and efflux of potassium and an influx of sodium and calcium ions. 
 
3.1.3 Calcium Influx 
Loss of plasma membrane integrity will cause calcium to diffuse down the 
concentration gradient and into the cell. Many studies have shown increased cytosolic 
calcium in TBI. A weight drop model of rat brain injury showed increased calcium content 
one hour after injury (Shapira, Yadid et al. 1989). In a rat fluid percussion injury model, 
calcium accumulation was demonstrated immediately after injury (Fineman, Hovda et al. 
1993). Measurements of extracellular calcium after injury showed a sharp drop two hours 
after injury, indicating influx into neurons (Nilsson, Laursen et al. 1996).  Stretch injury 
models of rat hippocampal neurons result in a sharp rise in intracellular calcium (Lusardi, 
Wolf et al. 2004). The concentration of free calcium in neurons has been shown to 
increase after brain injury (Shapira, Yadid et al. 1989, Fineman, Hovda et al. 1993, Cargill 
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and Thibault 1996, Zhou, Xiang et al. 2001) and is thought to be linked to many of the 
neurodegenerative processes that occur following injury. The source of this increased 
calcium is not completely clear, but it is likely to be an influx from the extracellular space 
or released intracellularly from mitochondria or endoplasmic reticulum.  
Calcium is an essential ion in cells, and exhibits a large change in concentration 
between the outside (1.2mM) and the inside (100nM) of the cell (Gleichmann and 
Mattson 2011). It is a second messenger that transfers signals locally and globally within 
the neuron.  Elevated intracellular calcium has been linked to a wide array of cellular 
dysfunction(Trump and Berezesky 1995). An increase in intracellular calcium 
concentration is well known to initiate degenerative processes in multiple cell types(Stys, 
Ransom et al. 1990). Oxidative stress, mitochondrial dysfunction, and protease activation 
have been proposed to lead to neuronal degeneration through calcium-dependent 
pathways in neurodegenerative diseases such as Alzheimer’s, Huntington’s, and 
Parkinson’s disease (Nilsson, Hillered et al. 1993). Loss of calcium homeostasis is thought 
to be the final common pathway of neurodegeneration. Paradoxically, calcium may also 
play a protective role by activating vesicle proteins that promote membrane fusion to seal 
the cell membrane (Fishman, Tewari et al. 1990, Terasaki, Miyake et al. 1997, Fishman 
and Bittner 2003). These observations indicate that calcium may play a dual role in TBI, 
both in propagating neurodegeneration and as a signal to promote membrane repair.  
While it is agreed that there is an increase in intracellular calcium after injury, 
there is no clear consensus on the source of the calcium.  Calcium may enter the cell from 
the extracellular space through nonselective pores or through channels in the plasma 
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membrane (Blaustein 1988, LoPachin and Lehning 1997, Wolf, Stys et al. 2001). 
Substantial sources of intra-axonal calcium might also include the mitochondria(Thayer 
and Miller 1990, Nicholls, Vesce et al. 2003), which are capable of storing and releasing 
intracellular calcium(Parekh 2008).  
 
3.1.4 Axonal Beading 
Beading (Figure 3) is a well-
documented phenomenon in neurons 
that indicates injury severity 
(Takeuchi, Mizuno et al. 2005). It is a 
term that describes focal bead-like swellings that have been shown in diffuse axonal injury 
after brain injury. In models of TBI, beads are often co-localized with areas of cytoskeletal 
damage and an accumulation of organelles (Povlishock, Becker et al. 1983, Povlishock and 
Christman 1995, Smith, Meaney et al. 2003, Takeuchi, Mizuno et al. 2005, Greenwood, 
Mizielinska et al. 2007, Kilinc, Gallo et al. 2009). In in vitro experiments, beading can be 
used as a morphological indicator of the extent of neuronal injury.  
3.1.5 Hypothesis and summary of experiments 
Damage to the plasma membrane due to the application of mechanical forces, 
termed “mechanoporation,” has been hypothesized to be the initiating factor that 
precedes the sequence of secondary injury mechanisms after TBI. If this is true, then 
membrane damage in the absence of mechanical loading would be expected to result in 
Figure 3. Example of axonal beading in chick forebrain neurons. A) 
Neuron before injury B) The same neuron 30 minutes after fluid shear 
stress injury. Beads are denoted by white arrows 
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the same sequence of events including mitochondrial dysfunction, increased intracellular 
calcium, cytoskeletal disruption, and mitochondrial damage. To simulate membrane 
damage, membrane permeabilizing agents were used to simulate membrane damage and 
allow non-selective transport across the membrane in the absence of mechanical injury 
to see if the same pathologies in TBI would occur.  A major consequence of membrane 
disruption is the influx of calcium, so a calcium ionophore was used in the absence of 
preceding membrane disruption to investigate the role of calcium in TBI. To further 
investigate the role that calcium influx plays in membrane disruption, EGTA was used to 
chelate extracellular calcium after membrane disruption. 
 
3.2 Materials and Methods 
3.2.1 Membrane Permeabilization Methods 
Two separate methods were used to increase membrane permeability; the 
detergent saponin and the pore-forming peptide melittin. The use of different agents with 
different mechanisms of membrane permeabilization ensured that different possible 
effects of membrane permeabilization would be represented.   
Saponin 
Saponin is a detergent commonly used in fixed cells for immunohistochemistry 
and at low concentrations it can be used in live cells to disrupt the cell membrane 
(Gogelein and Huby 1984). It is reported to interact with membrane cholesterol, 
selectively removing it and leaving pores in the membrane(Jamur and Oliver 2010). The 
37 
 
 
 
cholesterol-selectivity of saponin makes it more likely that it will permeabilize the cell 
membrane of the neuron, which is rich in cholesterol, and avoid permeabilizing organelles 
such as mitochondria which are almost cholesterol free(Addabbo, Montagnani et al. 
2009).The size of pores created by saponin differs depending on the substrate, but in 
membranes it is reported to result in 3-5 nm holes(Seeman 1967). Saponin treatment is 
likely to allow for the exchange of ions as well as proteins.  
Melittin 
Melittin, the major toxin in bee venom, is an amphiphilic pore-forming peptide 
with antimicrobial properties. At low concentrations it can induce transient pores, and 
produces more stable pores at higher concentrations. It has been proposed that melittin 
integrates into the bilayer creating a torroidal (or “wormhole”) pore (Yang, Harroun et al. 
2001, Lee, Sun et al. 2013). Reports of the size of melittin-induced pores range from a 
diameter of 1-4nm (Ladokhin, Selsted et al. 1997, Rex and Schwarz 1998, Yang, Harroun 
et al. 2001) . Melittin is likely to allow for the exchange of ions, but less likely than saponin 
to allow for the efflux of intracellular proteins. 
3.2.2 Increasing Axonal Calcium: A23187 
Increased intracellular calcium without preceding membrane poration can be 
achieved by using the calcium ionophore A23187(Reed and Lardy 1972). It is commonly 
used for research purposes to increase intracellular calcium in living cells because it 
shuttles free calcium in the direction of the concentration gradient.  
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3.2.3 Chelating Extracellular Calcium: EGTA 
Ethylene glycol tetraacetic acid (EGTA) chelates calcium.  It can be added to the 
extracellular medium to prevent calcium influx from the extracellular medium.  
 
3.3 Results 
3.3.1 Permeabilizing the Plasma Membrane Results in Pathologies Similar to That of TBI  
Beading 
Beading is the hallmark morphological change of TBI, and if increased membrane 
permeability is leading to downstream secondary effects, increasing membrane 
permeability in the absence of mechanical trauma should also lead to beading. To test 
this hypothesis, saponin and melittin were used to chemically increase plasma membrane 
permeability. First, it was established that these agents were able to increase membrane 
permeability by loading cells with calcein red/orange and imaging before and after the 
addition of saponin or melittin (Figure 4, Figure 6).  The percent loss of calcein 
fluorescence intensity in the axons was used as a measure of membrane permeability.  
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Both saponin and melittin treatment resulted in a significant increase in 
membrane permeability as compared to controls. Saponin treated cells lost more than 
50% of their initial fluorescence after 20 minutes of incubation and melittin treated cells 
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Figure 4. Representative image of intracellular 
Calcein loss before (A) and 20 minutes after (B) 
the addition of 0.01% Saponin 
 
Figure 5. Saponin treatment results in increased 
membrane permeability. Neurons were loaded with 
Calcein Red/Orange and imaged before and 20 minutes 
after the addition of 0.01% Saponin. (One-tailed t-test, 
p<0.0001. n> 15 cells) 
 
Figure 6. Representative image of intracellular 
Calcein loss before (A) and 30 minutes after (B) the 
addition of 100nM melittin 
 
Figure 7. Melittin treatment results in increased 
membrane permeability. Neurons were loaded with 
Calcein Red/Orange and imaged before and 30 minutes 
after the addition of 100nM melittin (One-tailed t-test, 
p<0.01. n> 15 cells for each condition). All values are 
presented as means ± SEM. 
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lost more than 35%, while control cells lost less than 10% of their initial calcein 
fluorescence on average.   
These findings were consistent with previous reports that saponin and melittin 
increase membrane permeability and validate their use as a model for membrane 
damage. Specifically, a study by Pratt in 2005 used a similar technique of observing calcein 
efflux to establish that melittin permeabilized the membrane of sheep lymphocytes(Pratt, 
Ravnic et al. 2005) and in 1997 Matsuzaki also used Calcein efflux to measure melittin 
pore formation in phospholipid vesicles (Matsuzaki, Yoneyama et al. 1997).  
Phase imaging before and after the addition of saponin (Figure 8) and melittin 
(Figure 9) showed that both membrane-permeabilizing agents resulted in beading. These 
observations establish that membrane permeabilization even in the absence of 
mechanical injury is sufficient to induce beading.  
 
 
Figure 8. Permeabilizing the membrane with saponin results in axonal beading. A, Phase image of chick forebrain neuron before 
the addition of saponin. B, the same neuron 10 minutes after the addition of 0.01% saponin. Beads indicated by white arrows. 
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Figure 9. Permeabilizing the membrane with melittin results in axonal beading. A, Phase image of chick forebrain neuron before 
the addition of melittin. B, the same neuron 10 minutes after the addition of 100nM melittin. Beads indicated by white arrows. 
 
Increased Axonal Calcium 
Intracellular calcium is increased after TBI, and this increase is hypothesized to be 
mainly the result of calcium influx from the extracellular space after membrane poration. 
To test this, the calcium indicator dye Fluo-3 was used to measure relative changes in 
axonal calcium before and after increasing membrane permeability with saponin (Figure 
10) and melittin (Figure 12).  Changes in axonal Fluo-3 intensity were normalized by 
changes in Calcein Red/Orange intensity to account for dye loss due to membrane 
damage. Axonal calcium changes were quantified and compared to control cells where 
no membrane-permeabilizing agents were added. To establish that increased calcium was 
a result of extracellular influx, EGTA was used to chelate extracellular calcium. Saponin 
treatment resulted in an almost two-fold increase axonal calcium that was prevented with 
the addition of EGTA (Figure 11). Similar results were seen with melittin (Figure 13), 
confirming that increases in cytosolic calcium are due to influx from an extracellular 
source.  
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Figure 10. Representative image of Fluo-3 
intensity increase before (A) and 15 minutes 
after (B) the addition of 0.01% Saponin 
 
Figure 11. Saponin treatment results in intracellular axonal calcium increase 
that is prevented when extracellular calcium is chelated with EGTA. Cells 
were treated with 0.01% Saponin for 15 minutes and extracellular calcium 
was chelated with 1mM EGTA, which reduced the calcium increase back to 
baseline levels. (Kruskal-Wallis test followed by Dunn’s Multiple 
Comparison Test, p<0.0001, n>8 cells for each condition). All values are 
presented as means ± SEM. 
 
Figure 12. Representative image of Fluo-3 
intensity increase before (A) and 25 minutes 
after (B) the addition of 100nM melittin 
 
Figure 13. Melittin treatment results in intracellular axonal 
calcium increase that is prevented when extracellular calcium is 
chelated with EGTA. Cells were treated with 100nM melittin for 
25 minutes and extracellular calcium was chelated with 1mM 
EGTA, which reduced the calcium increase back to baseline levels. 
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison 
Test, p<0.0001, n>8 cells for each condition). All values are 
presented as means ± SEM. 
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Cytoskeletal Disruption 
Cytoskeletal disruption is a pathology seen in TBI. In the hypothesized pathway 
(Figure 1), mechanoporation leads to cytoskeletal disruption and beading, presumably as 
a result of calcium-activated protease cascades that degrade the cytoskeleton. If this is 
the case, then increasing membrane permeability without mechanical damage should 
also lead to similar effects.  Neuronal membranes were permeabilized using saponin and 
melittin and then underwent a simultaneous fixation and extraction procedure to remove 
free tubulin before staining for microtubules. Axons were imaged and focal disruptions in 
microtubules were quantified as a measure of cytoskeletal disruption. Both saponin 
(Figure 14) and melittin (Figure 15) treatment resulted in a statistically significant increase 
in focal disruptions. 
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Figure 14. Cytoskeletal changes after saponin treatment. Cells were treated with 0.01% saponin for 30 minutes, after which they 
underwent a simultaneous fixation and extraction of free tubulin before being stained for tubulin. A, Representative image of 
saponin-treated neuron stained for tubulin. Arrow denotes focal disruption of microtubules. B, Plot Profile of intensity of 
representative neuron, arrow corresponds with area identified as having disrupted microtubules. C, Saponin treated cells have a 
higher percentage of cells with focal disruption in microtubules. D, Saponin treated cells have more focal disruptions in 
Microtubules. One-tailed mann-whitney test, p<0.005. N>80 cells from three coverslips for each condition. Error bars represent 
SEM. 
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Figure 15. Cytoskeletal changes after melittin treatment. Cells were treated with 100nM melittin for 30 minutes, after which they 
underwent a simultaneous fixation and extraction of free tubulin before being stained for tubulin. A, Representative image of 
melittin-treated neuron stained for tubulin. Arrow denotes focal disruption of microtubules. B, Plot Profile of intensity of 
representative neuron, arrow corresponds with area identified as having disrupted microtubules. C, Melittin treated cells have a 
higher percentage of cells with focal disruption in microtubules. D, Saponin treated cells have more focal disruptions in 
Microtubules. One-tailed mann-whitney test, p<0.05. n>65 cells from three coverslips for each condition. Error bars represent 
SEM. 
 
Mitochondrial Dysfunction 
Mitochondrial dysfunction is seen after TBI(Lifshitz, Sullivan et al. 2004). In the 
hypothesized pathway (Figure 1), this occurs as a result of excess calcium sequestration 
and increased energy need in order to restore ionic homeostasis. Since mitochondrial 
dysfunction results in changes in mitochondrial morphology, mitochondria were stained 
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with Mitotracker Green so that mitochondrial changes could be observed.  Treating cells 
with melittin resulted in mitochondria that were shorter and rounder, indicating 
mitochondrial dysfunction (Figure 16).  
 
Figure 16. Melittin treatment results in change in mitochondrial morphology. Representative image of a neuron before and 30 
minutes after the addition of 100nm melittin. The change in axonal mitochondria, stained with Mitotracker Green, can be seen. 
 
Changes in mitochondrial morphology were quantified and melittin treatment 
was shown to result in mitochondria that were rounder and less elongated (Figure 17). 
 
Figure 17. Membrane permeabilization with melittin results in a change in mitochondrial morphology. A, 30 minutes of 100nm 
melittin treatment results in a decrease in mitochondrial length (p<0.01) and B, an increase in mitochondrial roundness (p<0.05). 
(One-tailed t-test. n>100 mitochondria from at least 15 cells for each condition). All values are presented as means ± SEM. 
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The mitochondria in cells treated with saponin followed a similar trend. While 
control cells became slightly longer and more elongated, saponin-treated cells became 
significantly shorter and rounder, indicating mitochondrial dysfunction (Figure 18).  
 
Figure 18. Membrane permeabilization with saponin results in a change in mitochondrial morphology. A, 30 minutes of 0.01% 
saponin treatment results in a decrease in mitochondrial length (p<0.01) and B, an increase in mitochondrial roundness (p<0.001). 
(One-tailed t-test. n>30 mitochondria from at least 8 cells for each condition). All values are presented as means ± SEM. 
 
 
3.3.2 Selectively Increasing Cytosolic Calcium Results in Pathologies Similar to TBI 
Beading 
Permeabilizing the membrane using saponin and melittin was shown here to 
result in pathologies seen in TBI. Membrane permeabilization also induces the influx of 
calcium into the cell. To examine the contribution of calcium to axonal pathology, calcium 
ionophore was used to allow for the influx of extracellular calcium without preceding 
membrane damage. First, it was established that A23187 was increasing intracellular 
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calcium by using Fluo-3 AM to make measurements of relative calcium changes (Figure 
19).  
       
 
 
The addition of calcium ionophore A23187 to the extracellular media resulted in 
more than a four-fold increase in axonal calcium, indicating that A23187 is successful in 
increasing axonal calcium. This increase was completely prevented when EGTA was added 
to the extracellular media to chelate extracellular calcium, indicating that the intracellular 
calcium increase seen with A23187 treatment is purely a result of calcium influx from the 
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Figure 19. Representative image of Fluo-3 intensity 
increase before (A) and 30 minutes after (B) the 
addition 10uM A23187. 
 
Figure 20. Chelating extracellular calcium with EGTA prevents 
the increase in axonal calcium caused by Calcium Ionophore 
A23187.  Neurons were treated with 10µM A23187 for 30 
minutes. The addition of 1mM EGTA reduced axonal calcium 
changes back to baseline levels (One-way ANOVA followed by 
Tukey’s Multiple Comparison test, n≥20 cells for each 
condition). All values are presented as means ± SEM. 
 
49 
 
 
 
extracellular media (Figure 20). Increasing intracellular calcium without preceding 
membrane damage resulted in the formation of axonal beads (Figure 21).  
 
 
Figure 21. Increasing intracellular calcium with calcium ionophore A23187 results in a beaded morphology. A, Phase image of chick 
forebrain neuron before the addition of Saponin. B, the same neuron 20 minutes after the addition of 10uM A23187. Beads 
indicated by white arrows. 
 
To confirm that beading was a result of calcium influx with A23187, EGTA was used 
to chelate extracellular calcium and completely prevented the formation of axonal beads 
(Figure 22).  
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Figure 22. Chelating extracellular calcium with EGTA prevents bead formation induced by calcium ionophore. Cells were incubated 
in 10µM A23187and 1mM EGTA for 20 minutes. A, EGTA added with A23187 reduces the percent of beaded cells compared to 
A23187 treatment alone. B, A23187 treated cells show significantly more beads than the control or EGTA sham cells. Adding EGTA 
to the A23187 treated cells brings beading back to baseline levels (Kruskal-Wallis test followed by Dunn’s Multiple Comparison 
Test, p<0.0001, n>75 cells from three experiments). All values are presented as means ± SEM. 
 
 
Inducing calcium entry with calcium ionophore A23187 resulted in over 80% of 
cells presenting with beads. Preventing calcium entry by chelating extracellular calcium 
with EGTA completely prevented A23187-induced bead formation.  
Cytoskeletal Disruption 
Increased cytosolic calcium, a result of increased membrane permeability, is 
thought to lead directly to cytoplasmic disruption through an activation of proteases and 
calpains. Therefore, increasing cytosolic calcium even in the absence of mechanical 
damage or membrane disruption should lead to cytoskeletal disruption. To test this, 
neurons were incubated in 10µM A23187 to increase intracellular calcium and then 
underwent a fixation and extraction procedure to stain microtubules. The plot profile for 
each axon was created and quantified in ImageJ, yielding the normalized number of 
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microtubule disruptions in each axon. When compared to controls, A23187 treated cells 
had more than twice the number of focal disruptions (Figure 23).  
 
Figure 23. Cytoskeletal changes after increasing intracellular calcium with calcium ionophore A23187. Cells were treated with 
10µM A23187 for 30 minutes, after which they underwent a simultaneous fixation and extraction of free tubulin before being 
stained for tubulin. A, Representative image of A23187-treated neuron stained for tubulin. Arrow denotes focal disruption of 
microtubules. B, Plot Profile of intensity of representative neuron, arrow corresponds with area identified as having disrupted 
microtubules. C, A23187 treated cells have a higher percentage of cells with focal disruption in microtubules. D, A23197 treated 
cells have more focal disruptions in Microtubules. One-tailed mann-whitney test, p<0.005. N>80 cells from three coverslips for 
each condition. Error bars represent SEM. 
 
 
Mitochondrial Dysfunction 
Excess intracellular calcium is sequestered by the mitochondria, which become 
overloaded and damaged as they are overtaxed. Damaged mitochondria exhibit a change 
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in shape, from elongated to more circular. To establish that increasing intracellular 
calcium with calcium ionophore A23187 also resulted in mitochondrial dysfunction, 
mitochondria were stained with Mitotracker Green so that mitochondrial changes could 
be observed.  Treating cells with A23187 resulted in mitochondria that were shorter and 
rounder, indicating mitochondrial dysfunction (Figure 24).  
 
Figure 24. A23187 treatment results in change in mitochondrial morphology. Representative image of a neuron before and 30 
minutes after the addition of 10µM A23187. The change in axonal mitochondria, stained with Mitotracker green, can be seen. 
 
3.3.3 Blocking Calcium Influx Mitigates Beading after Permeabilizing the Cell Membrane 
Permeabilizing the cell membrane is hypothesized to lead to axonal beading 
through a variety of mechanisms. Membrane permeabilization results in a loss of ionic 
homeostasis and an increase in metabolic need as mitochondria work to produce the ATP 
required to restore ionic homeostasis. One major contributor to the loss of ionic 
homeostasis is the influx of calcium, which has been shown to lead to beading without 
general membrane permeabilization. It is clear that calcium contributes to axonal 
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beading, but not that it is the only contributor. To evaluate the role of calcium in axonal 
beading after membrane permeabilization, EGTA was used to chelate extracellular 
calcium and prevent calcium influx after membrane permeabilization. Permeabilizing the 
cell membrane with saponin resulted in axonal beading that was reduced by more than 
50%, but not abolished, when extracellular calcium was chelated with EGTA (Figure 25).  
 
Figure 25. Chelating extracellular calcium reduces axonal beading after permeabilizing the membrane with saponin. Cells were 
incubated in 0.01% saponin and 1mM EGTA for 20 minutes. A, EGTA added with saponin reduces the percent of beaded cells 
compared to saponin treatment alone. B, Saponin treated cells show significantly more beads than the control or EGTA sham cells. 
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.01, n>35 cells from three experiments). C, In cells that 
present at least one bead, cells treated with saponin and EGTA have significantly less beading than cells treated with saponin alone 
( Mann Whitney test, p<0.05,  n≥35 cells from three experiments). All values are presented as means ± SEM. 
 
The contribution of extracellular calcium to axonal beading after membrane 
damage was also investigated using melittin to permeabilize the cell membrane. Like 
saponin, melittin permeabilizes the cell membrane and allows for ion exchange, but is less 
likely than saponin to allow for protein exchange. Chelating extracellular calcium with 
EGTA when permeabilizing the membrane with melittin produced similar results as when 
saponin was used to permeabilize the membrane, beading was mitigated but not 
abolished (Figure 26).  
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Figure 26. Chelating extracellular calcium prevents axonal beading after permeabilizing the membrane with melittin. Cells were 
incubated in 100nM melittin and 1mM EGTA for 20 minutes. A, EGTA added with melittin reduces the percent of beaded cells 
compared to melittin treatment alone. B, Melittin treated cells show significantly more beads than the control or EGTA sham cells. 
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.0001, n>80 cells from three experiments). C, In cells that 
present at least one bead, cells treated with melittin and EGTA have significantly less beading than cells treated with melittin alone 
( Mann Whitney test, p<0.05,  n≥15 cells from three experiments). All values are presented as means ± SEM. 
 
3.4 Discussion 
Membrane damage is hypothesized to be the initiating factor in all subsequent 
secondary damage after mechanical injury in TBI.  Secondary damage includes increased 
intracellular calcium, cytoskeletal disruption, mitochondrial damage, and axonal beading. 
To evaluate the role of membrane damage in axonal pathology, neuronal membranes 
were permeabilized using both saponin and melittin and secondary pathologies were 
observed.  Both treatments were successful in permeabilizing the membrane, increasing 
intracellular calcium, disrupting microtubules, and producing axonal beads.  
To further investigate the mechanism of axonal pathology after membrane 
damage, the calcium portion of the pathway was isolated and calcium ionophore A23187 
was used to increase intracellular calcium without preceding membrane damage. 
Increasing intracellular calcium was also able to initiate common pathologies of TBI, 
55 
 
 
 
including cytoskeletal disruption, mitochondrial damage, and axonal beading. This 
confirmed that calcium influx plays a major role in axonal pathology after injury. However, 
it is not the only important factor. When extracellular calcium was chelated using EGTA 
and the cell membrane was permeabilized, axonal beading was reduced but not 
completely prevented, implying that there are more factors at play than just calcium. 
Work from the Povlishock lab has shown that mechanoporation is occurring after 
TBI and that a subset of mechanoporated neurons progress to cellular degeneration and 
subsequent death (Singleton and Povlishock 2004, Farkas, Lifshitz et al. 2006).  Similar 
results have been shown in vitro, reaffirming the importance of membrane poration 
(Geddes, Cargill et al. 2003, Kilinc, Gallo et al. 2007, Kilinc 2008, Kilinc, Gallo et al. 2008, 
LaPlaca, Prado et al. 2009). Here, we show that membrane poration in the absence of 
mechanical damage is sufficient to induce the secondary pathologies seen in TBI. 
George et al. showed that axotomy-induced neuronal death is dependent on 
extracellular calcium, indicating that calcium influx is a mechanism for neuronal 
degeneration and death (George, Glass et al. 1995). Gwag et al have shown that calcium 
ionophore can lead to neuronal degeneration via two mechanisms; low concentrations 
lead to apoptosis whereas high concentrations result in necrosis (Gwag, Canzoniero et al. 
1999). Bellomo et al have shown that calcium ionophore A23187 can induce blebbing that 
is prevented when extracellular calcium is not present, and that ionophore use also 
results in cytoskeletal alterations (Bellomo and Mirabelli 1992). Emery et al. have also 
shown that A23187 leads to mitochondrial abnormalities and cytoskeletal disruption in 
neurons (Emery and Lucas 1995). 
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Here, we show that increasing axonal calcium is sufficient to induce the secondary 
damage seen in TBI and that preventing calcium influx after membrane permeabilization 
is able to reduce, but not completely prevent, axonal beading. Extracellular calcium plays 
an important role in axonal pathology, but is not the only factor at play after membrane 
damage. Even if calcium is not present there is still a loss of ionic homeostasis involving 
the influx of sodium and an efflux of potassium as well as other ions. The restoration of 
ionic homeostasis taxes the mitochondria. If the mitochondria become dysfunctional, the 
cell will be unable to restore homeostasis. Disrupted mitochondrial function also results 
in an increase in oxidative stress and a release of sequestered mitochondrial calcium, 
which may also contribute to beading. 
The results presented here show that membrane permeabilization with saponin 
and melittin result in an influx of extracellular calcium because saponin and melittin 
treatment results in an increase in intracellular calcium that is prevented when EGTA is 
used to chelate extracellular calcium. However, these studies do not provide evidence for 
intracellular calcium release. It is likely that permeabilizing the membrane also allows for 
the influx of EGTA into the cell, where it can chelate intracellular calcium as well. 
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Chapter 4: The Contribution of Mitochondria to Membrane 
Damage-Induced Axonal Pathology 
4.1 Background 
Mitochondrial impairment has been reported after TBI (Maxwell, McCreath et al. 
1995, Xiong, Gu et al. 1997, Dikranian, Cohen et al. 2008). Mitochondrial health has been 
associated with TBI recovery, and patients with marginal mitochondrial impairment 
demonstrate a better outcome than those with profound mitochondrial impairment, who 
have a poor prognosis (Signoretti, Marmarou et al. 2008). In vitro experiments have 
suggested that beads may form where mitochondria are present, suggesting that they 
play a significant role in axonal pathology (Greenwood, Mizielinska et al. 2007, Kilinc, 
Gallo et al. 2008) . Mitochondria are vital organelles that provide energy and act as 
calcium buffers. Mitochondria are hypothesized to play multiple important roles in axonal 
pathology: as an energy source, ROS source, and calcium source. TBI has been shown to 
result in a rapid loss of ATP(Sullivan, Keller et al. 1998), which can lead to necrosis due to 
a lack of available ATP to fuel membrane pumps, preventing the restoration of 
homeostasis and leading to neuronal death(Santos, Moreno et al. 1996). 
 
4.1.1 Axonal Mitochondria 
Mitochondria perform multiple vital roles inside the cell. They are the main source 
of cellular energy, and also serve to store and release intracellular calcium (Rizzuto, 
Bernardi et al. 2000, Parekh 2008). Mitochondria are dynamic organelles which localize 
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to regions of high energy use along the axon (Bereiter-Hahn 1990, Hollenbeck and Saxton 
2005). They travel along microtubules using kinesin and dynein in a combination of 
saltatory and bidirectional movements, as well as stationary docking (Ligon and Steward 
2000, Hollenbeck and Saxton 2005, Pathak, Sepp et al. 2010).  Importantly, mitochondria 
have been shown to accumulate in beads (Greenwood, Mizielinska et al. 2007).   
The main function of mitochondria is to produce high energy intermediates (NADH 
and ATP) through the tri-carboxylic acid (TCA) cycle and oxidative phosphorylation 
(Gleichmann and Mattson 2011). The TCA cycle feeds the electron transport chain which 
converts oxygen to water and pumps protons from the mitochondrial matrix to generate 
a proton gradient, which in turn is used by an ATPase to generate ATP from ADP. The 
movement of protons creates a negative membrane potential in the mitochondria, so 
cations such as calcium will tend to accumulate in the mitochondrial matrix(Rizzuto, 
Bernardi et al. 2000). 
 
4.1.2  Causes of Mitochondrial Dysfunction 
Calcium 
Mitochondria play in important role not only for energy production but also for 
calcium signaling.  Mitochondria serve as calcium buffers, helping to regulate the cytosolic 
concentration of calcium by sequestering it inside the inner mitochondria matrix if it gets 
too high. Axonal mitochondria do not normally accumulate calcium(Scarpa, Malmstrom 
et al. 1976), but when intracellular calcium is increased above 5 µM, the calcium can be 
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sequestered in the mitochondria (Blaustein 1988). However, large increases in 
intracellular calcium due to extracellular influx have been closely associated with 
mitochondrial dysfunction (Nasr, Gursahani et al. 2003). 
The transport of calcium into the inner mitochondrial matrix depolarizes the 
mitochondria and inhibits oxidative phosphorylation and ATP synthesis (Won, Kim et al. 
2002). Calcium accumulation in mitochondria can also result in a loss of matrix 
components, impairment of mitochondrial function, and swelling of the organelle leading 
to outer membrane rupture (Lemasters, Nieminen et al. 1998). Accumulated intra-
mitochondrial calcium can also lead to the opening of what has been termed the 
mitochondrial permeability pore (MPP). This is defined as a non-selective increase in the 
permeability of the inner membrane to solutes of molecular weight less than 
approximately 1,500 Da(Fiskum 2000) and has been associated with excessive calcium 
accumulation(Fiskum 2000, Hansson, Mansson et al. 2004). 
Oxidative stress 
Under conditions of oxidative stress, mitochondria experience a change in 
permeability of the inner mitochondrial membrane that results in a complete collapse of 
the mitochondrial membrane potential. This loss of membrane potential is accompanied 
by mitochondrial swelling and the release of cytochrome c into the cytoplasm, where it 
activates certain caspases and induces apoptotic death(Simpkins, Yi et al. 2010).  The loss 
of ATP can also cause ATP-dependent membrane transporters to fail which can lead to 
necrosis from increased osmotic stress. 
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4.1.3  The Mitochondrial Permeability Pore (MPP) and the Mitochondrial Permeability 
Transition (MPT) 
Under certain stress conditions (including high calcium concentrations and 
oxidative stress) mitochondria undergo what is referred to as the Mitochondrial 
Permeability Transition (MPT) which involves an opening of the Mitochondrial 
Permeability Pore (MPP). The MPP refers to a channel of the inner mitochondrial 
membrane thought to be ~3nm (Bernardi, Krauskopf et al. 2006) that allows for the free 
diffusion of solutes less than 1500 Da (Halestrap 2009). While the details of the MPP are 
not well understood, the dominant hypothesis is that the pore spans the mitochondrial 
inner and outer membranes and is composed of proteins from both membranes and from 
the mitochondrial matrix (Kim, He et al. 2003). The MPT causes mitochondrial swelling 
and uncoupling of oxidative phosphorylation (Gunter and Pfeiffer 1990). This prevents 
mitochondria from producing ATP and leads to ATP depletion and bioenergetic failure 
(Halestrap 2009). 
The MPT can also occur in an unregulated fashion. This mechanism of pore 
opening does not require calcium for conductance and is not blocked by calcium chelators 
or drugs known to prevent the opening of the MPP(He and Lemasters 2002). It has been 
reported that unregulated MPP opening occurs at high concentrations of various chemical 
induces and that the size of regulated and unregulated pores is similar (Kim, He et al. 
2003). 
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4.1.4  Mitochondria and Oxidative Stress 
Mitochondrial dysfunction can result in a decrease in essential ATP and an 
increase in the production of reactive oxygen species (ROS) (Lemasters, Nieminen et al. 
1998, Simpkins, Yi et al. 2010).  The brain may be particularly vulnerable to oxidative 
damage because of its high rate of metabolic activity, the non-replicating nature of 
neurons, and the high ratio of membrane to cytoplasm (Evans 1993, Shohami, Beit-Yannai 
et al. 1997).  Mitochondria are one of the main sources ROS (Lemasters, Nieminen et al. 
1998), where free oxygen radicals are generated as byproducts from the electron 
transport chain (Adam-Vizi 2005, Cozzolino and Carri 2012).  In vivo, neuronal injury has 
been shown to result in mitochondrial dysfunction and ROS formation (Arundine, Aarts 
et al. 2004). The formation of ROS has also been documented in multiple models of TBI 
(Kontos and Povlishock 1986, Ikeda and Long 1990, Povlishock, Erb et al. 1992, Muir, Lyeth 
et al. 1995, Hall, Andrus et al. 1996, Shohami, Beit-Yannai et al. 1997, Arundine, Aarts et 
al. 2004).  
Oxidative stress is caused by an imbalance between ROS generation and oxidative 
defense systems (Ebadi, Srinivasan et al. 1996, Jenner 1996, Simonian and Coyle 1996).  
An increase in oxidative stress can be caused by either an increase in ROS, a decrease in 
antioxidants, or both. ROS, or free radicals, are highly reactive molecules that contain an 
unpaired electron in the outermost orbit, increasing their potential for chemical 
reactivity(Ikeda and Long 1990). They are normal byproducts of oxidative metabolism 
that are constantly produced and are also tightly controlled by endogenous antioxidant 
mechanisms. Sources of ROS in the brain include mitochondria, nitric oxide synthase 
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(NOS), and arachidonic acid metabolism (Hall, Yonkers et al. 1992, Schulz, Lindenau et al. 
2000).  Mitochondria produce ROS when electrons spontaneously leak from the electron 
transport chain and react with available O2 to produce superoxide (𝑂2
−) [Equation 2].  
The superoxide radical is the most commonly occurring cellular free radical and is 
produced when an oxygen molecule gains an electron(Gilgun-Sherki, Rosenbaum et al. 
2002). Superoxide can be converted to H2𝑂  by superoxide dismutases (SODs) and 
glutathione peroxidase (Won, Kim et al. 2002). If not converted, the superoxide can be 
processed to produce the hydroxyl radical ( OH. ) via the Fenton reaction [Equation 6] or 
to produce peroxynitrite (OONO) by reacting with nitric oxide [Equation 7]. These ROS 
also inhibit the electron transport chain in the mitochondria and can amplify the 
generation of free radicals (Choi, Klintworth et al. 2011). 
Equation 2 O2 + 𝑒
− → 𝑂2
−.  
Equation 3 O2 + 𝑂2
−. + 2H+ → H2O2 + O2 
Equation 4 Fe2+ + 𝑂2
− + 2H+ → Fe3+. + H2O2 
Equation 5 Fe3+ + 𝑂2
− → Fe3+ +. O2 
Equation 6 Fe2+ + H2O2 → Fe
3+ + OH +OH− .  
Equation 7 O2
− + NO. → ONNOH → OH+ONO..  
Table 1. Equations for the main reactions responsible for cellular oxidative stress  
 
Cells normally have a number of mechanisms to defend against increased 
oxidative stress (Evans 1993, Simonian and Coyle 1996).  Natural antioxidants fall into two 
categories: enzymes and low molecular weight antioxidants (LMWAs). Enzymes include 
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SOD and catalase(Gilgun-Sherki, Rosenbaum et al. 2002).  The LMWA group contains 
tocopherols (Vitamin E), glutathione, and ascorbic acid (Vitamin C).  These serve to 
protect the cell from increased oxidative stress under normal conditions of ROS 
production. 
 
4.1.5  Hypothesis and Summary of Experiments 
 The goal of this chapter is to investigate the role that mitochondria play in axonal 
pathology, including common consequences of mitochondrial dysfunction: increased 
oxidative stress and increased cytosolic calcium released from intracellular sources.  First, 
mitochondrial function was disrupted using Carbonyl cyanide m-chlorophenylhydrazone 
(CCCP) and downstream pathologies were observed, hypothesizing that mitochondrial 
dysfunction would induce axonal beading, increased cytosolic calcium, and cytoskeletal 
disruption. Since increased oxidative stress is a consequence of mitochondrial damage, 
the component of oxidative stress without preceding mitochondrial or membrane 
damage was isolated using the hydroperoxide donor tert-butyl hydroperoxide (TbHp), 
hypothesizing that this too would lead to axonal beading, mitochondrial dysfunction, 
increased cytosolic calcium, and focal disruption of microtubules. The component of 
oxidative stress was then further investigated using the antioxidant glutathione as a 
general scavenger and catalase as a hydrogen-peroxide-specific antioxidant to mitigate 
beading after isolated perturbations to mitochondria, cytosolic calcium, and membrane 
permeability. It was assumed that if oxidative stress was playing a role in downstream 
pathology after these insults then antioxidant use would decrease axonal beading.   
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 Mitochondrial damage can lead to the release of mitochondrially sequestered 
calcium, thereby increasing cytosolic calcium. To investigate the role of intracellularly-
released calcium, the intracellular calcium chelator BAPTA-AM was used to chelate 
intracellular calcium with the assumption that if increased cytosolic calcium was 
contributing to neuronal degeneration then chelating intracellular calcium would prevent 
beading after isolated perturbations to the damage pathway. To elucidate the source of 
increased cytosolic calcium, relative calcium measurements were used while chelating 
extracellular calcium with EGTA after disrupting mitochondrial function with CCCP and 
increasing oxidative stress with TbHp, hypothesizing that if intracellular calcium release 
was contributing to higher axonal calcium levels then EGTA would not be able to abolish 
the calcium increase. Finally, the role of the mitochondrial permeability transition (MPT) 
was investigated using Cyclosporin A (CsA) to prevent the regulated opening of the MPP 
and damaging the neuron using CCCP to target mitochondria, TbHp to induce oxidative 
stress, saponin and melittin to increase membrane permeability, and A23187 to increase 
cytosolic calcium. It was hypothesized that if the MPT was playing a role in downstream 
pathology after these perturbations then CsA would be able to reduce beading.  
 
4.2 Materials and Methods 
4.2.1 Inducing mitochondrial dysfunction with CCCP 
Carbonyl cyanide m-chlorophenylhydrazone (CCCP) is a proton ionophore used 
extensively to study energy coupling in mitochondria(Benz and Mclaughlin 1983). It 
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transports hydrogen ions across membranes and acts as an uncoupler of oxidative 
phosphorylation (Vaur, Sartor et al. 2000).  This is because the electron transport chain 
pumps protons out of the mitochondrial matrix in order to create an electrochemical 
gradient (Werth and Thayer 1994). Therefore CCCP uncouples electron transfer and 
inhibits ATP synthesis in the mitochondria, collapsing the proton gradient and membrane 
potential across the inner mitochondrial membrane (Suzuki, Higuchi et al. 1999). 
 
4.2.2 Inducing Increased Oxidative Stress with TbHp 
Tert-butyl hydroperoxide (TbHp) was used to induce oxidative stress in cells.  It is 
a membrane-permeable hydrogen peroxide donor widely used to induce oxidative stress 
in a variety of cells (Altman, Zastawny et al. 1994, Nardini, Pisu et al. 1998, Sestili, 
Guidarelli et al. 1998, Kanupriya, Prasad et al. 2007).  
 
4.2.3 Preventing Increased Oxidative Stress with Antioxidants 
Two different antioxidants were used to investigate the contribution of oxidative 
stress to axonal pathology: Glutathione (GSH) and catalase. GSH was used as a general 
scavenger for all ROS and catalase was used specifically for its interaction with hydrogen 
peroxide.  
Glutathione 
Oxidative stress was battled using Glutathione (GSH), which acts as an antioxidant 
and is the most abundant non-protein thiol found in the brain(Shohami, Beit-Yannai et al. 
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1997). It is a tri-peptide consisting of glycine, cysteine, and glutamic acid. GSH reacts 
directly with radicals in nonenzymatic reactions (Dringen, Gutterer et al. 2000). 
Glutathione has a molecular weight of 307.32 and is not cell membrane permeable. For 
these experiments, GSH was used as a general scavenger to decrease oxidative stress 
from all sources. Cells were pre-incubated in GSH before the addition of any damaging 
insults in order to increase the probability of GSH entering the cell. 
Catalase 
Catalase (MW 250 kDa) was used to specifically target hydrogen peroxide by 
catalyzing its conversion into water and oxygen. Hydrogen peroxide is freely diffusible 
through the cell membrane, so extracellular catalase would still be able to reduce 
hydrogen peroxide concentrations.  
 
4.3.4 Chelating Intracellular Calcium with BAPTA-AM 
1,2-bis-(2-aminophenoxy)ethane-Af,N,N',N'-tetraacetic acid ac-etoxymethyl 
ester (BAPTA-AM) is a cell membrane permeable analog of the calcium chelator BAPTA. 
It cannot chelate calcium until the acetoxymethyl group is removed by cytoplasmic 
esterases and it is converted to BAPTA(Tymianski and Tator 1996) Therefore BAPTA-AM 
is a useful tool to chelate intracellular calcium while not affecting extracellular calcium.   
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4.3.5 Preventing the MPT with Cyclosporin A 
 Cyclosporin A (CsA) inhibits the MPT (Fournier, Ducet et al. 1987, Crompton, 
Ellinger et al. 1988, Broekemeier and Pfeiffer 1989, Pastorino, Snyder et al. 1993, 
Nieminen, Saylor et al. 1995, Crompton, Virji et al. 1998, Bernardi, Krauskopf et al. 2006). 
In addition to preventing the regulated opening of the MPP, CsA also inhibits the calcium-
dependent phosphatase calcineurin(Ho, Clipstone et al. 1996) but is ability to block the 
MPT is unrelated to its immunosuppressive activity(Kim, He et al. 2003). Cyclosporin A 
does not block an unregulated opening of the MPP (He and Lemasters 2002, Kim, He et 
al. 2003).  He et al. have proposed two functional modes for the MPP: one activated by 
calcium and inhibited by CsA, and a second unregulated mode that is calcium 
independent and insensitive to CsA.  In some cases the inhibition of the MPT by CsA can 
be transitory or ineffective (Kristal and Brown 1999).  
In one theorized model of pore formation and the MPT, pores are formed by the 
aggregation of misfolded and damaged integral membranes in the mitochondria. 
Chaperone-like proteins block conductance through the misfolded protein clusters but 
increased calcium opens these pores in a manner which can be blocked by CsA – referred 
to as “regulated” pore opening.  However when the protein clusters exceed the 
chaperone proteins available to block conductance CsA is no longer able to block the pore 
opening and this is referred to as “unregulated” pore opening. It is thought that CsA 
inhibits the MPT by interfering with the binding of cyclophilin D to the adenine nucleotide 
translocator within the mitochondria (Connern and Halestrap 1994, Connern and 
Halestrap 1996, Nicolli, Basso et al. 1996, Sullivan, Rabchevsky et al. 2005).  When CsA 
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binds to cyclophilin D in the MPP complex, cyclophilin D remains associated with the 
complex but the complex is no longer able to form a pore (Connern and Halestrap 1994).  
 
 
4.3 Results 
4.3.1 Disrupting Mitochondria Results in a Pathology seen in TBI 
In the hypothesized pathway (Figure 1), damaged mitochondria prevent cell 
recovery and contribute to axonal pathology by increasing oxidative stress and releasing 
sequestered calcium which can lead to microtubule disruption and beading.  Therefore 
isolated mitochondrial impairment in the absence of mechanical and chemical membrane 
disruption should lead to the cellular pathologies seen in TBI. To test this, CCCP was used 
to disrupt mitochondrial function to see if mitochondrial disruption led beading and 
increased cytosolic calcium 
Mitochondrial Dysfunction 
First, it was established that CCCP was capable of disrupting mitochondrial 
function by quantifying changes in mitochondrial morphology (Figure 27) after CCCP 
treatment. 
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Figure 27. Disrupting mitochondrial function with CCCP results in a change in mitochondrial morphology. 60 minutes of 100µM 
CCCP treatment results in A, a decrease in mitochondrial length (p<0.01) and B, an increase in mitochondrial roundness 
(p<0.0001). (One-tailed t-test. n>100 mitochondria from at least 8 cells for each condition). All values are presented as means ± 
SEM. 
 
Beading 
When chick forebrain neurons were treated with CCCP for 60 minutes, the result 
was a beaded morphology similar to that obtained by mechanical injury models (Figure 
28). 
 
Calcium Increase 
It is hypothesized that one of the ways in which mitochondria contribute to the 
propagation of neuronal degeneration is through the release sequestered calcium.  To 
determine if intracellular calcium is increased as a result of mitochondrial dysfunction, 
Figure 28. Disrupting mitochondria with CCCP 
results in a beaded morphology. A, Phase image 
of chick forebrain neuron before the addition of 
CCCP. B, the same neuron 60 minutes after the 
addition of 100µM CCCP. Beads indicated by 
white arrows. 
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CCCP was used to disrupt mitochondrial function without preceding membrane damage. 
Fluo-3 was used as a calcium indicator (Figure 29). Ratiometric calcium measurements 
were made using Calcein Red/Orange to correct for possible loss of dye, comparing 
fluorescence ratio before treatment and 60 minutes after the addition of 100nM CCCP.  It 
was shown that CCCP results in a significant increase of axonal calcium (Figure 30). 
 
Figure 29. Representative diagram of increase in Fluo-3 fluorescence before (A) and 60 minutes after (B) the addition of 100nM 
CCCP 
 
Cytoskeletal Disruption 
Inducing mitochondrial dysfunction is thought to result in an increase in cytosolic 
calcium through the release of mitochondrially sequestered calcium. High intracellular 
calcium concentrations have been correlated with microtubule disruption through an 
activation of proteases. To see if disrupting mitochondrial function leads to focal 
disruptions of microtubules, neuronal cultures were treated with 100 nm CCCP for 60 
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Figure 30. CCCP treatment results in a significant increase in 
axonal calcium. Calcium ratio was calculated as the normalized 
ratio of axonal Fluo-3 to Calcein Red/Orange fluorescence 
before and 60 minutes after the addition of 100nM CCCP (One-
tailed t-test, p<0.0001, n>20 cells for each condition). All values 
are presented as means ± SEM. 
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minutes before undergoing a fixation-extraction procedure and being stained for tubulin. 
Custom Matlab code was used to create and filter plot profiles of fluorescence intensity 
along the axon to identify focal disruption in microtubules (Figure 31). CCCP treatment 
resulted in an increase in percentage of cells that presented with focal disruptions – from 
43% to 72%. There was also a statistically significant increase in the normalized number 
of focal disruptions.  
 
Figure 31. Cytoskeletal changes after CCCP treatment. Cells were treated with 100nM CCCP for 60 minutes, after which they 
underwent a simultaneous fixation and extraction of free tubulin before being stained for tubulin. A, Representative image of 
CCCP-treated neuron stained for tubulin. Arrow denotes focal disruption of microtubules. B, Plot Profile of intensity of 
representative neuron, arrow corresponds with area identified as having disrupted microtubules. C, CCCP treated cells have a 
higher percentage of cells with focal disruption in microtubules. D, CCCP treated cells have more focal disruptions in 
Microtubules. One-tailed mann-whitney test, p<0.01. N>75 cells from three coverslips for each condition. Error bars represent 
SEM. 
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4.3.2 Increasing Oxidative Stress with TbHp Results in a Pathology seen in TBI  
In the hypothesized TBI pathway, oxidative stress is increased as a result of 
mitochondrial dysfunction and can contribute to further impairment of the mitochondrial 
function. Therefore increased oxidative stress damages the mitochondria preventing the 
ATP-dependent restoration or maintenance of ionic homeostasis and the release of 
mitochondrially-sequestered calcium. Calcium can propagate the injury pathway through 
caspase and calpain-dependent pathways. The increased oxidative stress is also assumed 
to lead to lipid peroxidation and increased membrane permeability, thereby resulting in 
a loss of ionic homeostasis and an influx of extracellular calcium as well as furthering the 
bioenergetics crisis and need for mitochondrial ATP production.  
If the hypothesized pathway (Figure 1) is correct, increasing oxidative in the 
absence of preceding membrane disruption and mitochondrial damage should lead to the 
cellular pathologies seen in TBI. To test this, the hydroperoxide donor TbHp was used to 
see if increasing oxidative stress led to beading, increased axonal calcium, mitochondrial 
disruption, and cytoskeletal alterations.  
Beading 
Increased oxidative stress is hypothesized to lead to beading through two main 
calcium-dependent pathways. The first is through damaging mitochondria and increasing 
cytosolic calcium through the release of mitochondrially sequestered calcium. The second 
is by causing secondary membrane damage through lipid peroxidation leading to an influx 
of extracellular calcium. High intracellular calcium levels then lead to beading through 
protease activation and cytoskeletal disruptions. If these hypotheses are correct then 
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increasing oxidative stress should lead to beading. To test this neurons were treated with 
TbHp to see if axonal beads would form, and it was confirmed that increasing oxidative 
stress with TbHp results in the formation of axonal beads (Figure 32). 
 
Figure 32. Increasing oxidative stress with TbHp results in a beaded morphology. A,  Phase image of chick forebrain neuron before 
the addition of TbHp. B, the same neuron 15 minutes after the addition of 200mM TbHp. Beads indicated by white arrows. 
 
Mitochondrial Dysfunction 
Increased oxidative stress disrupts mitochondrial function. To see if increasing 
oxidative stress with TbHp results in mitochondrial dysfunction in cultured neurons, 
mitochondria were stained with Mitotracker Green and treated with 100mM TbHp for 30 
minutes (Figure 33). Cells were imaged before and after treatment and changes in 
mitochondrial morphology were quantified.  
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Figure 33. TbHp treatment results in change in mitochondrial morphology. Representative image of a neuron before and 30 
minutes after the addition of 100mM TbHp. The change in axonal mitochondria, stained with Mitotracker Green, can be seen. 
 
Figure 34. Increasing oxidative stress with TbHp results in a change in mitochondrial morphology. 30 minutes of 100mM TbHp 
treatment results in A, a decrease in mitochondrial length (p<0.05) and B, an increase in mitochondrial roundess (p<0.0001). 
(One-tailed t-test. n>100 mitochondria from at least 7 cells for each condition). All values are presented as means ± SEM. 
 
TbHp treatment resulted in shorter and rounder mitochondria (Figure 34), indicative of 
mitochondrial dysfunction.  
Calcium Increase 
Increasing oxidative stress is assumed to disrupt mitochondria and result in the 
release of sequestered mitochondrial calcium. Oxidative stress is also thought to increase 
membrane permeability though the oxidation of membrane lipids, thereby leading to the 
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influx of extracellular calcium. To determine if intracellular calcium is increased as a result 
of increased oxidative stress, TbHp was used to increase oxidative stress without 
preceding mitochondria or membrane disruption. Fluo-3 was used as a fluorescent 
calcium indicator (Figure 35).  Ratiometric calcium measurements were made using 
Calcein Red/Orange to correct for possible loss of dye.  The fluorescence ratios before 
treatment and 60 minutes after the addition of 100mM TbHp were compared.  It was 
shown that increasing oxidative stress with TbHp results in a significant increase of axonal 
calcium (Figure 36). 
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TbHp – Microtubule disruption 
Increased oxidative stress is hypothesized to lead to microtubule disruption through 
multiple pathways. Oxidative stress disrupts mitochondrial function and results in a 
release of mitochondrially sequestered calcium, which can activate proteases that disrupt 
the cytoskeleton. Increased oxidative stress is also hypothesized to induce lipid 
peroxidation and secondary membrane damage, leading to an influx of extracellular 
calcium which can also activate proteases and lead to microtubule disruption. To see if 
increased oxidative stress leads to cytoskeletal disruption, neurons were treated with 
100mM TbHp for 30 minutes before undergoing a simultaneous fixation extraction 
procedure and being stained for tubulin (Figure 37). The results showed an increase in the 
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Figure 35. Representative diagram of increase in 
Fluo-3 fluorescence before (A) and 30 minutes 
after (B) the addition of 100 mM TbHp 
 
Figure 36. TbHp treatment results in a significant increase in axonal 
calcium. Calcium ratio was calculated as the normalized ratio of 
axonal Fluo-3 to Calcein Red/Orange fluorescence before and 30 
minutes after the addition of 100 mM TbHp (One-tailed t-test, 
p<0.0001, n>25 cells for each condition). All values are presented as 
means ± SEM. 
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percentage of cells presenting any focal disruptions—from 39% to 57% -- as well as a 
statistically significant increase in the normalized number of focal disruptions.  
 
Figure 37. Cytoskeletal changes after TbHp treatment. Cells were treated with 100mM TbHp for 30 minutes, after which they 
underwent a simultaneous fixation and extraction of free tubulin before being stained for tubulin. A, Representative image of 
TbHp-treated neuron stained for tubulin. Arrow denotes focal disruption of microtubules. B, Plot Profile of intensity of 
representative neuron, arrow corresponds with area identified as having disrupted microtubules. C, TbHp treated cells have a 
higher percentage of cells with focal disruption in microtubules. D, TbHp treated cells have more focal disruptions in 
Microtubules. One-tailed mann-whitney test, p<0.01. n>70 cells from three coverslips for each condition. Error bars represent 
SEM. 
 
4.3.3 Contribution of Oxidative Stress 
 Oxidative stress is thought to lead to axonal beading by damaging mitochondria, 
thereby resulting in the release of mitochondrially sequestered calcium and even more 
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oxidative stress as a result of mitochondrial ROS production, as well as through leading to 
an influx of extracellular calcium after increasing plasma membrane permeability through 
lipid peroxidation.  In the hypothesized damage pathway, oxidative stress is thought to 
occur downstream of mitochondrial disruption, which occurs as a result of increased 
axonal calcium following increased membrane permeability. Therefore, reducing 
oxidative stress after any of these steps should serve to reduce beading. To test this, the 
antioxidants glutathione and catalase were combined with isolated perturbations to the 
damage pathway and axonal beading was quantified.  
CCCP + Glutathione 
Mitochondria play a crucial role in propagating the injury pathway and also in 
promoting recovery after injury.  After damage to the plasma membrane, recovery of 
ionic homeostasis is an energy intensive process requiring the production of ATP by 
mitochondria. Damage to the mitochondria results in an increased production of ROS, 
which in turn serve to further damage mitochondria participating in a positive feedback 
loop.  These are all hypothesized to promote axonal beading by impairing the extrusion 
of calcium by plasma membrane pumps, the release of calcium from mitochondria, and 
the increase in membrane permeability. To investigate the contribution of oxidative 
stress to this pathway, the antioxidant glutathione was used in conjunction with CCCP to 
damage mitochondria (Figure 38).  Cells were pre-incubated in 1mM GSH for 60 minutes 
before being treated with 100µM CCCP for 50 minutes in the presence of GSH. When cells 
were pre-treated with GSH before CCCP treatment beading was reduced to 13 percent as 
opposed to the 43 percent of cells that presented with beads when CCCP was used alone. 
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When beading was quantified, pre-treatment with GSH reduced beading back to baseline 
levels (Figure 38). 
 
Figure 38. Antioxidant treatment with glutathione (GSH) reduces axonal beading after CCCP treatment. Cells were incubated in 
100µM CCCP for 60 minutes after pretreatment with 1mM glutathione for 60 minutes. A, Glutathione reduces the percentage of 
beaded cells compared to CCCP treatment alone. B, CCCP treated cells show significantly more beads than the control or glutathione 
treated cells. Pre-incubating cells with glutathione before CCCP treatment results in significantly less beading than CCCP treatment 
alone. (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.0001, n>80 cells from three experiments). All values 
are presented as means ± SEM. 
 
CCCP + Catalase 
The contribution of hydrogen peroxide to beading after CCCP treatment was 
investigated using catalase to catalyze the decomposition of hydrogen peroxide to oxygen 
and water. Cells were pretreated with 100µg/ml of catalase before the addition of 100µM 
CCCP. While catalase reduced the percentage of cells with beads (from 47% to 23%), in 
the fraction of cells that did have beads catalase did not reduce the number of beads per 
length (Figure 39).  
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Figure 39. Antioxidant treatment with catalase reduces beading after CCCP treatment. Cells were incubated in 100 µM CCCP after 
pretreatment with 100 µg/ml catalase for 60 minutes A, Catalase reduces the percent of beaded cells compared to CCCP treatment 
alone. B, CCCP treated cells show significantly more beads than the control or catalase treated cells. Pre-incubating cells with 
catalase before CCCP treatment results in significantly less beading than CCCP treatment alone. (Kruskal-Wallis test followed by 
Dunn’s Multiple Comparison Test, p<0.0001, n>75 cells from three experiments). C, In cells that present at least one bead, cells pre-
treated with catalase do not have significantly less beading after treatment with CCCP than that were not pretreated( Mann 
Whitney test, p>0.05,  n>15 cells from three experiments). All values are presented as means ± SEM. 
 
A23187 + Glutathione  
One of the ways in which increasing axonal calcium is hypothesized to promote 
beading is through the disruption of mitochondrial function. Influx of calcium leads to 
structural alterations of the inner mitochondrial membrane, which may increase ROS 
formation due to disorganization of the electron transport chain (Kowaltowski, Castilho 
et al. 1995). To investigate the role of increased oxidative stress after increased axonal 
calcium, calcium ionophore A23187 was used to isolate the effect of calcium overload 
without membrane disruption. If calcium overload leads to beading via ROS production, 
GSH ought to inhibit it. Cells were pretreated with 1mM GSH before the addition of 10µM 
A23187.  The presence of GSH slightly reduced the percentage of beaded cells from 77% 
to 60% and had a statistically significant decrease in the number of beads per length as 
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well as a reduction in beading in the fraction of cells that presented with beads (Figure 
40).  
 
Figure 40. Antioxidant treatment with glutathione (GSH) reduces axonal beading after increasing axonal calcium with calcium 
ionophore A23187. Cells were incubated in 10uM A231870 after pre-incubation with 1mM GSH for 60 minutes. A, GSH added with 
A23187 reduces the percent of beaded cells compared to A23187 treatment alone. B, A23187 treated cells show significantly more 
beading than the control or GSH sham cells. (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.05, n>60 cells 
from three experiments). C, In cells that present at least one bead, cells treated with A23187 and GSH have significantly less beading 
than cells treated with A23187 alone ( Mann Whitney test, p<0.05,  n>40 cells from three experiments). All values are presented as 
means ± SEM. 
 
A23187 + Catalase 
Having established that oxidative stress is playing a role in calcium-induced axonal 
beading, the contribution of hydrogen peroxide to A23187-induced beading was 
investigated using catalase. Catalase reduced the percentage of beaded cells from 73% to 
33% and brought the number of beads per length back to baseline levels as well as 
showing a statistically significant reduction in the number of beads per length in the cells 
that presented with beads (Figure 41). 
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Figure 41. Antioxidant treatment with catalase reduces axonal beading after increasing intracellular calcium with calcium ionophore 
A23187. Cells were incubated in 100µM catalase for 20 minutes after pre-incubation with 100µg/ml catalase for 60 minutes. A, 
Catalase added with A23187 reduces the percentage of beaded cells compared to A23187 treatment alone. B, A23187 treated cells 
show significantly more beading than the control or catalase treated cells, and significantly more beads than cells treated with 
A23187 and catalase. (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.001, n>80 cells from three 
experiments). C, In cells that present at least one bead, cells treated with A23187 and catalase have significantly less beading than 
cells treated with melittin alone ( Mann Whitney test, p<0.001,  n>25 cells from three experiments). All values are presented as 
means ± SEM. 
 
Saponin + Glutathione 
Damage to the plasma membrane leads to a loss of ionic homeostasis, which must 
be recovered in an energy-dependent process involving the mitochondria. The production 
of ATP through the electron transport chain results in the formation of ROS. Under injury 
conditions, this can result in an increase of oxidative stress which propagates the injury 
pathway by further damaging the mitochondria and preventing neuronal recovery. To 
investigate the contribution of oxidative stress to the injury pathway after membrane 
injury, plasma membrane permeability was increased using saponin, and the antioxidant 
GSH was used to reduce any increase in oxidative stress. Cells were pre-treated in 1mM 
GSH for 60 minutes before the addition of 0.01% Saponin for 15 minutes. The presence 
of glutathione reduced the percentage of beaded cells from 70% to 40% as well as 
resulting in a 50% reduction in the number of beads per length and a statistically 
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significant decrease in normalized beading in the fraction of cells that presented with 
beads (Figure 42).  
 
Figure 42. Antioxidant treatment with glutathione (GSH) reduces axonal beading after increasing membrane permeability with 
saponin. Cells were incubated in 0.01% saponin and 1mM GSH for 15 minutes after being pre-treated with 1mM GSH for 60 minutes. 
A, GSH added with saponin reduces the percent of beaded cells compared to saponin treatment alone. B, Saponin treated cells 
show significantly more beads than the control or GSH sham cells. (Kruskal-Wallis test followed by Dunn’s Multiple Comparison 
Test, p<0.01, n>65 cells from three experiments). C, In cells that present at least one bead, cells treated with saponin and GSH have 
significantly less beading than cells treated with saponin alone ( Mann Whitney test, p<0.01,  n≥35 cells from three experiments). 
All values are presented as means ± SEM. 
 
Saponin + Catalase 
Having established that oxidative stress is playing a role in saponin-induced axonal 
beading, the contribution of hydrogen peroxide after saponin treatment was investigated 
using catalase. When catalase was added to saponin-treated cells, it was not found to be 
neuroprotective. Pre-treatment with catalase before the addition of saponin resulted in 
an increased percentage of beaded cells as well as increased beading in the overall cell 
population, but did not change beading in cells that presented with beads (Figure 43). 
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Figure 43. Antioxidant treatment with catalase does not reduce axonal beading after increasing membrane permeability with 
saponin. Cells were incubated in 0.01% saponin after pre-incubation with 100 µg/ml catalase for 60 minutes. A, Catalase added 
with saponin increases the percentage of beaded cells compared to saponin treatment alone. B, Cells treated with saponin and 
catalase show significantly more beading than the control or catalase treated cells, as well as cells treated with saponin alone. 
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.001, n>55 cells from three experiments). C, In cells that 
present at least one bead, cells treated with saponin and catalase do not have less beading than cells treated with saponin alone ( 
Mann Whitney test, p>0.05,  n>20 cells from three experiments). All values are presented as means ± SEM. 
 
Melittin + Glutathione 
The contribution of oxidative stress to beading after membrane damage was also 
investigated using melittin to permeabilize the membrane, which may result in a different 
type of membrane permeability than saponin. Melittin is thought to result in smaller 
protein-lined pores that can allow for ion flux but not protein exchange.  Neurons were 
pre-incubated in 1mM GSH for 60 minutes before the addition of 50nM melittin for 20 
minutes. The presence of GSH halved the percentage of beaded cells (from 56% to 28%) 
and the number of beads per length compared to melittin treatment alone by more than 
half. Then number of beads per length in the fraction of cells that presented with beads 
was reduced from an average of 0.035 beads/µm to 0.024 beads/µm (Figure 44).  
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Figure 44. Antioxidant treatment with glutathione (GSH) reduces beading after increasing membrane permeability with melittin. 
Cells were incubated in 50nM melittin and 1mM GSH for 20 minutes. A, GSH added with melittin reduces the percent of beaded 
cells compared to melittin treatment alone. B, Melittin treated cells show significantly more beading than the control or GSH sham 
cells. (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.001, n>65 cells from three experiments). C, In cells that 
present at least one bead, cells treated with melittin and GSH have significantly less beading than cells treated with melittin alone 
( Mann Whitney test, p<0.01,  n>15 cells from three experiments). All values are presented as means ± SEM. 
 
Melittin + Catalase 
Having established that oxidative stress is playing a role in melittin-induced 
beading, contribution of hydrogen peroxide specifically was investigated using catalase. 
Neurons were pre-treated with 100µg/ml catalase for 60 minutes before the addition of 
100nM melittin for 15 minutes. The presence of catalase reduced the percentage of 
beaded cells from 34% to 20% and brought beading in the overall population back to 
baseline levels as well as showing reducing the number of beads per length in the fraction 
of beaded cells by over 50% (Figure 45).  
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Figure 45. Antioxidant treatment with catalase reduces axonal beading after increasing membrane permeability with melittin. Cells 
were incubated in 100nM melittin for 15 minutes after pre-incubation with 100 µg/ml catalase for 60 minutes. A, Catalase added 
with melittin reduces the percentage of beaded cells compared to melittin treatment alone. B, Melittin treated cells show 
significantly more beading than the control or catalase treated cells. Adding catalase brings beading back to baseline levels. 
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.05, n>75 cells from three experiments). C, In cells that 
present at least one bead, cells treated with melittin and catalase do not have significantly less beading than cells treated with 
melittin alone ( Mann Whitney test, p<0.0001,  n≥15 cells from three experiments). All values are presented as means ± SEM. 
 
3.3.5 Contribution of Intracellular Calcium to Axonal Pathology 
An increase in cytosolic calcium is seen after neuronal injury. This calcium can 
come from two sources; the influx of extracellular calcium or the release of intracellularly 
sequestered calcium.  The intracellular calcium is found mostly sequestered in the 
mitochondria and endoplasmic reticulum.  In the hypothesized pathway (Figure 1) 
calcium release from both sources plays a role in axonal pathology. Here, we investigate 
the role of intracellular calcium by creating isolated perturbations in the cell and chelating 
intracellular calcium using BAPTA-AM.  
CCCP + BAPTA 
Mitochondria represent a significant source of intracellular calcium. They buffer 
excess calcium, but when damaged they release the calcium that they have sequestered. 
CCCP treatment was shown to result in an increase in cytosolic calcium (Figure 30) and it 
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is hypothesized that this increased calcium leads to CCCP-induced beading (Figure 27). 
Therefore, chelating intracellular calcium should be neuroprotective. To investigate the 
contribution of intracellular calcium to axonal beading after mitochondrial injury, BAPTA-
AM was used to chelate intracellular calcium when damaging mitochondria with CCCP.  
Chelating intracellular calcium with BAPTA reduced the percentage of beaded cells from 
92% to 54% and brought the number of beads per length back to baseline levels as well 
as reducing beading in the fraction of cells that presented with beads (Figure 46).  
 
Figure 46. Chelating intracellular reduces axonal beading after CCCP treatment. Cells were incubated in 100µM CCCP after 
pretreatment with 100µM BAPTA-AM for 10 minutes A, BAPTA-AM reduces the percent of beaded cells compared to CCCP 
treatment alone. B, CCCP treated cells show significantly more beads than the control or BAPTA-AM treated cells. Pre-incubating 
cells with BAPTA-AM before CCCP treatment results in significantly less beading than CCCP treatment alone. (Kruskal-Wallis test 
followed by Dunn’s Multiple Comparison Test, p<0.0001, n>70 cells from three experiments). C, In cells that present at least one 
bead, cells pre-treated with BAPTA-AM have significantly less beading after treatment with CCCP than that were not pretreated( 
Mann Whitney test, p<0.0001,  n>35 cells from three experiments). All values are presented as means ± SEM. 
 
TbHp + BAPTA 
Increased oxidative stress plays into a positive feedback loop with mitochondria, 
damaging the mitochondria and resulting in even more oxidative stress. Damaged 
mitochondria are hypothesized to contribute to axonal pathology through a multitude of 
pathways, including the release of sequestered calcium.  Therefore, one of the ways in 
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which increased oxidative stress is thought to lead to axonal beading is through the 
release of sequestered intracellular calcium.  To test the contribution of oxidative-stress 
induced intracellular calcium release to axonal pathology, BAPTA-AM was used to chelate 
intracellular calcium after inducing oxidative stress with TbHp.  Intracellular calcium was 
chelated by pre-incubating neuronal cultures in 10µM BAPTA-AM for 20 minutes before 
the addition of 200mM TbHp for 40 minutes. The chelation of intracellular calcium 
resulted in a 50% reduction in the percentage of beaded cells and brought the number of 
beads per length back to baseline levels, as well as reducing the number of beads per 
length in the fraction of beaded cells by over 50% (Figure 47). 
 
Figure 47. Chelating intracellular calcium reduces axonal beading after increasing oxidative stress with TbHp. Cells were incubated 
in 200mM TbHp for 40 minutes after being pre-incubated in 10µM BAPTA-AM for 20 minutes.  A, BAPTA-AM reduces the percent 
of beaded cells compared to TbHp treatment alone. B, TbHp treated cells show significantly more beads than the control or BAPTA-
AM treated cells. Pre-incubating cells with BAPTA-AM before TbHp treatment results in significantly less beading than TbHp 
treatment alone.  (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.0001, n≥85 cells from three experiments). 
C, In cells that present at least one bead, cells pre-treated with BAPTA-AM have significantly less beading after treatment with TbHp 
than that were not pretreated (Mann Whitney test, p<0.0001,  n ≥ 45 cells from three experiments. ) All values are presented as 
means ± SEM. 
 
A23187 + BAPTA 
Permeabilizing the cell membrane results in an influx of extracellular calcium that 
damages the mitochondria and results in the release of sequestered mitochondrial 
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calcium. To investigate the role that intracellular calcium release plays when extracellular 
calcium is introduced inside the cell in the absence of membrane permeabilization BAPTA-
AM was used to chelate intracellular calcium while inducing calcium influx with calcium 
ionophore A23187. BAPTA-AM did not reduce beading levels in ionophore treated cells 
(Figure 48). 
 
Figure 48. Chelating intracellular calcium does not reduce axonal beading after increasing intracellular calcium with A23187. Cells 
were incubated in 10µM A23187 after being pre-incubated in 10µM BAPTA-AM for 20 minutes.  A, BAPTA-AM does not reduce the 
percent of beaded cells compared to A23187 treatment alone. B, A23187 treated cells show significantly more beads than the 
control or BAPTA-AM treated cells. Pre-incubating cells with BAPTA-AM before A23187 treatment does not result in less beading 
than A23187 treatment alone.  (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p>0.05, n≥75 cells from three 
experiments). C, In cells that present at least one bead, cells pre-treated with BAPTA-AM do not have less beading after treatment 
with A23187 than thosethat were not pretreated (Mann Whitney test, p>0.05,  n>65 cells from three experiments). All values are 
presented as means ± SEM. 
 
Saponin + BAPTA 
Permeabilizing the membrane results in an influx of extracellular calcium. 
Mitochondria attempt to sequester this calcium, but once damaged release the calcium 
they have sequestered. To investigate the contribution of the intracellular calcium release 
to axonal pathology, BAPTA-AM was used to chelate intracellular calcium while 
90 
 
 
 
permeabilizing the cell membrane with saponin (Figure 49). Chelating intracellular 
calcium with BAPTA-AM did not mitigate axonal beading 
 
Figure 49. Chelating intracellular calcium reduces axonal beading after saponin treatment does not reduce axonal beading. Cells 
were incubated in 0.01% Saponin after being pre-incubated in 10 µM BAPTA-AM for 20 minutes.  A, BAPTA-AM slightly reduces 
the percent of beaded cells compared to saponin treatment alone. B, Saponin treated cells show significantly more beads than 
the control or BAPTA-AM treated cells. Pre-incubating cells with BAPTA-AM before saponin treatment results in significantly less 
beading than saponin treatment alone.  (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p>0.05, n≥75 cells 
from three experiments). C, In cells that present at least one bead, cells pre-treated with BAPTA-AM do not have less beading 
after treatment with saponin than that were not pretreated (Mann Whitney test, p>0.05,  n>35 cells from three experiments). All 
values are presented as means ± SEM. 
 
Melittin + BAPTA 
The role that intracellular calcium release plays after membrane damage was also 
investigated using melittin to increase membrane permeability. Cells were pre-incubated 
in 10 µM BAPTA-AM for 20 minutes before the addition of 50nM melittin for 20 minutes. 
The presence of BAPTA reduced the percentage of beaded cells by more than 50%, as well 
as reducing beading in the overall population by over 50% and reducing beading in the 
fraction of cells that present with beads (Figure 50).   
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Figure 50. Chelating intracellular calcium reduces axonal beading after melittin treatment. Cells were incubated in 50nM melittin 
after being pre-incubated in 10 µM BAPTA-AM for 20 minutes.  A, BAPTA-AM reduces the percent of beaded cells compared to 
melittin treatment alone. B, Melittin treated cells show significantly more beads than the control or BAPTA-AM treated cells. Pre-
incubating cells with BAPTA-AM before melittin treatment results in significantly less beading than melittin treatment alone.  
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.05, n≥50 cells from three experiments). C, In cells that 
present at least one bead, cells pre-treated with BAPTA-AM have significantly less beading after treatment with melittin than that 
were not pretreated (Mann Whitney test, p<0.05,  n>20 cells from three experiments. ) All values are presented as means ± SEM. 
 
3.3.5 Calcium Contribution 
CCCP + EGTA 
As part of the hypothesized pathway (Figure 1), damaged mitochondria release 
sequestered calcium. CCCP treatment to disrupt mitochondrial results in an increase in 
axonal calcium (Figure 30). To investigate the source of the calcium, EGTA was used to 
chelate extracellular calcium and prevent extracellular calcium influx. When EGTA was 
used in conjunction with CCCP, the calcium increase was prevented (Figure 51).  
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TbHp + EGTA 
Increased oxidative stress is thought to contribute to increased cytosolic calcium 
through multiple mechanisms: first, the release of mitochondrially sequestered calcium 
and second, the influx of extracellular calcium after lipid-peroxidation induced secondary 
membrane damage. To test this hypothesis, TbHp was used to increase oxidative stress 
and EGTA was used to chelate extracellular calcium. The results showed that TbHp 
treatment resulted in increased axonal calcium compared to control cells, and that adding 
EGTA to TbHp treated cells reduced the increase in calcium but that it was still statistically 
higher than controls (Figure 52).  
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* * Figure 51. Quantification of cytosolic calcium after CCCP 
treatment Neurons treated with 100µM CCCP for 60 minutes 
exhibit a significantly greater change in axonal calcium than 
control or EGTA-treated cells (p<0.001). When 1mM EGTA is 
added in addition to CCCP treatment the axonal calcium ratio is 
significantly greater than the EGTA controls (p<0.01). (Kruskal-
Wallis followed by Dunn’s multiple comparison test, n>20 cells for 
each condition). All values are presented as means ± SEM. 
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3.3.3 Contribution of the Mitochondrial Permeability Pore 
Excess intracellular calcium is buffered by mitochondria which can sequester it up 
to a certain point. When mitochondria are overloaded with calcium, they release the 
sequestered calcium through an opening of the MPP, which can open in either a regulated 
or unregulated fashion. Cyclosporin A has been shown to prevent the regulated opening 
of the MPP.  To investigate the contribution of regulated MPP opening, Cyclosporin A was 
used to prevent the regulated MPT while adding a chemical insult to neurons.  Axonal 
beading was quantified as a measure of the extent of neuronal damage.   
CCCP + CsA 
Damage to the mitochondria is hypothesized to result in an opening of the MPP, 
which contributes to beading through a release of sequestered calcium and a 
continuation of the hypothesized injury pathway. In order to test for the contribution of 
the MPT pore to beading after mitochondrial injury, CsA was added with CCCP to disturb 
Axonal Calcium: TbHp + EGTA
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Figure 52. Neurons treated with 100mM TbHp for 30 minutes exhibit a 
significantly greater change in axonal calcium than control or EGTA-
treated cells. When 1mM EGTA is added in addition to TbHp treatment the 
axonal calcium ratio is reduced but still remains higher than control values. 
(One-way ANOVA followed by Tukey’s multiple comparison test. 
p<0.0001, n>25 cells for each condition). All values are presented as means 
± SEM. 
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mitochondrial function and prevent the opening of the MPP (Figure 53). CsA treatment 
was shown to reduce beading in CCCP treated cells.  
 
Figure 53. Preventing the opening of the mitochondrial permeability pore with Cyclosporin A (CsA) reduces axonal beading after 
damaging mitochondria with CCCP. Cells were incubated in 100µM CCCP and 1µM CsA for 60 minutes. A, CsA reduces the percent 
of beaded cells compared to CCCP treatment alone. B, CCCP treated cells show significantly more beads than the control or CsA 
treated cells. Adding CsA to CCCP treated cells results in significantly less beading than CCCP treatment alone. (Kruskal-Wallis test 
followed by Dunn’s Multiple Comparison Test, p<0.001, n>80 cells from three experiments). C, In cells that present at least one 
bead, cells treated with CsA and CCCP do not have significantly less beading after treatment with saponin alone( Mann Whitney 
test, p<0.01,  n>35 cells from three experiments). All values are presented as means ± SEM. 
 
TbHp + CsA 
Increased oxidative stress is hypothesized to lead to beading through a variety of 
pathways. One is through inducing lipid peroxidation in the plasma membrane which in 
turn results in increased membrane permeability and a loss of ionic homeostasis, 
including an influx of calcium which can overload and destabilize mitochondria as well as 
activate proteases that lead to beading. Another posited theory for the contribution of 
oxidative stress to beading is direct damage to the mitochondria and induction of the 
MPT, which results in a release of sequestered calcium. To test for the contribution of the 
MPT to beading, oxidative stress was increased using TbHp and the regulated opening of 
the MPT was prevented using CsA. CsA reduced the percentage of beaded cells from 66% 
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to 49% which accounts for a statistically significant reduction in beads per length in the 
entire population, but no change in beading when looking at the fraction beaded (Figure 
54).  
 
Figure 54. Preventing the regulated opening of the mitochondrial permeability pore with Cyclosporin A (CsA) reduces axonal 
beading after increasing oxidative stress with TbHp. Cells were incubated in 100mM TbHp and 1µM CsA for 30 minutes A, CsA  
reduces the percent of beaded cells compared to TbHp treatment alone. B, TbHp treated cells show significantly more beads than 
the control or CsA treated cells. Adding CsA to TbHp treated cells results in significantly less beading than TbHp treatment alone. 
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.05, n≥80 cells from three experiments). C, In cells that 
present at least one bead, cells treated with CsA and  TbHp do not have significantly less beading after treatment with TbHp alone( 
Mann Whitney test, p<0.01,  n>40 cells from three experiments). All values are presented as means ± SEM. 
 
Saponin + CsA 
An increase in membrane permeability results in a loss of ionic homeostasis which 
the cell has to work to restore in an energy-dependent manner, taxing the mitochondria 
which produce that energy. The loss of ionic homeostasis also results in an influx of 
calcium which can overload the mitochondria and lead to an opening of the mitochondrial 
permeability pore. This sort of mitochondrial disruption results in a bioenergetics crisis, 
releases sequestered calcium, and increases oxidative stress. To investigate the role that 
the MPT plays after membrane injury, Cyclosporin A was used to prevent regulated MPP 
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opening after membrane permeabilization with saponin.  CsA reduced the percentage of 
beaded cells and brought the number of beads per length back to baseline levels.  
 
Figure 55. Preventing the regulated opening of the mitochondrial permeability pore with Cyclosporin A (CsA) reduces axonal 
beading after membrane poration with saponin. Cells were incubated in 0.01% saponin and 1µM CsA for 20 minutes A, CsA reduces 
the percent of beaded cells compared to saponin treatment alone. B, Saponin treated cells show significantly more beads than the 
control or CsA treated cells. Adding CsA to saponin treated cells results in significantly less beading than saponin treatment alone. 
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.001, n>80 cells from three experiments).  All values are 
presented as means ± SEM. 
 
Melittin + CsA 
The contribution of the MPT to axonal beading after membrane damage was also 
investigated using melittin to permeabilize the membrane and CsA to prevent the 
regulated opening of the MPP. Pre-treatment with CsA reduced the percentage of beaded 
cells by 50% and brought the number of beads per length back to baseline levels as well 
as resulting in a statistically significant decrease in beading in the fraction of beaded cells 
(Figure 56).  
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Figure 56. Preventing the regulated opening of the mitochondrial permeability pore with Cyclosporin A (CsA) reduces axonal 
beading after membrane poration with melittin. Cells were incubated in 100nM melittin and 1µM CsA for 15 minutes A, CsA reduces 
the percent of beaded cells compared to melittin treatment alone. B, Melittin treated cells show significantly more beads than the 
control or CsA treated cells. Adding CsA to melittin treated cells results in significantly less beading than melittin treatment alone 
and shows no difference from control cells. (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.01, n>80 cells 
from three experiments). C, In cells that present at least one bead, cells treated with CsA and melittin have significantly less beading 
than treatment with melittin alone (Mann Whitney test, p<0.01, n≥14 cells from three experiments). All values are presented as 
means ± SEM. 
 
A23187 + CsA 
If a regulated opening of the MPP is contributing to beading when intracellular 
calcium is increased, then preventing that opening should reduce downstream effects 
including axonal beading.  In order to explore the contribution of the MPP, intracellular 
calcium was increased with calcium ionophore A23187 and the regulated opening of the 
MPP was prevented using CsA. When CsA was used in conjunction with A23187 there was 
no statistically significant change in beading in the overall cell population and the number 
of beads in beaded cells was actually increased (Figure 57).  
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Figure 57. Preventing the regulated opening of the mitochondrial permeability pore with Cyclosporin A (CsA) does not reduce axonal 
beading after increasing intracellular calcium with calcium ionophore A23187. Cells were incubated in 10 µM and 1 µM CsA for 20 
minutes. A, CsA does not reduce the percent of beaded cells compared to A23187 treatment alone. B, A23187 treated cells show 
significantly more beads than the control or CsA treated cells. Adding CsA to A23187 treated cells does not result in less beading 
than A23187 treatment alone. (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p>0.05, n≥80 cells from three 
experiments). C, In cells that present at least one bead, cells treated with CsA and A23187 have significantly more beading after 
treatment with A23187 alone (Mann Whitney test, p<>0.05, n>70 cells from three experiments). All values are presented as means 
± SEM. 
 
 
4.4 Discussion 
It is hypothesized that mitochondrial dysfunction, secondary to mechanical 
trauma, plays an important role in axonal pathology in TBI. Consistent with that 
hypothesis, directly impairing mitochondrial function with CCCP without preceding 
mechanical damage CCCP resulted in axonal beading (Figure 28), focal disruptions in 
microtubules (Figure 31) and increased intracellular calcium (Figure 29,Figure 30), 
consistent with in vivo axonal pathologies seen in TBI. They are consistent with 
experiments by Werth and Vaur which showed increased intracellular calcium after CCCP 
treatment (Werth and Thayer 1994, Vaur, Sartor et al. 2000).  The expectation here was 
that disrupting mitochondrial function with CCCP would cause calcium release from 
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mitochondria that could lead to plasma damage and the influx of extracellular calcium. 
To inspect the source of CCCP-induced axonal calcium, relative axonal calcium levels were 
quantified using EGTA to chelate extracellular calcium and showed that when EGTA was 
present in the extracellular media intracellular calcium levels were decreased but were 
still significantly higher than EGTA controls (Figure 50), implying a dual source of cytosolic 
calcium increase. These findings are consistent with those of Vaur who concluded that 
CCCP activated calcium influx from the extracellular medium(Vaur, Sartor et al. 2000) as 
well those of Werth which indicated that CCCP treatment resulted in a release of calcium 
from the mitochondria(Werth and Thayer 1994). 
In the hypothesized pathway (Figure 1), increased oxidative stress damages the 
mitochondria and increases membrane permeability via lipid peroxidation. This results in 
an increase of axonal calcium via both the release of mitochondrially sequestered calcium 
and an influx of calcium from the extracellular media. Increasing the oxidative stress of 
the cells using the hydrogen peroxide donor TbHp resulted in beading (Figure 32), focal 
disruption of microtubules (Figure 37) and increased axonal calcium (Figure 35,Figure 36) 
consistent with this hypothesis. Chelation of extracellular calcium with EGTA partially 
inhibited the cytosolic calcium increase in response to TbHp (Figure 48).  When compared 
to A23187 treatment where the only calcium source was extracellular (Figure 21) this 
provides support for the conclusion that TbHp causes both intracellular release of calcium 
as well as influx from the extracellular space. These findings are consistent with those of 
others that showed that treatment with  hydrogen peroxide treatment resulted in 
beading(Lim, Lee et al. 2002, Roediger and Armati 2003) and microtubule disruption and 
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that increasing oxidative stress via TbHp treatment results in increased intracellular 
calcium (Kanupriya, Prasad et al. 2007).  
The antioxidant glutathione was used to investigate the role of oxidative stress in 
axonal pathology after various isolated injuries.  It is hypothesized that membrane injury, 
increased intracellular calcium, and mitochondrial damage each lead to an increase in 
oxidative stress.  Therefore, reducing the increase in oxidative stress with an antioxidant 
should help to prevent some of the downstream effects.  This proved to be the case as 
glutathione prevented beading when mitochondria were targeted with CCCP (Figure 38), 
intracellular calcium was increased with calcium ionophore A23187 (Figure 40), and 
membrane permeability was increased using saponin(Figure 42) and melittin(Figure 44). 
The success of glutathione in preventing beading after these treatments provides 
evidence that oxidative stress is playing a role in the downstream pathology.   Others have 
also shown that oxidative stress is increased under these isolated perturbations of the 
damage pathway.  Bonfoco et al showed that calcium overload of mitochondria leads to 
the generation of superoxide anion O2.- (Bonfoco, Krainc et al. 1995).  
To further probe the type of oxidative stress, the antioxidant catalase was also 
used in conjunction with these chemical insults. Since catalase is an antioxidant specific 
to hydrogen peroxide, the effectiveness of catalase in preventing beading would show 
that hydrogen peroxide is contributing significantly to downstream pathology. Catalase 
was indeed effective in preventing beading when mitochondria were targeted with CCCP 
(Figure 39), intracellular calcium was increased with calcium ionophore A23187 (Figure 
41), and membrane permeability was increased using melittin (Figure 45). Surprisingly, 
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catalase was not neuroprotective when membrane permeability was increased using 
saponin (Figure 43) and in fact resulting in a statistically significant increase in beading. 
This is in stark contradiction to melittin, the other method used to permeabilize the 
membrane. Perhaps the difference between the two can be explained by the type of 
membrane permeabilization and possible size of pores. Melittin creates smaller, possibly 
transient pores that likely allow for ion exchange but not the flow of larger molecules. 
Catalase is not permeable to intact membranes (Schimmel and Bauer 2002) and has a 
stoke’s radius of 5.12 nm. It is possible that larger and more prolonged membrane 
poration with saponin could allow for the influx of catalase into the cell. Here, instead of 
reducing extracellular hydrogen peroxide catalase may be interacting directly with 
mitochondria.   
In neurons, the primary source of ROS is from mitochondria, which are also one of 
the primary sources of intracellular calcium. Increased oxidative stress damages the 
mitochondria and also results in the release of sequestered calcium. To investigate the 
role that intracellular calcium plays in axonal pathology, intracellular calcium was 
chelated using BAPTA-AM. BAPTA-AM reduced beading caused by damaging 
mitochondria with CCCP (Figure 46), increasing oxidative stress with TbHp (Figure 47), and 
increasing membrane permeability with melittin (Figure 50), indicating that intracellular 
calcium plays a significant role in downstream pathology after these treatments.  
Chelating intracellular calcium was not neuroprotective when intracellular calcium was 
increased using calcium ionophore A23187 to allow for the entry of extracellular calcium 
(Figure 48). This was the expected result because intracellular calcium release is small 
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compared to the amount of calcium that is constantly introduced into the cell due to 
ionophore treatment. 
Cytosolic calcium has been shown to be increased after TBI. Understanding the 
source of this calcium is important to understanding the pathways and mechanisms of 
axonal pathology after brain injury. Cytosolic calcium can be increased by either entering 
the cell from the extracellular media or being released from intracellular sources such as 
the mitochondria or endoplasmic reticulum.  To investigate the source of the increased 
cytosolic calcium, extracellular calcium was chelated using EGTA and live calcium imaging 
was performed to quantify relative changes in calcium before and after treatment.   
The release of sequestered mitochondrial calcium is said to occur due to a change 
in mitochondrial permeability due to the opening of the MPP. To test the contribution of 
the MPT, the regulated opening of the MPP was prevented using Cyclosporin A. 
Neuroprotective effects of CsA were interpreted as evidence that the MPT was occurring.  
CsA treatment reduced beading caused by disrupting mitochondria with CCCP, indicating 
that the MPT is playing a role in beading with CCCP treatment.  Niemenin et al. have tried 
observing calcein entry into mitochondria as an indicator of the MPT but concluded that 
CCCP depolarized mitochondria but did not induce a permeability transition on its own 
(Nieminen, Saylor et al. 1995).  These conflicting results may be due to differences in 
concentrations and timing of reagents used, or differences in mitochondria due to cell 
types, as mitochondria from different cells may behave differently(Andreyev and Fiskum 
1999).  Niemenin et al used cultured hepatocytes and used 10µM CCCP for less than 20 
minutes, compared to the 100µM treatment for 60 minutes that is used here.  
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CsA treatment was neuroprotective when oxidative stress was increased with 
TbHp (Figure 54), indicating that the MPT is occurring when oxidative stress is increased. 
This has also been shown by Niemenin at all who observed that after the addition of TbHp 
mitochondria quickly filled with Calcein, indicating the onset of the MPT(Nieminen, Saylor 
et al. 1995), even at a lower concentration of 100µM. Imberti et al also showed that TbHp 
treatment uncoupled mitochondria, an event they associated with an MPT and showed 
that CsA protected against mitochondrial depolarization and cell death(Imberti, Nieminen 
et al. 1993).  
CsA treatment was neuroprotective when increasing membrane permeability with 
saponin and melittin. This indicates that regulated opening of the MPP is happening 
downstream of increased membrane permeability and that is contributing significantly to 
axonal beading.  
CsA treatment was not neuroprotective when increasing intracellular calcium with 
calcium ionophore A23187. This indicates that A23187 is not resulting in MPT, or that the 
MPT is occurring in a fashion that is not mitigated by CsA. However, many others have 
shown that calcium ionophore A23187 specifically is capable of inducing the MPT 
(Petersen, Castilho et al. 2000). If the MPT is occurring here, it is possible that it involves 
an unregulated pore opening that does not require calcium for conductance and is not 
blocked by CsA(Kim, He et al. 2003).  This is the most likely scenario as it is well established 
that increased calcium results in an MPT, and specifically that it can occur following 
exposure to calcium ionophore.  The contradictions between these results may be 
explained by differences in concentrations of ionophore used. For example, Peterson et 
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al showed MPT induction that was mitigated with CsA while using concentrations of 
A1287 that ranged from 0.1 – 4 µM, which is much less than the 10 µM used in these 
experiments.  
Further evidence of MPP involvement in TBI may be found in in vivo models using 
CsA that have shown it to be neuroprotective.  In vivo CsA preserved mitochondrial 
function (Okonkwo, Buki et al. 1999) and reduced cortical cell loss. Importantly, CsA has 
been shown to promote functional recovery, including motor and cognitive function 
(Alessandri, Rice et al. 2002). In vitro, CsA has been shown to be neuroprotective by 
delaying axotomy after axonal stretch injury (Staal, Dickson et al. 2007). Evidence for CsA 
neuroprotection is so strong that it has even been suggested to be responsible for the 
relatively mild neurological impairment suffered by a TBI patient who had been 
undergoing treatment with CsA for its immunosuppressive properties at the time of his 
injury(Gogarten, Van Aken et al. 1998). 
Brain injury is not the only neurological condition involving mitochondrial 
dysfunction or oxidative stress. Other diseases that involve energy deficits and increased 
oxidative stress as a result of mitochondrial damage include Alzheimer’s disease, 
Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease, and Freidrich’s 
ataxia(Simpkins, Yi et al. 2010). Thus, understanding the role that mitochondria and 
oxidative stress can play in TBI pathology may also lead to advancements in treating these 
other neurological disorders.  
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Chapter 5: The Role of Secondary Membrane Damage in Axonal 
Pathology 
5.1 Background 
5.1.1 Secondary Membrane Disruption 
Immediately following a traumatic insult to the brain, the plasma membrane of 
neurons is disrupted and potentiates detrimental processes which lead to cell death and 
dysfunction(LaPlaca, Prado et al. 2009). Membrane disruption has been identified as one 
of the earliest events after experimental traumatic brain injury (Pettus, Christman et al. 
1994, Povlishock, Marmarou et al. 1997, Shi and Borgens 2000, Borgens 2001). This 
membrane disruption can be transient, permanent, or delayed (Farkas, Lifshitz et al. 
2006). As membrane disruption is hypothesized to be a precursor to all events in the 
injury pathway, it is an important therapeutic target to prevent downstream pathologies. 
However, if membrane damage only occurs as a result of mechanical trauma at the time 
of injury the therapeutic time window for membrane protection may be unfeasibly small. 
However, if secondary membrane damage is also occurring after the initial 
mechanoporation, there may be hope for the therapeutic potential of plasma membrane 
repair at later time points.  
There is some evidence in vivo for the occurrence of secondary membrane 
damage. In a rat model of head injury, it was noted that persistently elevated intracranial 
pressure post-injury was associated with chronic membrane poration (Lafrenaye, McGinn 
et al. 2012).  In vivo experiments using permeability markers delivered after injury have 
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also noted that increased membrane permeability may not be limited to the moment of 
injury. These experiments include controlled cortical impact models in mice (Whalen, 
Dalkara et al. 2008) and impact acceleration models in rates (Koob, Duerstock et al. 2005, 
Farkas, Lifshitz et al. 2006). 
5.1.2 Lipid Peroxidation in Traumatic Brain injury 
Oxygen radical-mediated lipid peroxidation has been suggested to be an 
important factor in posttraumatic neuronal degeneration (Braughler and Hall 1992, Hall, 
Yonkers et al. 1992). TBI has been shown to result in a rapid, and sometimes biphasic, 
increase in lipid peroxidation (Marmarou, Foda et al. 1994, Promyslov and Demchuk 1995, 
Hsiang, Yeung et al. 1997, Sullivan, Keller et al. 1998, Vagnozzi, Marmarou et al. 1999). 
Lipid peroxidation leads to perturbations of the plasma membrane that increase 
membrane permeability (Girotti 1985).  
5.1.3 Cell Membrane Repair by Poloxamer 188  
Poloxamer 188 (P188) is a compound that has membrane-protecting properties.  
It is a tri-block copolymer that consists of two hydrophilic polyethylene oxide chains 
flanking a central hydrophobic polyoxypropylene molecule(Moghimi and Hunter 2000). It 
has been shown to rescue cells from many membrane-damaging insults such as ionizing 
radiation(Hannig, Zhang et al. 2000), thermal damage(Padanilam, Bischof et al. 1994), 
electroporation(Lee, River et al. 1992, Sharma, Stebe et al. 1996), and shear stress 
injury(Kilinc, Gallo et al. 2007) by interacting with the cell membrane(Marks, Pan et al. 
2001, Maskarinec and Lee 2003). P188 prevents axonal beading and reduces membrane 
permeability in a mechanical shear stress model of axonal injury in chick forebrain 
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neurons(Kilinc, Gallo et al. 2007) . P188 has also been shown to successfully rescue 
neurons from NMDA injury (Marks, Pan et al. 2001).  Because of its ability to seal damaged 
membranes P188 is a potential therapeutic as well as a tool to investigate the 
contribution of membrane damage to cellular degeneration after injury. The role of P188 
as a therapeutic agent will be dependent on the time window during which membrane 
damage is occurring and can be reversed.   
Poloxamers are triblock copolymers made of poly(ethylene glycol)-
poly(polypropylene glycol))-poly(ethyleneglycol).   Polaxamers are synthesized by the 
sequential addition first of propylene oxide and then ethylene oxide to a low molecular 
weight water-soluble organic compound, propylene glycol.  The hydrophobic portion is 
the inner polyoxypropylene glycol which changes from a water soluble to a water-
insoluble polymer as the molecular weight goes above 750(Schmolka 1977).  Poloxamers 
are non-ionic surfactants that currently have many approved medical applications, 
including uses as food additives, stool softeners, wound cleansers, emulsifying agents in 
intravenous fat emulsions, organ perfusates, and enhancing drug delivery. They have also 
been shown to be therapeutic in situations where the cell membrane may be disrupted 
or permeabilized such as radiation injury, thermal burns, frostbite, reperfusion injury, 
spinal cord injury and electrical shock (Schmolka 1977, Maskarinec and Lee 2003, 
Borgens, Bohnert et al. 2004, Curry, Wright et al. 2004).  Poloxamers with different 
hydrophilic: hydrophobic ratios have different properties and poloxamers with low 
hydrophilic: hydrophobic ratios have been shown to destabilize membranes(Moghimi and 
Hunter 2000). 
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5.1.4 Hypothesis and Summary of Experiments 
In the hypothesized injury pathway, secondary membrane damage can occur after 
the initial mechanoporation of the membrane as a consequence of lipid peroxidation due 
to increased oxidative stress. This increase in oxidative stress is presumed to come about 
as a result of mitochondrial dysfunction, which occurs when mitochondria are overloaded 
with sequestered calcium.    
To test whether secondary membrane damage can occur downstream of the 
injury pathway, axonal membrane permeability measurements were made after 
increasing axonal calcium, damaging mitochondria, and increasing oxidative stress. To see 
if this membrane damage could be treated by P188, P188 was added to the treatment 
solutions and axonal beading was quantified. Lastly, lipid peroxidation measurements 
were made to investigate the mechanism of secondary membrane damage, lipid 
peroxidation measurements were made.  
5.2 Materials and Methods 
5.2.1 Measurement of Lipid Peroxidation 
Lipid Peroxidation measurements were made using Molecular Probes® Image-iT® 
Lipid Peroxidation Kit for live cell analysis. The reagent localizes to the cell membrane and 
displays a shift in peak fluorescence emission from ~590 nm (Red) to ~510 nm (Green) 
when it is oxidized by lipid hydroperoxides. This oxidation-dependent emission shift 
enables ratiometric fluorescence imaging of lipid hydroperoxides in live cells.  
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The Molecular Probes® protocol was adapted to measure lipid peroxidation in 
axons. Neurons in video dishes were incubated with 1mM of the Lipid Peroxidation Sensor 
for 30 minutes at 37°C. Cells were rinsed three times and baseline fluorescence images 
were taken using an excitation/emission of 581/591 nm (Texas Red® filter set) for the 
reduced dye, and the other at excitation/emission of 488/510 nm (traditional FITC filter 
set) for the oxidized dye.  Treatment was then added and a second fluorescence image 
was taken after the allotted treatment time.  
To quantify changes in lipid peroxidation, ImageJ was used to measure the total 
integrated axonal fluorescence intensity at each wavelength for each image.  The ratio of 
Green: Red fluorescence was calculated for each image, and the fold change for each axon 
was calculated by normalizing by the baseline fluorescence ratio.  
 
 
5.2.2 Cell membrane repair with P188 
 P188 is used here both a therapeutic and investigative tool. The goals were to 
determine its capability to protect membrane integrity and to reduce axonal beading. This 
provided evidence that secondary membrane damage was occurring after isolated 
perturbations to the damage pathway and that this damage could be treated with P188.  
 P188 has been demonstrated to successfully seal permeabilized membrane 
bilayers (Maskarinec and Lee 2003). While the mechanism by which it seals damaged 
membranes is not completely understood, there is some evidence of insertion into the 
Fold Change = 
𝐺2
𝑅2−
⁄
𝐺1
𝑅1
⁄
𝐺1
𝑅1
⁄
 
Equation 8. Calculation for Fold Change measurement for Lipid Peroxidation. G1 
= Total integrated Green Fluorescence before treatment, R1 = Total integrated Red 
Fluorescence before treatment, G2 = Total integrated Green Fluorescence after 
treatment, R2 = Total integrated Red Fluorescence after treatment, 
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membrane (Marks, Pan et al. 2001). Experiments using Langmuir monolayers (Wu, 
Majewski et al. 2004) and bilayers (Wu, Majewski et al. 2005) have provided evidence 
that poloxamers can selectively insert into low lipid-density regions of membranes.  Here, 
poloxamer is used as a tool to protect membrane integrity. 
5.3 Results 
5.3.1 Increasing Intracellular Calcium Results in Increased Membrane Permeability 
To determine if membrane damage occurs downstream of increased axonal 
calcium, calcium ionophore A23187 was used to increase axonal calcium without 
preceding membrane damage. The loss of the intracellular dye Calcein Red/Orange was 
used to indicate axonal permeability. In the hypothesized pathway (Figure 1) axonal 
calcium is increased as a result of calcium influx due to membrane permeability and 
overloads the mitochondria resulting in increased oxidative stress and membrane 
damage through lipid peroxidation. Control cells lost less than 10% of their baseline 
calcein fluorescence after 30 minutes while cells treated with 10 µM A23187 lost more 
than 40% (Figure 58), indicating that increasing axonal calcium with A23187 results in 
increased membrane permeability.   
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5.3.2 Damaging Mitochondria Results in Increased Membrane Permeability 
To determine if membrane damage occurs downstream of mitochondrial damage, 
CCCP was used to damage mitochondria without primary membrane damage or increased 
axonal calcium. The loss of the intracellular dye Calcein Red/Orange was used to indicate 
axonal permeability. In the hypothesized pathway (Figure 1), damaged mitochondria 
increase the oxidative stress of the cell, leading to increased membrane permeability as 
a result of lipid peroxidation. Control cells lost less than 20% of their baseline calcein 
fluorescence after 60 minutes while cells treated with 100 µM CCCP lost almost 40% 
(Figure 59), indicating that damaging mitochondria with CCCP results in increased 
membrane permeability.   
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Figure 58. Increasing intracellular calcium with calcium ionophore 
A23187 results in increased membrane permeability. The Percent 
Calcein Loss was calculated as percentage decrease in axonal 
fluorescence intensity 20 minutes after the addition of 10 µM 
A23187. (One-tailed t-test, p <0.0001, n>20).   All values are 
presented as means ± SEM. 
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5.3.3 Increasing Oxidative Stress Results in Increased Membrane Permeability 
To determine if membrane damage occurs downstream of increased oxidative 
stress, TbHp was used to increase the oxidative stress of the cell without preceding 
mechanoporation, increased axonal calcium, or mitochondrial injury. In the hypothesized 
pathway (Figure 1), oxidative stress is increased as a result of mitochondrial damage and 
leads to increased membrane permeability through lipid peroxidation. The loss of the 
intracellular dye Calcein Red/Orange was used to indicate axonal permeability. In the 
hypothesized pathway, damaged mitochondria increase the oxidative stress of the cell, 
leading to increased membrane permeability as a result of lipid peroxidation. Control cells 
lost less than 10% of their baseline Calcein fluorescence after 60 minutes while cells 
treated with 100mM TbHp lost almost 30% (Figure 60), indicating that damaging 
mitochondria with TbHp results in increased membrane permeability.   
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Figure 59. Disrupting mitochondrial function with CCCP results in 
increased membrane permeability. Percent Calcein Loss was 
calculated as percentage decrease in axonal fluorescence 
intensity 60 minutes after the addition of 100 µM CCCP. (One-
tailed t-test, p <0.0001, n≥35).   All values are presented as means 
± SEM. 
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5.3.4 P188 Does not reduce beading After Increasing Intracellular Calcium 
In the hypothesized pathway (Figure 1), axonal calcium is increased due to 
mechanoporation after injury and leads to beading through a pathway that includes 
protease and calpain activation.  Increased axonal calcium is also hypothesized to lead to 
beading through a second, less direct pathway, through lipid peroxidation that occurs as 
a result of increased oxidative stress from mitochondria that are damaged when 
overloaded with calcium. Since beading is occurring directly downstream of increased 
axonal calcium, protecting the membrane with P188 should not eliminate beading, but it 
may slightly decrease beading due to secondary membrane damage downstream of 
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Figure 60. Increasing oxidative stress with TbHp results in increased 
membrane permeability. Percent Calcein Loss was calculated as 
percentage decrease in axonal fluorescence intensity 20 minutes 
after the addition of 100 µM TbHp. (One-tailed t-test, p <0.0001, 
n≥15).   All values are presented as means ± SEM. 
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increased axonal calcium.  When Poloxamer 188 was added in conjunction with calcium 
ionophore A23187, it did not decrease beading (Figure 61).  
 
Figure 61. P188 does not reduce axonal beading when cytosolic calcium is increased with A23187. Cells were incubated in 10µM 
A23187 and 100µM P188. A, P188 did not reduce the percent of beaded cells. B, A23187 treated cells show significantly more 
beading than controls, but P188 does not cause any change in beading levels (Kruskal-Wallis test followed by Dunn’s Multiple 
Comparison test, p>0.05, n>65 cells from three experiments) . C, In cells that present at least on bead, cells that have been treated 
with P188 in addition to A23187 show no difference in beading as compared to those treated with A23187 alone (Mann Whitney 
test, p >0.05, n≥70 cells from three experiments).   All values are presented as means ± SEM. 
 
P188 is known to help preserve membrane integrity and calcium ionophore 
treatment has been shown to disrupt membrane integrity (Figure 58), but P188 did not 
reduce axonal beading when added with calcium ionophore A23187.  This could be 
because membrane permeability per se plays a relative small contribution in beading as 
compared to increased axonal calcium, which is a major consequence of membrane 
permeability. It is also possible that the type of membrane damage induced by ionophore 
treatment cannot be prevented with P188. 
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5.3.5 P188 Does Not Reduce Increase in Membrane Permeability Associated with A23187 
Treatment 
The potential for P188 neuroprotection is premised on its ability to protect plasma 
membrane integrity. To see if P188 was able to protect membrane integrity after cytosolic 
calcium increase with A23187, P188 was added at the same time as A23187 and changes 
in membrane permeability were measured by quantifying loss of the intracellularly 
loaded dye Calcein. After 30 minutes of incubation control cells lost less than ten percent 
of their initial fluorescence while cells treated with 10 µM A23187 lost around 40% (Figure 
62). There was no change in permeability when P188 was present.  
 
5.4.6 P188 Does Not Reduce Cytosolic Calcium Increase Associated with A23187 
Treatment 
As P188 does not protect the plasma membrane from increased leakiness due to 
A23187 treatment, it would also not be expected to prevent the increase in cytosolic 
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Figure 62. A23187 treatment results in increased plasma 
membrane permeability that is not mitigated when P188 is 
present. Cells were treated with 10µM A23187 and 100µM 
P188 for 30 minutes (one-way analysis of variance followed 
by Tukey’s multiple comparison, p>0.05, n>25 cells for each 
condition). All values are presented as means ± SEM. 
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calcium. To ensure that this was the case, P188 was added at the same time as A23187 
and relative changes in cytosolic intracellular calcium were measured. Neurons were 
imaged before treatment and again after 30 minutes of treatment with µM A23187 and 
100 µM P188. A23187 treatment resulted in a four-fold increase in cytosolic calcium and 
there was no significant change when P188 was on board (Figure 63).  
 
 
5.3.7 P188 Reduces beading after Mitochondrial Dysfunction is induced with CCCP 
In the hypothesized pathway (Figure 1), mitochondrial injury leads to increased 
oxidative stress and a subsequent increase in membrane permeability due to lipid 
peroxidation.  If beading is a result of the effects of the increased membrane permeability, 
then protecting the membrane using Poloxamer 188 should reduce beading.  When CCCP 
was used to disrupt mitochondrial function, P188 was effective in reducing axonal 
beading (Figure 64). 
Calcium Ratio: A23187 + P188
C
on
tr
ol
P
18
8
A
23
18
7
A
23
18
7 
+ 
P1
88
0
1
2
3
4
5
ns
ns
***
C
a
lc
iu
m
 R
a
ti
o
Figure 63. A23187 treatment results in 
intracellular axonal calcium increase that is not 
mitigated when P188 is present. Cells were 
treated with 10 µM A23187 and 100 µM P188 
for 30 minutes (one-way analysis of variance 
followed by Tukey’s multiple comparison, 
p>0.05, n>25 cells for each condition). All values 
are presented as means ± SEM. 
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Figure 64. P188 reduces axonal beading after CCCP treatment. Cells were incubated in 100 µM CCCP and 100 µm P188. A, P188 
added with CCCP reduces the percent of beaded cells compared to CCCP treatment alone. B, CCCP treated cells show significantly 
more beads than the DMSO Control or P188 Sham. Adding P188 to the CCCP treated cells brings beading back to baseline levels 
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.001, n≥65 cells from three experiments). C, In cells that 
present at least one bead, cells treated with CCCP and P188 have significantly less beading than cells treated with CCCP alone ( 
Mann Whitney test, p<0.001,  n>25) cells from three experiments. All values are presented as means ± SEM. 
 
Disrupting mitochondria with CCCP has been shown to result in increased plasma 
membrane permeability (Figure 59) and treatment with P188 which is thought to protect 
membrane integrity is able to prevent beading. These results support the hypothesis that 
secondary membrane damage can occur downstream of mitochondrial disruption and 
that the degenerative effects of this membrane damage can be mitigated with P188. 
 
5.3.8 P188 Reduces Increase in Membrane Permeability Associated with CCCP Treatment 
The effectiveness of P188 in mitigating axonal beading after CCCP treatment is 
presumed to be a result of preventing secondary membrane damage induced by CCCP. 
To ensure that this is the case, membrane permeability changes were measured with 
CCCP and P188. Neurons were imaged before and after 60 minutes of treatment and 
changes in axonal fluorescence for the intracellular dye calcein were quantified. Control 
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cells lost around 15 percent of their initial fluorescence while CCCP-treated cells lost more 
than 30 percent. When P188 was added at the same time as CCCP, the percent of calcein 
loss was less than 25%. There was a statistically significant decrease from cells with CCCP 
alone, and no statistical significance from control cells (Figure 65).  
  
5.3.9 Poloxamer Reduces Cytosolic Calcium Increase Associated with CCCP Treatment 
CCCP treatment has been shown to result in secondary membrane damage which 
is mitigated when P188 is present. This is presumed to be a result of P188’s ability to 
preserve membrane integrity. One effect of secondary membrane damage after CCCP 
treatment should be a loss of ionic homeostasis and a flow of ions in the direction of their 
concentration gradient. Cytosolic calcium is increased after CCCP treatment (Figure 30) 
and if the influx of extracellular calcium through a leaky membrane is contributing to that 
increased calcium then protecting the membrane with P188 should reduce that increase. 
Relative changes in cytosolic calcium were measured after CCCP treatment. The increase 
after 60 minutes of 100µM CCCP treatment was twice the increase shown in control cells. 
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Figure 65. CCCP treatment results in increased 
plasma membrane permeability that is 
mitigated when P188 is present. Cells were 
treated with 100 µM CCCP and 100 µM P188 for 
60 minutes (one-way analysis of variance 
followed by Tukey’s multiple comparison, 
p<0.05, n>15 cells for each condition). All values 
are presented as means ± SEM. 
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When 100µM P188 was present in addition to CCCP the increase in calcium was 
statistically less than CCCP alone but still more than controls (Figure 66). 
 
 
 
5.3.10 Poloxamer 188 Reduces beading after Increasing Oxidative Stress 
In the hypothesized pathway (Figure 1), increased oxidative stress as a result of 
mitochondrial damage results in further mitochondrial disruption and membrane damage 
through lipid peroxidation.   The damage to the membrane results in a loss of ionic 
homeostasis which ultimately leads to beading.  If P188 can protect the membrane, it 
should also be able to reduce beading.  When 100µM P188 was added in with 200mM 
TbHp to increase oxidative stress, the percentage of cells which presented with beads was 
not reduced but the intensity of beading was decreased (Figure 67). 
Axonal Calcium: CCCP +P188
C
on
tr
ol
P
18
8
C
C
C
P
C
C
C
P
 +
 P
18
8
0
1
2
3
4
*
C
a
lc
iu
m
 R
a
ti
o
Figure 66. CCCP treatment results in increased 
cytosolic calcium that is mitigated when P188 is 
present. Cells were treated with 100 µM CCCP 
and 100 µM P188 for 60 minutes (one-way 
analysis of variance followed by Tukey’s 
multiple comparison, p<0.05, n>15 cells for 
each condition). All values are presented as 
means ± SEM. 
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Figure 67. P188 reduces axonal beading after TbHp treatment. Cells were incubated in 200mM TbHp and 100 µM P188. A, P188 
added with TbHp does not reduce the percentage of cells showing at least one bead. B, Adding P188 to TbHp treated cells 
significantly reduces beading (Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test, p<0.05, n≥85 cells from three 
experiments. C, In cells that present at least one bead, cells treated with P188 and TbHp have significantly less beading than cells 
treated with TbHp (Mann Whitney test, p<0.001,  n≥85 cells from three experiments). All values are presented as means ± SEM. 
 
It is worth noting that in this experiment almost every single TbHp treated cell 
presented with beads. It is possible that using a lower concentration of TbHp where not 
every cell was beaded would also result in P188 reducing the percentage of beaded cells. 
Taken with the results showing that TbHp treatment increases membrane permeability 
(Figure 60) this provides supporting evidence that increased oxidative stress disrupts the 
plasma membrane in a manner that is mitigated by P188. 
 
5.3.11 Poloxamer 188 Reduces Increase in Membrane Permeability Resulting from TbHp 
Treatment 
P188 was successful in reducing axonal beading due to increased oxidative stress. 
This is presumed to be a result of P188’s ability to protect the integrity of the membrane. 
In order to make this interpretation it must first be shown that P188 is in fact protecting 
the plasma membrane from increased membrane permeability. To test this, neurons 
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were imaged before and 30 minutes after treatment and changes in axonal fluorescence 
for the intracellular dye calcein were quantified. Control cells lost less than ten percent of 
their initial fluorescence while TbHp-treated cells lost almost thirty percent. The addition 
of 100µM P188 with 100mM TbHp reduced the loss of fluorescence to an average of less 
than 15 percent, which was not a statistically significant change from controls (Figure 68).   
 
5.3.12 Poloxamer 188 Does Not Reduce Increase in Cytosolic Calcium Resulting from TbHp 
Treatment 
TbHp treatment results in an increase in cytosolic calcium (Figure 36), a major 
contributor to which comes from intracellularly sequestered calcium release (Figure 52) 
as well as some from extracellular calcium influx, presumably as a result of secondary 
membrane damage due to TbHp treatment. When P188 is present at the time of TbHp 
treatment there is no significant increase in membrane permeability, meaning that there 
is limited potential for the influx of extracellular calcium. To see how P188 protection of 
the membrane affected cytosolic calcium changes, relative changes in intracellular 
calcium were measured with 100mM TbHp and 100 µM P188.  TbHp treatment resulted 
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Figure 68. TbHp treatment results in increased 
plasma membrane permeability that is 
mitigated when P188 is present. Cells were 
treated with 100 mM TbHp and 100 µM P188 
for360 minutes (one-way analysis of variance 
followed by Tukey’s multiple comparison, 
p<0.001, n>20 cells for each condition). All 
values are presented as means ± SEM. 
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in a relative change in intracellular calcium that was more than two-fold that of controls, 
with no discernable change when P188 was present (Figure 69).  
 
 
5.3.12 Increasing Intracellular Calcium Results in Lipid Peroxidation 
In the hypothesized pathway (Figure 1), calcium overload causes mitochondrial 
dysfunction and an increase in oxidative stress which results in lipid peroxidation and 
increased membrane permeability.  To see if increasing intracellular calcium resulted in 
lipid peroxidation, calcium ionophore A23187 was use to induce an influx of calcium and 
changes in lipid peroxidation were measured. Cells treated with 10µM A23187 for 30 
minutes had higher levels of lipid peroxidation than controls (Figure 70). 
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Figure 69. TbHp treatment results in increased 
cytosolic calcium that is not mitigated when 
P188 is present. Cells were treated with 100mM 
TbHp and 100 µM P188 for360 minutes (one-
way analysis of variance followed by Tukey’s 
multiple comparison, p<0.001, n>20 cells for 
each condition). All values are presented as 
means ± SEM. 
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5.3.13 Mitochondrial Disruption Results In Lipid Peroxidation 
Mitochondrial disruption should lead to an increase in oxidative stress, resulting 
in lipid peroxidation of the plasma membrane. To test for this, CCCP was used to disrupt 
mitochondria and lipid peroxidation was measured, revealing greater levels of lipid 
peroxidation in CCCP-treated cells than control cells (Figure 71).  
 
 
5.3.14 Increasing Oxidative Stress Results in Lipid Peroxidation 
Lipid peroxidation should occur under conditions of increased oxidative stress, 
therefore increasing oxidative stress with TbHp should result in increased levels of lipid 
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Figure 70. Increasing intracellular calcium with calcium ionophore 
A23187 results in lipid peroxidation. Cells were incubated 10 µM 
A23187 for 20 minutes after a 30 minute incubation with 1 mM 
Image-iT® Lipid Peroxidation Sensor at 37°C. , The fold change was 
calculated as the ratiometric measurement of axonal fluorescence 
of 610nm/590nm normalized to the baseline fluorescence before 
treatment. (One-tailed t-test, p<0.001, n>25). All values are 
presented as means ± SEM.  
 
Figure 71. Damaging mitochondria with CCCP results in lipid 
peroxidation. Cells were incubated 100 µM CCCP for 60 
minutes after a 30 minute incubation with 1 mM Image-iT® 
Lipid Peroxidation Sensor at 37°C. , The fold change was 
calculated as the ratiometric measurement of axonal 
fluorescence of 610nm/590nm normalized to the baseline 
fluorescence before treatment. (One-tailed t-test, p<0.05,  
n>15). All values are presented as means ± SEM.  
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peroxidation. To test for this, TbHp was used to increase the oxidative stress of the cell 
and changes in axonal lipid peroxidation were measured, revealing increased levels of 
lipid peroxidation in TbHp-treated cells as compared to controls (Figure 72). 
  
 
5.4 Discussion 
The results in this chapter provide evidence that secondary membrane damage is 
occurring after targeted insults to the hypothesized TBI pathway. These insults included 
increasing cytosolic calcium, disrupting mitochondrial function, and increasing oxidative 
stress, and that lipid peroxidation is playing a part in these effects. It also provides 
evidence that P188 is able to reduce membrane permeabilization and axonal beading 
after disrupting mitochondrial function and increasing oxidative stress, but not after 
increasing cytosolic calcium with A23187.  
In order for plasma membrane protection to be a valid therapeutic target for TBI, 
there must be a reasonable therapeutic time window for membrane damage. If 
membrane damage is occurring only at the moment of mechanical injury, the time 
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) Figure 72. Increasing oxidative stress with TbHp 
results in lipid peroxidation. Cells were incubated in 
100 mM TbHp for 20 minutes after a 30 minute 
incubation with 1 mM Image-iT® Lipid Peroxidation 
Sensor at 37°C. The fold change was calculated as 
the ratiometric measurement of axonal 
fluorescence of 610nm/590nm normalized to the 
baseline fluorescence before treatment. (One-tailed 
t-test, p<0.001, n>30). All values are presented as 
means ± SEM.  
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window of application for membrane-protective treatments such as P188 would transient 
and brief, limiting the potential for membrane protection.  However, if membrane 
damage is ongoing or recurring then targeting the membrane has greater therapeutic 
potential.  
Post-injury treatment of P188 has been shown to be neuroprotective in neurons 
undergoing shear injury when it was added after the mechanical insult (Kilinc, Gallo et al. 
2007). This indicates that there is a window of opportunity for a therapeutic application 
of P188 after mechanical injury.  The results here show that increased membrane 
permeability, as well as lipid peroxidation, are occurring after increased cytosolic calcium, 
mitochondrial damage, and increased oxidative stress.  
Primary membrane damage at the time of injury is hypothesized to lead to a loss 
of ionic homeostasis and an influx of calcium, leading to beading through protease 
activation. A secondary pathway is hypothesized to lead in a less direct manner to 
neuronal degeneration by damaging mitochondria and increasing oxidative stress, leading 
to secondary membrane permeability through lipid peroxidation. Therefore inducing an 
influx of calcium in the absence of preceding membrane damage should also lead to 
increased membrane permeability and lipid peroxidation. Indeed, A23187 application did 
result in increased membrane permeability (Figure 62) as well as lipid peroxidation (Figure 
70). P188 was not able to reduce A23187-induced beading or calcium influx. This is to be 
expected as A23187-induced calcium influx is likely to be much greater than that caused 
by secondary membrane damage and leads more directly to beading. However, P188 was 
also unsuccessful in reducing the changes in membrane permeability. P188 was able to 
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reduce the changes in membrane permeability after CCCP and TbHp application, all of 
which are hypothesized to be caused by the same mechanism. The fact that P188 was 
unable to protect the cell membrane from damage after increasing cytosolic calcium with 
A23187 implies a different mechanism of increasing membrane permeability or a 
different form of damage that is not treatable with P188. It is also possible that the 
kinetics of A23187-induced damage are so extreme compared to the other types of 
damage that P188 is unable to mitigate it. 
Mitochondrial damage, a consequence of TBI, is hypothesized to lead to increased 
oxidative stress and increased membrane permeability via lipid peroxidation, as well as a 
release of mitochondrially sequestered calcium which can lead to beading. Secondary 
membrane damage can also lead to beading by allowing an influx of extracellular calcium. 
To investigate these ideas, CCCP was used to induce mitochondrial dysfunction without 
preceding membrane damage or calcium influx and was shown to result in increased 
membrane permeability (Figure 65) and lipid peroxidation (Figure 71), providing evidence 
for secondary membrane permeability. Indirect evidence for secondary membrane 
permeability was also given by the fact that P188 was able to bring axonal beading back 
to baseline levels (Figure 64), and calcein imaging to measure changes in membrane 
permeability confirmed that P188 was bringing increases in membrane permeability back 
to baseline levels (Figure 65). Calcium imaging with P188 also showed that changes in 
cytosolic calcium were reduced but still higher than controls. Similar to the experiment 
where EGTA used to chelate extracellular calcium reduced cytosolic calcium levels after 
CCCP treatment to a level that was still higher than EGTA controls (Figure 66), this 
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provides supporting evidence for a dual source of calcium from extracellular influx as well 
as intracellular release.  
Increased oxidative stress in TBI is hypothesized to lead to secondary membrane 
damage through lipid peroxidation, thereby leading to an influx of extracellular calcium 
which can lead to beading. Increased oxidative stress can also induce mitochondrial 
dysfunction, inducing the release of mitochondrially sequestered calcium and leading to 
axonal beading through that pathway. Increasing oxidative stress with TbHp was shown 
to result in increased membrane permeability (Figure 68) and lipid peroxidation (Figure 
72). Calcein imaging to measure changes in membrane permeability with P188 shows that 
the presence of P188 brought membrane permeability back to baseline levels (Figure 68) 
and P188 reduced axonal beading (Figure 67).  P188 did not, however, reduce axonal 
calcium (Figure 69), providing even more evidence for the release of calcium from 
intracellular stores.  
The most therapeutically significant finding in this chapter is the evidence of 
secondary membrane permeability through lipid peroxidation. This means that increased 
membrane permeability in TBI is not limited to the initial mechanoporation and there may 
be an extended time window for therapeutic intervention through membrane protection. 
P188 was used here as one option to protect membrane integrity, but the opportunity for 
other membrane-protection methods exists.  
 These findings, in the absence of initial mechanoporation, are not specific to TBI 
and can possibly be applied to other neurological conditions involving mitochondrial 
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dysfunction and increased oxidative stress. Oxidative stress has been implicated in the 
pathogenesis of Alzheimer’s Disease (Volicer and Crino 1990), Parkinson’s disease(Adams, 
Graham et al. 1991, Schulz, Lindenau et al. 2000) , and ALS (Barber, Mead et al. 2006). 
Mitochondrial dysfunction has also been implicated in neurodegenerative disease such 
as Alzheimer’s disease, Parkinson’s disease, ALS, and Huntington’s disease.  If 
mitochondrial dysfunction and increased oxidative stress lead to increased membrane 
permeability in other disease conditions, this opens the door for more therapeutic 
interventions.  
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Chapter 6: Conclusions and Future Work 
6.1 Summary of Principle Findings 
The work presented here contributes to the understanding of injury mechanisms 
and the role that the disruption of plasma membrane integrity plays in the initiation and 
progression of axonal pathology in the context of Traumatic Brain Injury. It shows that 
increasing membrane permeability, even in the absence of mechanical injury, is sufficient 
to induce many of the consequences of TBI including axonal beading, focal disruption of 
microtubules, increased cytosolic calcium, and mitochondrial dysfunction. Increasing 
cytosolic calcium, even without preceding membrane damage, was also sufficient to 
cause these pathologies, and chelating extracellular calcium reduced axonal beading, 
providing further evidence of the deleterious effects of calcium influx.  These findings are 
consistent with previous work regarding mechanoporation and secondary damage due to 
calcium influx.  
Mitochondrial dysfunction, in the absence of preceding membrane damage, also 
led to axonal beading, focal disruption of microtubules, and increased cytosolic calcium. 
Oxidative stress, a major consequence of mitochondrial damage, resulted in similar 
effects including further disruption of mitochondrial function. Reducing oxidative stress 
with antioxidants after isolated perturbations to membrane integrity, mitochondrial 
function, and cytosolic calcium, prevented axonal beading which supports the idea that 
increased oxidative stress is occurring after these insults and that it plays a role in beading. 
Evidence for dual sources of calcium were provided by calcium measurements made after 
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increasing oxidative stress or disrupting mitochondrial function while preventing the 
influx of calcium from the extracellular space, revealing that cytosolic calcium increases 
may result influx from the extracellular space as well as intracellular release, most likely 
from mitochondria.  Chelating intracellular calcium reduced axonal beading after 
disruption of mitochondrial function, increased oxidative stress and membrane 
disruption with melittin, but not after membrane disruption with saponin or increasing 
intracellular calcium with calcium ionophore A23187.  Preventing the regulated opening 
of the mitochondrial permeability pore with Cyclosporin A (CsA) reduced axonal beading 
after disrupting mitochondrial function, increasing oxidative stress, and permeabilizing 
the membrane but not after increasing cytosolic calcium with A23187. 
Finally, the possibility of secondary membrane damage and therapeutic 
interventions was investigated by measuring changes in membrane permeability and 
protecting membrane integrity with P188. It was demonstrated that increased membrane 
permeability and lipid peroxidation are induced under conditions of oxidative stress, 
mitochondrial dysfunction, and increased axonal calcium. P188 was able to prevent 
axonal beading after increasing oxidative stress or inducing mitochondrial dysfunction, 
but not after increasing cytosolic calcium with calcium ionophore A23187.  
 
6.2. Implications of the current study 
The experiments here support the hypothesized injury pathway and allow for the 
exploration of different therapeutic targets.  Understanding the link between different 
131 
 
 
 
parts of the TBI pathway allows for drug development that can be targeted to appropriate 
pieces of the pathway. The potential targets shown here include the plasma membrane, 
intracellular calcium, mitochondria, and oxidative stress. 
 Membrane damage, at the beginning of the TBI pathway, is first initiated through 
mechanical forces (“mechanoporation”).  Loss of plasma membrane integrity leads to 
many of the secondary injuries seen in TBI, including increased cytosolic calcium, 
mitochondrial dysfunction, cytoskeletal disruption, and axonal beading. Membrane 
damage on its own does not have to be a death sentence. The cell has mechanisms for 
repairing damaged membranes and restoring cellular integrity in ATP-dependent 
processes. However, depending on the extent of the damage, this is not always possible. 
Since membrane damage initiates the proceeding damage sequences, it is likely the best 
target for saving the cell.  However, if membrane damage is limited to the moment of 
injury, the time window for membrane-protecting interventions may not be 
therapeutically viable.  Here, we provide evidence that membrane damage can be 
ongoing due to secondary damage that results in lipid peroxidation and further increases 
in membrane permeability. We also provide evidence that this increase in membrane 
permeability can be mitigated using P188, which has already been shown to be 
neuroprotective in mechanical models of neuronal injury. Since P188 can protective of 
the membrane even without direct insults to membrane integrity, there seems to be great 
therapeutic potential that warrants further study of membrane-targeted 
neuroprotection. 
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 Calcium, both from extracellular and intracellular sources, was shown to play a 
significant role in axonal pathology. Increasing cytosolic calcium, even in the absence of 
mechanical trauma or primary membrane damage, results in a similar pathology to that 
of TBI. Preventing the influx of extracellular calcium is able to prevent beading after 
targeting isolated components of the TBI pathway, as is chelating intracellular calcium. All 
of these point towards calcium as being an important contributor to neuronal 
degeneration and death after injury, meaning that calcium may be an important target 
for neuroprotection. However, chelating calcium is not a valid therapeutic target because 
of the many important roles that calcium plays in neurons – most notably as part of the 
production of an action potential. Removing calcium may prove to be more detrimental. 
However, there may be other, more therapeutically valid, options for mitigating the 
uncontrolled increase in cytosolic calcium. Influx of calcium through a leaky membrane 
cannot be alleviated unless the membrane damage is repaired, but calcium through other 
sources may be a potential target. In mild-stretch injuries where mechanoporation may 
be temporary or more limited, calcium may still enter the cell through other channels, 
and may be functionally coupled to sodium entry (Wolf, Stys et al. 2001).  Therefore, 
adjusting calcium entry through membrane channels may be a valid target.  For example, 
NMDA receptor activation has been shown to result in calcium influx and in some cases 
NMDA-receptor agonists have been neuroprotective. However, in all cases they have 
failed in clinical trials (Ikonomidou and Turski 2002). Cytosolic calcium can also be 
increased as a result of release from intracellular stores, and is increased after disruption 
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of mitochondrial function and increased oxidative stress. These routes of release may also 
be valid therapeutic targets.  
 Mitochondria were shown to be dysfunctional (through morphological changes) 
after damage to the plasma membrane, increased intracellular calcium, and increased 
oxidative stress. They contribute to the progression of axonal injury by releasing 
sequestered calcium and increasing oxidative stress. Although not investigated here, 
mitochondrial dysfunction may also prevent neuronal recovery when there is not enough 
ATP to fuel the energy-dependent processes of repairing the plasma membrane and 
restoring ion homeostasis. If these dysfunctions are a result of the MPT, then that is a 
potential therapeutic target as well. 
 Oxidative stress is another major aspect of the TBI Pathway. It was shown here 
that increasing oxidative stress, even in the absence of preceding membrane damage or 
mitochondrial dysfunction, is sufficient to mimic the pathology seen in TBI. Increased 
oxidative stress causes mitochondrial dysfunction, results in the release of calcium from 
intracellular stores, results in focal cytoskeletal disruption, and is able to induce secondary 
membrane permeability and lipid peroxidation. In addition, antioxidant use was 
successful in mitigating axonal beading after increased membrane permeability, 
increased cytosolic calcium, and disruption of mitochondrial function. These results 
indicate that targeting the oxidative stress part of the damage pathway is a valid 
therapeutic strategy. 
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 Many attempts have already been made to target these parts of the pathway, 
specifically with cyclosporin A and antioxidant use. No drugs have passed phase III clinical 
trials (Schouten 2007, Jain 2008).  The reason for this is often due to adverse side effects 
or drug delivery issues. The timing of drug therapy may also be very important, depending 
on the temporal progression of injury.  Drug delivery to the brain is incredibly difficult due 
to the defense of the blood brain barrier (BBB). Brain injury can result in a breakdown of 
the BBB(Zhou, Xiang et al. 2001). This has been suggested as a way to target drug delivery 
to impaired areas of the brain. Assuming that compromised areas of the BBB are co-
localized with mechanoporated neurons, this could be a great advantage that should be 
taken advantage of. In this possible scenario, an understanding of the injury pathway and 
progression of neurodegeneration would guide treatment strategies. Targeting the 
plasma membrane with membrane-protecting drugs could have great potential, but may 
also seal the BBB and prevent successful administration of other drugs to combat 
oxidative stress or mitochondrial dysfunction.  
 There are several limitations to the work shown here, some of which can be 
addressed with simple experiments referenced in the future work section. While these 
experiments provide insight into the pathway of neuronal degeneration after TBI, they do 
not provide information about the time course of injury progression which is also 
important for deciding on therapeutic strategies. They can, however, provide insight into 
the sequence of events even if the time course is contracted compared to human TBI.  
These experiments include only non-myelinated neurons in isolation, ignoring the 
contribution of other cell types.  Injury in DAI is primarily seen in the white matter of the 
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brain, which consists mainly of axons. In these experiments measurements are only made 
on axons, but insults are given to the entire cell.  Time course measurements were not 
made, primarily due to the damage inflicted by fluorescence imaging which limited the 
number of measurements that could be made.  
 In spite of the limitations to this work, great progress has been made in 
understanding the pathway and mechanisms of axonal pathology related to TBI.  The 
experiments shown here support the hypothesis that membrane damage leads to calcium 
influx and subsequent mitochondrial disruption. Damaged mitochondria undergo the 
MPT through an opening of the MPP and release sequestered calcium and increase the 
production of ROS, increasing the oxidative stress of the cell. This results in lipid 
peroxidation and further damage to the plasma membrane, propagating and potentiating 
the cycle of calcium influx ultimately leading to axonal beading. Most importantly this 
work provides evidence of an injury cycle instead of a linear progression, opening up more 
opportunities for therapeutic intervention.  
6.4 Future Work 
 There are a number of obvious extensions of the work presented here.  The ability 
to isolate and perturb aspects of the TBI pathway opens many doors to understanding the 
many pieces of the injury puzzle. The ultimate goal is to understand the mechanisms of 
injury in order to develop therapies to restore functional recovery. 
 The work presented here shows measurements of mitochondrial morphology and 
cytoskeletal disruption as evidence of axonal injury that matches TBI pathology. However, 
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in addition to being evidence of injury these can also be used as metrics for neuronal 
health. Here, neuronal health was measured morphologically by quantifying axonal 
beading, but future work can also look at cytoskeletal and mitochondrial alterations to 
quantify the protective effects of EGTA, BAPTA-AM, antioxidants, CsA, or P188 as well as 
other agents that provide clues as to the mechanism of neuronal degeneration. 
Additionally, making these measurements may help progress the understanding of the 
mechanisms behind axonal beading. 
 Along the same lines, a study of axonal transport may also be important. Transport 
deficits have been shown with TBI, as well as many other neurological disorders. Thy 
dynamics of vesicular transport with and without injury can be examined through live 
imaging of mitochondria. These membrane-bound organelles are good models for 
transport because they are relatively easily to visualize and travel both anterogradely and 
retrogradely on the axonal cytoskeleton.  
 The importance of mitochondrial health and the contribution of the MPT was 
indirectly observed here using CsA. While the neuroprotective effects of CsA have often 
been used as evidence of the MPT, this is not a direct measurement. Direct measurements 
of the MPT and the opening of the MPP can be made to give a better understanding of 
when this transition is occurring relative to other changes in the cell. 
 Mitochondrial health should also be investigated with regards to cell death, as well 
as promoting neuronal regeneration. For functional recovery the ultimate strategy may 
not be to keep neurons alive, but to promote plasticity or to induce the controlled death 
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of neurons not functioning properly.  Neurons undergoing necrotic death may induce 
excitotoxic injury on nearby, initially healthy, cells and promote the secondary injury 
sequence that way. Apoptosis, or controlled cell death, is an energy-dependent 
programmed form of cell death (Choi, Klintworth et al. 2011). Mitochondrial dysfunction 
results in ATP-depletion which may promote necrotic death (Cheng, Kong et al. 2012).  
 The contribution of cytoskeletal integrity to neuronal health has been investigated 
before, and a link has been made between calpain activation and axonal beading after 
increased intracellular calcium due to mechanoporation. The work presented here does 
not address calpain activation specifically. However, to further the understanding of the 
mechanism behind bead formation one could inhibit calpains while inducing isolated 
perturbations to the damage pathway.  
 In vivo there may be other cell types contributing to both the degeneration and 
restoration of neuronal health. Most notably, astrocytes appear to have higher GSH levels 
than neurons, both in vivo and in culture (Cooper and Kristal 1997, Dringen, Gutterer et al. 2000). 
Simplified experiments with isolated neurons can help to provide a better understanding of the 
progression of axonal pathology, but the presence of other cell types can help to add another 
layer to this story. 
 Diffuse axonal injuries are known for occurring in the white matter of the brain, 
which consists primarily of axons. The work presented in this dissertation includes the 
entire cell, including the soma, which is undoubtedly affected by the insults being given. 
To better replicate what is happening in TBI it would be a good idea to isolate the 
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application of the insult to the axon only, using microfluidics devices or campenot 
chambers. 
 The most important aspect of recovery after TBI is not whether or not a neuron is 
alive and looks healthy, but if it is signaling properly. This is a requirement for functional 
recovery, which is what really matters. The assumption is being made here that neurons 
with a normal morphology will also have normal signaling patterns, but it will be 
important to investigate that directly.   
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Appendices 
Appendix A: An Automated Interactive Bead Measurement Program 
Beading is a well-documented phenomenon in neurons that parallels neuronal 
damage. It is a term that describes focal bead-like swellings that have been shown in 
diffuse axonal injury after brain trauma and other neurological conditions such as 
epilepsy, amyotrophic lateral sclerosis, and multiple sclerosis(Takeuchi, Mizuno et al. 
2005).  It is often colocalized with areas of microtubule disruption and an accumulation 
of organelles (Povlishock, Erb et al. 1992, Smith, Meaney et al. 2003, Takeuchi, Mizuno et 
al. 2005, Greenwood, Mizielinska et al. 2007, Kilinc, Gallo et al. 2008). In in vitro 
experiments, beading can be used as a morphological indicator of the extent of neuronal 
injury.  However, difficulty in quantifying the degree of beading has made this 
problematic.  
 Previous attempts to quantify beading have been modest at best.  The most 
primitive method involved simply stating the presence of beads. Some researchers 
compare the ratio of beaded or unbeaded axons (Swann, Al-Noori et al. 2000, Roediger 
and Armati 2003, Takeuchi, Mizuno et al. 2005). One of the most advanced methods of 
quantifying beading has simply involved normalizing the number of beads by the length 
of the axon(Kilinc, Gallo et al. 2008). Beads are often associated with areas of disrupted 
transport and organelle accumulation, which results in a tendency of the human eye 
towards dark swellings which may not actually have a significantly larger diameter than 
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the rest of the axon. Some scientists attempt to limit the subjectivity of deciding what is 
and is not a bead by setting the minimum size of a bead to be at least two times the width 
of the axon(Beirowski, Nogradi et al. 2010). However, these methods leave much to be 
desired.  Which section of the axon represents the true width? Normalizing by the length 
of the axon does not take the size of the bead into account – what if a big bead is a larger 
sign of injury than a small bead?  The most advanced method of analyzing axonal beading 
to date (Kilinc, Gallo et al. 2009) attempts to address this subjectivity but is unable to 
achieve satisfactory agreement between what is identified as a bead and what a human 
participant would choose.  To address these concerns the Automated Interactive Bead 
Measurement program was developed with a complete user interface to allow users to 
quantify beading in single cultured axons.  
While there have not been many successful attempts to quantify being in neurons, 
there have been many attempts to segment axons and quantify different aspects of 
neuronal morphology. These attempts have met with many of the same challenges as this 
beading program. The work down towards these efforts shows a lot of insight that and 
advice that can be incorporated into the program.  For example, Neurphology J  (Ho, Chao 
et al. 2011) acknowledges some problems with skeletonization and undesired branches. 
Eric Meijering has provided a nice review of various neuronal quantification 
methods(Meijering 2010).  
To develop the Automated Interactive Bead Measurement Program, all functions 
were written separately in Matlab script and tested on images to ensure that all of the 
pieces were working properly, and were then compiled into a user interface to allow the 
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user to easily and efficiently quantify beading in their images (Figure 73). The interface 
allows the user to process images one by one, or all at once. Since many of the functions 
are time intensive, automating many images at once saves the user time by allowing them 
to accomplish other tasks while the program runs, and then returning for validation. 
 
Figure 73. User interface for segmenting axons and quantifying axonal beading. 
The input to the program is a list of phase microscopy images of single cultured 
neurons.  The important functions of the program are preprocessing, axon segmentation, 
determination of the axon spine, axon width measurement, bead identification, and cell 
morphology calculations. 
Preprocessing 
The first step to the image processing is to run it through median filters. This is 
especially important for the edge finding that is incorporated into the segmentation. The 
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median filter smooths the image without losing important details and prevents the edge 
functions from finding too many unnecessary edges.   Images of cultured neurons often 
contain debris that can affect the segmentation if it is too close to the cell.  To remedy 
this, the user interface includes a “remove debris” button that allows the user to 
interactively select regions to be removed and uses Matlab’s  “roifill()” function to 
smoothly interpolate that region 
Segmentation  
The axon segmentation part of the program is a combination of global and local 
thresholding combined with edge detection and user validation. The axon segmentation 
section of the program is one of the most vital. Small deviations in the axon are incredibly 
important for bead identification, which is why this section allows for user validation and 
edits in each step of the process.  The first step is a global otsu filter on the image, which 
is used to identify the halo of the cell which helps to identify the cell body. This is 
necessary because identifying the cell body is important both for removing it from the 
axon and for orienting the axon for future calculations. The second step of the 
segmentation is to locally threshold the axon based on the local standard deviation. This 
was done by breaking the image up into multiple blocks and calculating the standard 
deviation for each block.  Low standard deviations are assumed to be the background 
which should be mostly uniform.  High standard deviations are assumed to be areas that 
contain edges, and are then locally thresholded using Matlab’s built-in Otsu filter. The 
user interface allows the user to select “fudge factors” for the various thresholds used 
(maximum block size, standard deviation, and level). The maximum block size is important 
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because if a block falls entirely within an axon, it may also have a small standard deviation 
and be mistaken for the background. This can be remedied by including a mean intensity 
threshold into the background identification.  
Sometimes this segmentation may result in an axon that is not fully connected. 
Since the segmentation algorithm includes a step to identify the axon by selecting the 
largest region, any breaks in the segmentation may result in a significantly shorter axon. 
To remedy this, the user interface includes a “connect” button which allows the user to 
draw a line connecting the pieces of axon if they have been separated and prevent pieces 
from being lost.  
Edge detection is used to further improve the segmentation. Edges are found in 
the original image using a canny filter. Small segments are removed. The edges are first 
subtracted from the segmented axon, which helps to remove any extra bits in the 
segmentation. The edges are then added back to the axon, dilated, and holes are filled. 
Any extraneous edge pieces not attached to the axon are then removed. This serves to 
add in important curves that the segmentation may have missed.  
Spine 
The identification of the spine of the axon is an important step for quantifying the 
morphology of the axon. This is achieved using Matlab’s bwmorph ‘thin’ function instead 
of ‘skel’.  This is because ‘thin’ does a better job of finding the centerline of the axon 
without including as many unnecessary branches. However, there is no convenient way 
to find the main spine of the axon. The spine was pruned by identifying each branch of 
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the skeleton and then removing the ones shorter than the threshold set by the user 
through the user interface. 
Width  
Accurate width identification is 
important since the bead identification 
is based on the width. Finding the width 
of the axon at each point on the 
skeleton is difficult because the axon is 
curved and it is hard to distinguish the two points to measure between.  Early attempts 
to measure the width involved creating a circle at every points on the skeleton, and 
choosing the diameter of the circle that had the best overlap. This was very time intensive, 
so a new method was used based on methods for finding the width of blood vessels. The 
slope of the spine was found for every points, so that a line perpendicular to each point 
could be plotted (Figure 74). The length of the area of the line that overlapped with the 
axon was used as the measurement of axonal width at that point.  
Bead Identification 
The method used to identify what was a bead was any region that was significantly 
larger than the average region.  To do this, all the regional maxima were identified as 
possible beads. While they required additional filtering to decide what was a bead, it was 
also useful in identifying all the areas that were definitely not beads.  The width of all the 
points that were not possible beads were averaged to find the average width of the axon, 
and the standard deviation was also found because it would help to determine what was 
Figure 74. Perpendicular lines along the axon in order to calculate 
the width at every point on the spine 
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significantly larger than the average axon. The possible beads were then filtered using the 
average width and standard deviation to find all points on the spine that had significantly 
larger widths.  The area of these beads was also estimated by assuming they were circular. 
Since this method could result in overlapping beads, and beads that were within a certain 
threshold of each other (2*width) were combined into one.  Because not all focal 
enlargements are not signs of injury and should not be considered beads (i.e. growth 
cones), the user interface includes a “remove beads” button which allows the user to click 
on misidentified beads to remove them.  
 
Figure 75. Bead identification 
Calculations 
 The average width of the axon having already been identified, the remaining 
calculations remaining were the length of the axon, the number of beads, the ‘Beading 
Index’, and the tortuosity.  The method used to identify the length of the axon was to 
count the number of pixels in the spine. In order to quantify beading, a unitless number 
was devised to describe the area of the cell that was beading:  
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𝐵𝑒𝑎𝑑𝑖𝑛𝑔𝐼𝑛𝑑𝑒𝑥 =  
∑ 𝐴𝑟𝑒𝑎𝑖
𝑛
𝑖=1
𝑤𝑖𝑑𝑡ℎ𝐴𝑥𝑜𝑛 ∗ 𝐿𝑒𝑛𝑔𝑡ℎ𝐴𝑥𝑜𝑛
 
The beading index for each axon sums the area of the beads and divides it by the 
length*width of the axon, which means that the axon is approximated as being a 
rectangle.  
Tortuosity was defined as the linear distance between the two endpoints of the 
axon divided by the length of the axon. This means that a tortuosity value of 1 is a 
completely linear axon. In order to find the beginning and end points of the axon, the 
previously identified soma was used to find the beginning points of the axon and then 
traced until the end. Once all the calculations are complete, the program allows the user 
to export important calculations to the Matlab workspace for the user to save, further 
analyze, or export into Excel or statistical software.  
The Automated Interactive Bead Measurement Program provides a tool to 
objectively and quantitatively examine axonal beading in in vitro cultures. When used in 
conjunction with a brain injury model it can be used to better evaluate the effectiveness 
of therapeutic agents so that those that go on to clinical trials have a greater chance of 
being effective.  In future studies, it should be used to assess many different therapeutic 
agents alone and in combination.  
Future work to improve the program involves making the program more efficient 
so that it takes less time to analyze pictures. There are also some bugs that should be 
fixed, including checking for the existence of a value before accessing it. This will protect 
the user from running into an error and using all data. The initial segmentation may also 
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be improved by incorporating a sliding window threshold instead of a local block 
threshold.  More complicated skeleton pruning would also be helpful and would make 
the length measurement more accurate.  
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Code 
 
%  Author    :  Raha Dastgheyb 
%  File and function name : AutomatedInteractiveBeadMeasurement.m 
%  Version                : 1.0 
%  Date of completion     : 20 March 2013    
%  Inputs        :  An array of phase (and possbly fluorescent) images 
%of single cultured neurons. Make sure that there are at least 2 images 
%  selected when you load the images             
% 
%  Outputs       :   Number of beads, beading index, average width, 
%stdwidth, length, tortuousity, and an assortment of images        
%                
%  Description   :  
%       Interactivel quantifies beading in single cultured neurons 
  
  
function varargout = AutomatedInteractiveBeadMeasurement(varargin) 
% AUTOMATEDINTERACTIVEBEADMEASUREMENT MATLAB code for 
AutomatedInteractiveBeadMeasurement.fig 
%      AUTOMATEDINTERACTIVEBEADMEASUREMENT, by itself, creates a new 
AUTOMATEDINTERACTIVEBEADMEASUREMENT or raises the existing 
%      singleton*. 
% 
%      H = AUTOMATEDINTERACTIVEBEADMEASUREMENT returns the handle to a 
new AUTOMATEDINTERACTIVEBEADMEASUREMENT or the handle to 
%      the existing singleton*. 
% 
%      
AUTOMATEDINTERACTIVEBEADMEASUREMENT('CALLBACK',hObject,eventData,handle
s,...) calls the local 
%      function named CALLBACK in AUTOMATEDINTERACTIVEBEADMEASUREMENT.M 
with the given input arguments. 
% 
%      AUTOMATEDINTERACTIVEBEADMEASUREMENT('Property','Value',...) 
creates a new AUTOMATEDINTERACTIVEBEADMEASUREMENT or raises the 
%      existing singleton*.  Starting from the left, property value pairs 
are 
%      applied to the GUI before 
AutomatedInteractiveBeadMeasurement_OpeningFcn gets called.  An 
%      unrecognized property name or invalid value makes property 
application 
%      stop.  All inputs are passed to 
AutomatedInteractiveBeadMeasurement_OpeningFcn via varargin. 
% 
%      *See GUI Options on GUIDE's Tools menu.  Choose "GUI allows only 
one 
%      instance to run (singleton)". 
% 
% See also: GUIDE, GUIDATA, GUIHANDLES 
  
% Edit the above text to modify the response to help 
AutomatedInteractiveBeadMeasurement 
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% Last Modified by GUIDE v2.5 20-Mar-2013 00:25:06 
  
% Begin initialization code - DO NOT EDIT 
gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', 
@AutomatedInteractiveBeadMeasurement_OpeningFcn, ... 
                   'gui_OutputFcn',  
@AutomatedInteractiveBeadMeasurement_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 
if nargin && ischar(varargin{1}) 
    gui_State.gui_Callback = str2func(varargin{1}); 
end 
  
if nargout 
    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 
% End initialization code - DO NOT EDIT 
  
  
% --- Executes just before AutomatedInteractiveBeadMeasurement is made 
visible. 
function AutomatedInteractiveBeadMeasurement_OpeningFcn(hObject, 
eventdata, handles, varargin) 
% This function has no output args, see OutputFcn. 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% varargin   command line arguments to 
AutomatedInteractiveBeadMeasurement (see VARARGIN) 
  
% Choose default command line output for 
AutomatedInteractiveBeadMeasurement 
handles.output = hObject; 
  
% Update handles structure 
handles.blocksegment = {}; 
handles.axon = {}; 
handles.skeleton = {}; 
handles.finalAxon = {}; 
handles.beadImage = {}; 
handles.tortuosity = []; 
handles.originalImages = {}; 
handles.currentIndex = 1; 
handles.img = {}; 
handles.cF = 0; 
  
guidata(hObject, handles); 
  
% UIWAIT makes AutomatedInteractiveBeadMeasurement wait for user response 
(see UIRESUME) 
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% uiwait(handles.figure1); 
  
  
% --- Outputs from this function are returned to the command line. 
function varargout = 
AutomatedInteractiveBeadMeasurement_OutputFcn(hObject, eventdata, 
handles)  
% varargout  cell array for returning output args (see VARARGOUT); 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Get default command line output from handles structure 
varargout{1} = handles.output; 
  
% --- Executes on button press in LoadImage_button. 
function LoadImage_button_Callback(hObject, eventdata, handles) 
% hObject    handle to LoadImage_button (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
[FileName,PathName] = uigetfile({'*.*'},'Load Image 
Files','MultiSelect', 'on'); 
  
handles.FileNames = FileName; 
handles.numImages = length(FileName); 
for i = 1:handles.numImages 
    F = fullfile([PathName, char(FileName(i))]); 
    o = imread(F); 
    o = o(:, :, 1); 
    o = mat2gray(o); 
    o = im2uint8(o);% change scale to be from 0 to 255, not an intensity 
image 
    handles.originalImages{i} = o; 
     
    im = o; 
    im = Filter(im); 
    im = Filter(im); 
    im = Filter(im); 
    handles.img{i} = im; 
     
    handles.blocksegment{i} = zeros(size(o)); 
    handles.axon{i} = zeros(size(o)); 
    handles.skeleton{i} = zeros(size(o)); 
    handles.finalAxon{i} = zeros(size(o)); 
    handles.beadImage{i} = zeros(size(o)); 
    handles.Names{i} = FileName(i); 
  
end 
  
  
sliderStep = [1, 1]/(handles.numImages-1); 
  
set(handles.scroll_slider, 'SliderStep', sliderStep); 
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set(handles.scroll_slider, 'Max', handles.numImages); 
axes(handles.OriginalImage); 
imagesc(handles.originalImages{1}); 
colormap(gray); 
title('Original Image') 
guidata(hObject, handles); 
 
function scroll_slider_CreateFcn(hObject, eventdata, handles) 
  
  
% --- Executes during object creation, after setting all properties. 
  
Max = 2; 
if exist('handles.numImages','var') 
    Max = handles.numImages; 
end 
set(hObject, 'Value', 1); 
if(Max>1) 
    set(hObject, 'Max', Max);  
end 
  
sliderStep = [1, 1]/(Max-1); 
  
set(hObject, 'SliderStep', sliderStep); 
  
  
  
  
  
guidata(hObject, handles); 
  
% --- Executes on button press in AutoSegment_Button. 
function AutoSegment_Button_Callback(hObject, eventdata, handles) 
% hObject    handle to AutoSegment_Button (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
%set(hObject,'string','running','enable','off'); 
handles.cF = 1; 
cI = handles.currentIndex; 
img = handles.img{cI}; 
axes(handles.EditedImage); 
colormap(gray); 
blocksize = get(handles.MaxBlockSize_Slider, 'Value'); 
stdFF= get(handles.StdThresh_Slider, 'Value'); 
meanFF= get(handles.MeanFF_slider, 'Value'); 
threshFF= get(handles.threshFF_slider, 'Value'); 
%img = adapthisteq(img); 
%img = imagesc(img); 
img = AdaptOtsu(img, blocksize, stdFF, meanFF, threshFF); 
img = Cleanup(img); 
imshow(img); 
handles.blocksegment{cI} = img; 
handles.finalAxon{cI} = img; 
%set(hObject,'string','Auto Segment','enable','on'); 
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guidata(hObject, handles); 
% -------------------------------------------------------------------- 
function Untitled_1_Callback(hObject, eventdata, handles) 
% hObject    handle to Untitled_1 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% -------------------------------------------------------------------- 
function Untitled_2_Callback(hObject, eventdata, handles) 
% hObject    handle to Untitled_2 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA)  
% -------------------------------------------------------------------- 
function Untitled_3_Callback(hObject, eventdata, handles) 
% hObject    handle to Untitled_3 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
 
function [filteredimage] = Filter( inputImage ) 
%UNTITLED2 Summary of this function goes here 
%   Detailed explanation goes here 
filteredimage = inputImage; 
  
filteredimage = medfilt2(filteredimage); 
  
function [segmentedImage] = AdaptOtsu( img, maxBlock, stdFF, meanFF, 
threshFF)%create an anonymous function handle to calculate the indices 
based on 
%blocksize 
ind = @(x, rc) 1+((x-1)*rc); 
  
%first, cut it up into blocks and make a matrix of standard deviations 
im = imcomplement(img); 
[r c] = size(img); 
[blkr blkc] = bestblk(size(img), maxBlock); 
  
stdMatrix = zeros(size(img));   
  
for i = 1:r/blkr-1 
    for j = 1:c/blkc-1 
    window = im(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))); 
    stdevIntensity = std2(window); 
    stdMatrix(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, blkc))) 
= stdevIntensity; 
    end 
end 
  
%also make a matrix of the mean values, which will help with the 
%thresholding later 
  
  
meanMatrix = zeros(size(img));   
  
for i = 1:r/blkr-1 
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    for j = 1:c/blkc-1 
    window = im(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))); 
    meanIntensity = mean2(window); 
    meanMatrix(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = meanIntensity; 
    end 
end 
  
  
%make a final matrix of the max of the nearest neighbors of the stdMatrix 
  
%middle points 
  
finalStd = zeros(size(img));   
    for i = 2:r/blkr-2 
        for j = 2:c/blkc-2 
          s1= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j-1, 
blkc):ind(j, blkc))); 
          s2= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j+1, 
blkc):ind(j+2, blkc))); 
          s3= mean2(stdMatrix(ind(i-1, blkr):ind(i,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s4= mean2(stdMatrix(ind(i+1, blkr):ind(i+2,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s = [s1 s2 s3 s4]; 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s);         
        end 
    end 
     
  
%corner values 
    %top left corner 
     
    for i = 1 
        for j=1 
          s1= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j+1, 
blkc):ind(j+2, blkc))); 
          s2= mean2(stdMatrix(ind(i+1, blkr):ind(i+2,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s3= mean2(stdMatrix(ind(i+1, blkr):ind(i+2,blkr), ind(j+1, 
blkc):ind(j+2, blkc))); 
          s = [s1 s2 s3]; 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s); 
        end 
    end 
     
    %top right corner 
     
    for i = 1 
       for j= round(c/blkc)-1 
          s1= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j-1, 
blkc):ind(j, blkc))); 
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          s2= mean2(stdMatrix(ind(i+1, blkr):ind(i+2,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s3= mean2(stdMatrix(ind(i+1, blkr):ind(i+2,blkr), ind(j-1, 
blkc):ind(j, blkc))); 
          s = [s1 s2 s3]; 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s); 
     
        end    
    end 
     
        %bottom left corner 
     
    for i = round(r/blkr)-1 
       for j= 1 
          s1= mean2(stdMatrix(ind(i-1, blkr):ind(i,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s2= mean2(stdMatrix(ind(i-1, blkr):ind(i,blkr), ind(j+1, 
blkc):ind(j+1, blkc))); 
          s3= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j+1, 
blkc):ind(j+2, blkc))); 
          s = [s1 s2 s3]; 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s); 
        end 
         
    end 
     
        %bottom right corner 
         
    for i = round(r/blkr)-1 
       for j= round(c/blkc)-1 
          s1= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j-1, 
blkc):ind(j, blkc))); 
          s2= mean2(stdMatrix(ind(i-1, blkr):ind(i,blkr), ind(j-1, 
blkc):ind(j, blkc))); 
          s3= mean2(stdMatrix(ind(i-1, blkr):ind(i,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s = [s1 s2 s3]; 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s); 
     
        end 
    end 
     
%top row 
    for i = 1 
       for j= 2:round(c/blkc)-2 
          s1= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j-1, 
blkc):ind(j, blkc))); 
          s2= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j+1, 
blkc):ind(j+2, blkc))); 
          s3= mean2(stdMatrix(ind(i+1, blkr):ind(i+2,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s = [s1 s2 s3]; 
155 
 
 
 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s); 
        end  
    end 
%bottom row 
  
    for i = round(r/blkr)-1 
       for j= 2:round(c/blkc)-2 
          s1= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j-1, 
blkc):ind(j, blkc))); 
          s2= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j+1, 
blkc):ind(j+2, blkc))); 
          s3= mean2(stdMatrix(ind(i-1, blkr):ind(i,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s = [s1 s2 s3]; 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s); 
        end 
    end 
%left column 
    for i = 2:round(r/blkr)-2 
       for j= 1 
          s1= mean2(stdMatrix(ind(i-1, blkr):ind(i,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s2= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j+1, 
blkc):ind(j+2, blkc))); 
          s3= mean2(stdMatrix(ind(i+1, blkr):ind(i+2,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s = [s1 s2 s3]; 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s); 
        end 
    end    
%right column 
    for i = 2:round(r/blkr)-2 
       for j= round(c/blkc)-1 
          s1= mean2(stdMatrix(ind(i-1, blkr):ind(i,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s2= mean2(stdMatrix(ind(i, blkr):ind(i+1,blkr), ind(j-1, 
blkc):ind(j, blkc))); 
          s3= mean2(stdMatrix(ind(i+1, blkr):ind(i+2,blkr), ind(j, 
blkc):ind(j+1, blkc))); 
          s = [s1 s2 s3]; 
          finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))) = max(s); 
        end 
    end    
  
  
%calculate the mean of the ones less than the std, and the mean of the 
ones 
%greater than the std 
n = find(stdMatrix>0); 
meanStd = mean(stdMatrix(n)); 
stdThresh = meanStd*stdFF; 
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meanLow = []; 
meanHigh = []; 
levelLow = []; 
levelHigh = []; 
  
  
for i = 1:r/blkr-1 
    for j = 1:c/blkc-1 
    window = meanMatrix(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc))); 
    meanIntensity = mean2(window); 
    std = mean2(stdMatrix(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc)))); 
    level= graythresh(im(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc)))); 
        if (std < stdThresh) 
            meanLow = [meanLow meanIntensity]; 
            levelLow = [levelLow level];   
        else 
            meanHigh = [meanHigh meanIntensity]; 
            levelHigh = [levelHigh level]; 
        end 
    end 
end 
  
meanThresh = meanFF* mean(meanLow); 
  
thresholded = zeros(size(img)); 
%decide how to threshold 
  
im = imcomplement(img); 
  
for i = 1:r/blkr-1 
    for j = 1:c/blkc-1 
    window = im(ind(i, blkr):ind(i+1, blkr),ind(j, blkc):(ind(j+1, 
blkc))); 
    meanIntensity = mean2(meanMatrix(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc)))); 
    std = mean2(finalStd(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc)))); 
        if (std< stdThresh && meanIntensity < meanThresh) %defenitely 
background 
            thresholded(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc))) = 0; 
        elseif (std<stdThresh && meanIntensity > meanThresh) % probably 
foreground 
           thresholded(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc))) = 0; %im2bw(window, mean(levelLow)*threshFF); 
        elseif (std > stdThresh && meanIntensity < meanThresh) %maybe a 
noisy background, or a small corner of edge 
            thresholded(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc))) = im2bw(window, mean(levelLow)*threshFF); 
        elseif (std > stdThresh && meanIntensity > meanThresh)%definitely 
foreground 
            thresholded(ind(i, blkr):ind(i+1, blkr),ind(j, 
blkc):(ind(j+1, blkc))) = im2bw(window, threshFF*graythresh(window)); 
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        end 
           
    end 
end 
  
  
blocksegment = imclearborder(thresholded); 
blocksegment = im2bw(blocksegment);         
segmentedImage = blocksegment; 
  
  
% --- Executes on slider movement. 
function MaxBlockSize_Slider_Callback(hObject, eventdata, handles) 
% hObject    handle to MaxBlockSize_Slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of 
slider 
sliderValue = get(hObject,'Value'); 
set(handles.MaxBlockSize_String,'String', sliderValue); 
AutoSegment_Button_Callback(hObject, eventdata, handles); 
guidata(hObject, handles) 
  
% --- Executes during object creation, after setting all properties. 
function MaxBlockSize_Slider_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to MaxBlockSize_Slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: slider controls usually have a light gray background. 
if isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor',[.9 .9 .9]); 
end 
  
% --- Executes on slider movement. 
function StdThresh_Slider_Callback(hObject, eventdata, handles) 
% hObject    handle to StdThresh_Slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of 
slider 
sliderValue = get(hObject,'Value'); 
set(handles.StdThresh_String,'String', sliderValue); 
AutoSegment_Button_Callback(hObject, eventdata, handles); 
  
% --- Executes during object creation, after setting all properties. 
function StdThresh_Slider_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to StdThresh_Slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
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% Hint: slider controls usually have a light gray background. 
if isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor',[.9 .9 .9]); 
end 
  
  
function MaxBlockSize_String_Callback(hObject, eventdata, handles) 
% hObject    handle to MaxBlockSize_String (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of MaxBlockSize_String as 
text 
%        str2double(get(hObject,'String')) returns contents of 
MaxBlockSize_String as a double 
textValue = str2num( get(hObject,'String') ); 
set(handles.MaxBlockSize_Slider,'Value',textValue); 
AutoSegment_Button_Callback(hObject, eventdata, handles); 
guidata(hObject, handles) 
  
% --- Executes during object creation, after setting all properties. 
function MaxBlockSize_String_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to MaxBlockSize_String (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
  
function StdThresh_String_Callback(hObject, eventdata, handles) 
% hObject    handle to StdThresh_String (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of StdThresh_String as 
text 
%        str2double(get(hObject,'String')) returns contents of 
StdThresh_String as a double 
  
textValue = str2num( get(hObject,'String') ); 
set(handles.StdThresh_Slider,'Value',textValue) 
guidata(hObject, handles) 
  
% --- Executes during object creation, after setting all properties. 
function StdThresh_String_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to StdThresh_String (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
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% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% --- Executes on key press with focus on MaxBlockSize_Slider and none of 
its controls. 
function MaxBlockSize_Slider_KeyPressFcn(hObject, eventdata, handles) 
% hObject    handle to MaxBlockSize_Slider (see GCBO) 
% eventdata  structure with the following fields (see UICONTROL) 
%   Key: name of the key that was pressed, in lower case 
%   Character: character interpretation of the key(s) that was pressed 
%   Modifier: name(s) of the modifier key(s) (i.e., control, shift) 
pressed 
% handles    structure with handles and user data (see GUIDATA) 
  
function img = Cleanup(img) 
%fill holes 
img = imfill(img, 'holes'); 
  
%remove small bits 
img = bwareaopen(img, 700); 
  
function [axon, soma] = RemoveSoma(img, blocksegment) 
  
%calculate halo to add to image later 
Halobw = im2bw(img, graythresh(img)); 
%add halo to image so that it can be eroded properly 
im2 = imadd(Halobw, blocksegment); 
im2 = bwmorph(im2, 'close'); 
  
%fill holes 
im2 = imfill(im2, 'holes'); 
holesfilled = imfill(im2, 'holes'); 
s = holesfilled; 
l = bwlabel(s); 
while (max(max(l)) >1) 
   s = bwmorph(s, 'erode');  
   l = bwlabel(s); 
  
   if (max(max(l))==1) 
      break;  
   end 
   
end 
  
%get it to 50 pixels, and then find the centroid 
  
  
stats = regionprops(s, 'all'); 
centroid = cat(1, stats.Centroid); 
160 
 
 
 
  
c = 0; 
soma = holesfilled; 
while (length(find(soma>0))> 0) 
   soma = bwmorph(soma, 'erode');  
   c = c+1; 
end 
  
c = c-1; 
centers = round(centroid); 
soma(round(centroid(2)), round(centroid(1))) = 255; 
  
  
xc=centers(2); 
yc=centers(1); 
  
r=(c+20)^2; 
[x y]= find(soma<275); 
d=find(((x-xc).^2+(y-yc).^2) <= r); 
  
for i=1:length(d) 
       
  soma(x(d(i)),y(d(i)),:)=255; 
       
end 
%subtract soma from rest of image 
  
axon = imsubtract(blocksegment, soma); 
axon = im2bw(axon); 
  
%now find the longest region. This should be the axon 
  
  
labeled = bwlabel(axon); 
stats = regionprops(axon, 'all'); 
lengths = cat(1, stats.MajorAxisLength); 
id = find(lengths == max(lengths)); 
axon = ismember(labeled, id); 
  
% --- Executes on button press in roifill_push. 
function roifill_push_Callback(hObject, eventdata, handles) 
% hObject    handle to roifill_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
%img = handles.img; 
cI = handles.currentIndex; 
axes(handles.OriginalImage); 
img = roifill(handles.img{cI}); 
handles.img = img; 
axes(handles.OriginalImage); 
imagesc(img); 
  
colormap(gray); 
guidata(hObject, handles) 
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% --- Executes on slider movement. 
function MeanFF_slider_Callback(hObject, eventdata, handles) 
% hObject    handle to MeanFF_slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of 
slider 
sliderValue = get(hObject,'Value'); 
set(handles.MeanFF_string,'String', sliderValue); 
AutoSegment_Button_Callback(hObject, eventdata, handles); 
guidata(hObject, handles) 
  
% --- Executes during object creation, after setting all properties. 
function MeanFF_slider_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to MeanFF_slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: slider controls usually have a light gray background. 
if isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor',[.9 .9 .9]); 
end 
  
  
function MeanFF_string_Callback(hObject, eventdata, handles) 
% hObject    handle to MeanFF_string (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of MeanFF_string as text 
%        str2double(get(hObject,'String')) returns contents of 
MeanFF_string as a double 
textValue = str2num( get(hObject,'String') ); 
set(handles.MeanFF_slider,'Value',textValue); 
AutoSegment_Button_Callback(hObject, eventdata, handles) 
guidata(hObject, handles) 
  
% --- Executes during object creation, after setting all properties. 
function MeanFF_string_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to MeanFF_string (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
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 % --- Executes on slider movement. 
function threshFF_slider_Callback(hObject, eventdata, handles) 
% hObject    handle to threshFF_slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of 
slider 
sliderValue = get(hObject,'Value'); 
set(handles.threshFF_string,'String', sliderValue); 
AutoSegment_Button_Callback(hObject, eventdata, handles); 
guidata(hObject, handles) 
  
% --- Executes during object creation, after setting all properties. 
function threshFF_slider_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to threshFF_slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: slider controls usually have a light gray background. 
if isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor',[.9 .9 .9]); 
end 
  
function threshFF_string_Callback(hObject, eventdata, handles) 
% hObject    handle to threshFF_string (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of threshFF_string as 
text 
%        str2double(get(hObject,'String')) returns contents of 
threshFF_string as a double 
textValue = str2num( get(hObject,'String') ); 
set(handles.threshFF_slider,'Value',textValue); 
AutoSegment_Button_Callback(hObject, eventdata, handles); 
guidata(hObject, handles) 
  
% --- Executes during object creation, after setting all properties. 
function threshFF_string_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to threshFF_string (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% --- Executes on button press in connect_push. 
function connect_push_Callback(hObject, eventdata, handles) 
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% hObject    handle to connect_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
cI = handles.currentIndex; 
handles.cF = 1; 
%user uses lines to connect segments 
axes(handles.EditedImage); 
img = handles.finalAxon{cI}; 
h_i = imshow(img); 
h = imline(); 
b = createMask(h, h_i); 
b = bwmorph(b, 'dilate'); 
img = img + b; 
img = im2bw(img); 
imshow(img) 
handles.blocksegment{cI} = img; 
handles.finalAxon{cI} = img; 
guidata(hObject, handles) 
  
% --- Executes on button press in RemoveSoma_push. 
function RemoveSoma_push_Callback(hObject, eventdata, handles) 
% hObject    handle to RemoveSoma_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
set(hObject,'string','running','enable','off'); 
cI = handles.currentIndex; 
handles.cF = 1; 
axes(handles.EditedImage); 
img = handles.img{cI}; 
block = handles.blocksegment{cI}; 
[axon, soma] = RemoveSoma(img, block); 
handles.finalAxon{cI} = axon; 
imagesc(axon) 
handles.Soma{cI} = soma; 
set(hObject,'string','Remove Soma','enable','on'); 
guidata(hObject, handles) 
  
  
% --- Executes on button press in edges_push. 
function edges_push_Callback(hObject, eventdata, handles) 
% hObject    handle to edges_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
cI = handles.currentIndex; 
set(hObject,'string','running','enable','off'); 
handles.cF = 1; 
axes(handles.EditedImage); 
img = handles.img{cI}; 
axon = handles.finalAxon{cI}; 
edges = Edges(img, axon); 
axonEdges = subtractEdges(axon, edges); 
imagesc(axonEdges) 
hold on; 
[xc xr] = find(edges); 
handles.Edges{cI} = edges; 
handles.finalAxon{cI} = axonEdges; 
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set(hObject,'string','Incorporate Edges','enable','on'); 
guidata(hObject, handles) 
  
function edges = Edges(img, axon) 
  
%segment using edges 
  
BWcanny = edge(img, 'canny'); 
BWcanny = im2uint8(BWcanny); 
BWcanny = im2bw(BWcanny); 
BWcanny = imclearborder(BWcanny); 
%remove short edge lines 
lengthThresh = 60; 
labeledEdge = bwlabel(BWcanny); 
Estats = regionprops(BWcanny, 'all'); 
Elengths = cat(1, Estats.MajorAxisLength); 
ide = find(Elengths>lengthThresh); 
edges = ismember(labeledEdge, ide); 
  
function axon = subtractEdges(axon, edges) 
%Combine edges and segmented axon 
%subtract edges from axon to see what was extra 
  
subEdges = imsubtract(axon ,bwmorph(edges, 'dilate')); 
subEdges = im2bw(subEdges); 
subEdges = bwmorph(subEdges, 'clean'); 
subEdges = bwmorph(subEdges, 'spur'); 
subEdges = bwmorph(subEdges, 'clean'); 
subEdges = bwmorph(subEdges, 'spur'); 
subEdges = bwareaopen(subEdges, 100,8); 
subEdges = bwmorph(subEdges, 'clean'); 
subEdges = bwmorph(subEdges, 'spur'); 
subEdges = bwmorph(subEdges, 'clean'); 
subEdges = bwmorph(subEdges, 'spur'); 
  
%add edges, fill holes, then remove thin lines 
added = imadd(subEdges, edges); 
added = bwmorph(added, 'close'); 
added = imfill(added, 'holes'); 
%remove all thin unconnected lines 
  
% Morphologically open image 
se = strel('square',2); 
added2 = imopen(added,se); 
  
%the largest objects are the axon 
l = bwlabel(added2); 
Estats = regionprops(added2, 'area'); 
area = cat(1, Estats.Area); 
iarea = find(area >100); 
axon = ismember(l, iarea); 
  
%fill any holes, and make sure there is only one object there 
axon = bwmorph(axon, 'close'); 
l = bwlabel(added2); 
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Estats = regionprops(added2, 'area'); 
area = cat(1, Estats.Area); 
iarea = find(area == max(area)); 
axon = ismember(l, iarea); 
  
% --- Executes on button press in beads_push. 
function beads_push_Callback(hObject, eventdata, handles) 
% hObject    handle to beads_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
handles.cF = 2; 
set(hObject,'string','running','enable','off'); 
cI = handles.currentIndex; 
skel = handles.Skeleton{cI}; 
axon = handles.finalAxon{cI}; 
%find slope 
slope = slopeArray(skel); 
slopeImg = slopeimg(axon,skel); 
%find width 
widthAxon = widthaxon(axon,skel, slope); 
  
%find possible beads 
widthI = widthImg(axon, skel, slope); 
  
%find nonbead properties 
[meanAxonWidth, stdAxonWidth] = nonBeadProps(widthI); 
%filter beads 
beadImg = filterbeads(widthI, 1); 
nb1 = 0; 
%find close beads and combine them. Repeat until there are no more changes 
distthresh= meanAxonWidth*2; 
beads = beadImg; 
c=0; 
while(nb1 ~= length(find(beads))) 
nb1 = length(find(beads)); 
  
beads = combinedBeads(beads, distthresh); 
  
end 
  
imshow(axon) 
[beadx beady] = find(beads); 
hold on; 
plot(beady, beadx, 'r.') 
b = traceSpine(skel, handles.Soma{cI}); 
tort = calcTort(skel, b); 
handles.Tortuosity{cI} = tort; 
len = length(find(skel)); 
handles.AxonLength{cI} = len; 
handles.AxonWidth{cI} = meanAxonWidth; 
beadIdx = find(beads); 
  
sumB = 0; 
for i = 1:length(beadIdx) 
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    sumB = sumB + beads(beadIdx(i)); 
end 
  
beadingIndex = sumB/(len*handles.AxonWidth{cI}); 
  
handles.stdAxonWidth{cI} = stdAxonWidth; 
handles.widthImg{cI} = widthI; 
handles.BeadingIndex{cI} = beadingIndex; 
handles.numBeads{cI} = length(find(beads)); 
  
handles.Length{cI} = len; 
  
handles.beadImage{cI} = beads; 
set(hObject,'string','Calculate Beads','enable','on'); 
guidata(hObject, handles); 
  
  
  
  
  
% --- Executes on button press in Export_Calculations. 
function Export_Calculations_Callback(hObject, eventdata, handles) 
% hObject    handle to Export_Calculations (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
assignin('base', 'axon', handles.finalAxon); 
assignin('base', 'beads', handles.beadImage); 
assignin('base', 'numBeads', handles.numBeads'); 
assignin('base', 'skel', handles.Skeleton); 
%all done finding beads! now do the calculations 
assignin('base', 'Len', handles.Length); 
%numberofbeads 
%use improfile to find beads in each third of the axon 
%tortuosity 
assignin('base', 'meanAxonWidth', handles.AxonWidth'); 
assignin('base', 'Tortuousity', handles.Tortuosity'); 
assignin('base', 'stdAxonWidth', handles.stdAxonWidth'); 
assignin('base', 'widthImg', handles.widthImg'); 
assignin('base', 'beadingIndex', handles.BeadingIndex'); 
assignin('base', 'OriginalImage', handles.originalImages); 
assignin('base', 'Names', handles.Names'); 
  
guidata(hObject, handles); 
  
function skel = skeleton(axon) 
axon = imfill(axon, 'holes'); 
skel = bwmorph(axon, 'thin', Inf); 
skel = bwmorph(skel, 'spur'); 
  
function skel = prune(skel, lengthresh) 
branchpoints = bwmorph(skel, 'branchpoints'); 
b = skel-branchpoints; 
l = bwlabel(b); 
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%regionprops was not finding all labels, so wor with the number of pixels 
in bw label 
f = []; 
 
for i = 1:max(max(l)) 
   if length(find(l==i))<lengthresh 
       f = [f i]; 
   end 
     
end 
  
remove = ismember(l,f); 
skel = skel-remove; 
%now connect close segments 
skel = bwmorph(skel, 'dilate'); 
skel = bwmorph(skel, 'dilate'); 
skel = bwmorph(skel, 'dilate'); 
skel = bwmorph(skel, 'erode'); 
skel = bwmorph(skel, 'erode'); 
skel = bwmorph(skel, 'erode'); 
  
%remove anything that is not the longest segment 
  
l = bwlabel(skel); 
for i = 1:max(max(l)) 
   ll(i) = length(find(l==i));  
end 
skel = ismember(l, find(ll==max(ll))); 
  
function [S1, S2] = findSpine(skel) 
[S1,S2]= find(skel==1); 
  
function slope = slopeArray(skel) 
[S1, S2] = findSpine(skel); 
r = 3; 
for k = 1:length(S1)       
   %draw a box around that point 
   sx = S1(k); %x and y coordinates 
   sy = S2(k); 
   disk = skel(sx-r:sx+r, sy-r:sy+r); 
   %find all the x and y points in the box 
    [y x] = find(disk); 
   %calculate the slope 
   %slope(k) = diff(y')/diff(x'); 
   coeff = polyfit(x, y,1); 
   sk = coeff(1); 
   nnn = isnan(sk); 
   if(nnn== 1) 
      slope(k) = 1000; 
   else 
       slope(k) = sk;   
   end 
end 
  
function plotSlope = plotSlope(axon, skel, slopeArray) 
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[S1, S2] = findSpine(skel); 
imshow(axon) 
hold on; 
for i = 1:5:length(S1) 
  
xp = [1 2 3 4 5]; 
yp = xp*slopeArray(i); 
  
%center the third point of the x axis at S2(i) 
xp = S2(i)-2:S2(i) +2; 
%raise the third point of the y-axis to match the center point of S1(i) 
d = S1(i) - yp(3); 
yp = yp+d; 
plot(xp, yp); 
end 
  
function slope = slopeimg(axon,skel) 
[S1, S2] = findSpine(skel); 
slope = slopeArray(skel); 
for i = 1:length(S1) 
slope(S1(i),S2(i)) = slope(i); 
end 
handles.slopeImg = slope; 
  
function widthA = widthaxon(axon,skel, slope) 
  
[S1, S2] = findSpine(skel); 
perp = -1./slope; 
l = 50; % length of tangent line 
for i = 1:length(S1) 
     
%use the pythagorean theorem to find the range of x values 
u = perp(i); 
lengthx = round(sqrt(((l/2)^2)/(1+u^2))); %length on each side of 
centerpoint     
    if lengthx == 0 %in the case of a flat line 
       lengthx = round(l/2);  
    end 
  
xp = 1:2*lengthx+1; 
yp = xp*u; 
  
%in case of a vertical line 
%center the middle point of the x axis at S2(i) 
xd = S2(i) - xp(lengthx); 
xp = xp+ xd; 
  
%raise the middle point of the y-axis to match the center point of S1(i) 
  
d = S1(i) - yp(lengthx); 
yp = yp+d; 
  
if abs(u) >50  
   yp = 1:2*lengthx+1; 
   yp = yp+round(S1(i)/2); 
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   %and there will only be one x-value 
    for j = 1:length(yp) 
       xp(j) = S2(i); 
    end 
     
end 
  
%%also check the minimum and maximum ranges of yp 
if(min(yp)<1 || max(yp) > length(axon)) 
    for j = 1:length(xp) 
       yp(j) = d; 
    end 
end 
yp = round(yp); 
  
C = improfile (axon, xp, yp); 
  
%the number of 1s in C will be the width at that point (in pixels); 
%it is possible that the line will cross the axon at multiple locations, 
so look for the region that contains the center point  
  
C = bwlabel(C); 
if max(max(C)) > 1 
n = find(xp == S2(i)); 
C = ismember(C, C(n)); 
  
end 
w = length(find(C)); 
widthA(i) = w; 
  
end 
  
function plotAxon = plotAxon(axon,skel, slope) 
imshow(axon) 
hold on 
%use the pythagorean theorem to find the range of x values 
u = perp(i); 
lengthx = round(sqrt(((l/2)^2)/(1+u^2))); %length on each side of 
centerpoint     
    if lengthx == 0; %in the case of a flat line 
       lengthx = round(l/2);  
    end 
  
     
xp = 1:2*lengthx+1; 
yp = xp*u; 
  
%in case of a vertical line 
%center the middle point of the x axis at S2(i) 
xd = S2(i) - xp(lengthx); 
xp = xp+ xd; 
  
%raise the middle point of the y-axis to match the center point of S1(i) 
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d = S1(i) - yp(lengthx); 
yp = yp+d; 
  
if abs(u) >50  
   yp = 1:2*lengthx+1; 
   yp = yp+round(S1(i)/2); 
   %and there will only be one x-value 
    for j = 1:length(yp) 
       xp(j) = S2(i); 
    end     
end 
  
%%also check the minimum and maximum ranges of yp 
if(min(yp)<1 || max(yp) > length(axon)) 
    for j = 1:length(xp) 
       yp(j) = d; 
    end 
end 
yp = round(yp); 
plot(xp, yp); 
C = improfile (axon, xp, yp); 
  
%the number of 1s in C will be the width at that point (in pixels); 
%it is possible that the line will cross the axon at multilpe locations, 
so look for the region that contains the center point  
C = bwlabel(C); 
if max(max(C)) > 1 
n = find(xp == S2(i)); 
C = ismember(C, C(n)); 
  
end 
w = length(find(C)); 
  
function widthimg = widthImg(axon, skel, slope) 
width = widthaxon(axon, skel, slope); 
[S1, S2] = findSpine(skel); 
widthimg = zeros(size(axon)); 
    for i = 1:length(S1) 
    widthimg(S1(i),S2(i)) = width(i); 
    end 
     
  
  
function localMaximg = localMax(widthI) 
localMaximg = imregionalmax(widthI); 
handles.localMaxImg = localMaximg; 
  
function [meanAxonWidth, stdAxonWidth] = nonBeadProps(widthI) 
localMaximg = localMax(widthI); 
nonBeads = widthI; 
nonBeads(find(localMaximg))= 0; 
indnb = find(nonBeads);% List of all radii of non beads 
for i = 1:length(indnb) 
   nonBeadR = nonBeads(indnb);  %list of all the radii of non beads  
end 
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meanAxonWidth = mean(nonBeadR); 
handles.meanAxonWidth = meanAxonWidth; 
stdAxonWidth = std(nonBeadR); 
handles.stdAxonWidth = stdAxonWidth; 
  
function beadImg = filterbeads(widthI, stdThresh) 
possibleBeads = localMax(widthI); 
  
  
[meanAxonWidth, stdAxonWidth] = nonBeadProps(widthI); 
  
beadIdx = find (possibleBeads);  % location of the current maxes 
for i = 1:length(beadIdx) 
    if(widthI(beadIdx(i))<(meanAxonWidth + stdThresh*stdAxonWidth)) 
        possibleBeads(beadIdx(i)) = 0; 
    end 
end 
  
%the value of each bead is the area of the bead.  Assume that it is a 
%circle, so use r = width/2 to calculate it 
beads = im2double(possibleBeads); 
b = find(beads); 
for i = 1:length(b) 
    r = widthI(b(i))/2; 
    beads(b(i)) = pi*r^2; 
end 
  
beadImg = beads; 
  
function beads = combinedBeads(beadImg, distthresh) 
% 
beadimg2 = beadImg; 
  
%if some beads are really close, combine them into one 
[x y] = find(beadImg); 
%find points of the beads 
  
[X, Y] = meshgrid (x, y); 
  
Dx = X-X'; 
Dy = Y-Y'; 
  
distances = hypot(Dx, Dy); 
%get rid of 0s 
  
distances = distances + diag(nan(1, numel(x))); 
  
[xi yi] = find(distances<distthresh); 
  
%there will be double entries for every two points, so remove the 
%duplicates 
  
for i = 1:length(xi) 
    if i<= length(xi) 
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        yvalue = yi(i); 
        n = find (xi == yvalue); 
        xi(n) = []; 
        yi(n) = []; 
    end     
end 
  
for i = 1:length(xi) 
%each row contains the index of two points that need to be combined. 
y1 = y(xi(i)); 
x1 = x(xi(i)); 
y2 = y(yi(i)); 
x2 = x(yi(i)); 
  
  
%set the coordinates of the combined points to be the midpoint of the two 
points  
  
newx = round((x1 + x2)/2); 
newy = round((y1+y2)/2); 
beadimg2(x1,y1) =0; 
beadimg2(x2, y2) =0; 
  
%calculate the overlap of the two points to see what the new area value 
%is. Do this by plotting both circles in a new image. Then count the 
%total number of pixels 
temp1 = zeros(size(beadImg)); 
temp2 = zeros(size(beadImg)); 
tempimg = zeros(size(beadImg)); 
r1 = sqrt(beadImg(x1, y1)/pi); 
r2 = sqrt(beadImg(x2, y2)/pi); 
  
temp1(x1, y1) = 1; 
temp1 = bwdist(temp1); 
n = find(temp1<=r1); 
tempimg(n) = 1; 
temp2(x2, y2) = 1; 
temp2 = bwdist(temp2); 
n = find(temp2<=r1); 
tempimg(n) = 1; 
  
sizebead = length(find(tempimg)); 
beadimg2(newx, newy) = sizebead; 
  
  
end 
beads = beadimg2; 
  
function plotBeads = plotBeads(axon, beadImg) 
[beadx beady] = find(beadImg); 
imshow(axon) 
hold on; 
plot(beady, beadx, '.') 
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% --- Executes on button press in FindSpine_push. 
function FindSpine_push_Callback(hObject, eventdata, handles) 
% hObject    handle to FindSpine_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
cI = handles.currentIndex; 
set(hObject,'string','running','enable','off'); 
handles.cF = 3; 
axes(handles.EditedImage); 
%find skeleton 
axon = handles.finalAxon{cI}; 
skel = skeleton(axon); 
spineThresh= get(handles.SpineThresh_slider, 'Value'); 
%prune skeleton 
skel = prune(skel, spineThresh); 
handles.Skeleton{cI} = skel; 
imshow(axon) 
[skel1 skel2] = find(skel); 
hold on; 
plot(skel2, skel1, '.') 
set(hObject,'string','Find Spine','enable','on'); 
guidata(hObject, handles); 
  
  
% --- Executes on slider movement. 
function SpineThresh_slider_Callback(hObject, eventdata, handles) 
% hObject    handle to SpineThresh_slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of 
slider 
sliderValue = get(hObject,'Value'); 
set(handles.SpineThresh_string,'String', sliderValue); 
FindSpine_push_Callback(hObject, eventdata, handles); 
guidata(hObject, handles) 
  
% --- Executes during object creation, after setting all properties. 
function SpineThresh_slider_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to SpineThresh_slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: slider controls usually have a light gray background. 
if isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor',[.9 .9 .9]); 
end 
guidata(hObject, handles); 
  
  
  
function SpineThresh_string_Callback(hObject, eventdata, handles) 
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% hObject    handle to SpineThresh_string (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'String') returns contents of SpineThresh_string as 
text 
%        str2double(get(hObject,'String')) returns contents of 
SpineThresh_string as a double 
textValue = str2num( get(hObject,'String') ); 
set(handles.SpineThresh_slider,'Value',textValue); 
FindSpine_push_Callback(hObject, eventdata, handles); 
guidata(hObject, handles) 
  
  
% --- Executes during object creation, after setting all properties. 
function SpineThresh_string_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to SpineThresh_string (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
  
% --- Executes on button press in RemoveBeads_push. 
function RemoveBeads_push_Callback(hObject, eventdata, handles) 
% hObject    handle to RemoveBeads_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
handles.cF = 2; 
cI = handles.currentIndex; 
axes(handles.EditedImage); 
axon = handles.finalAxon{cI}; 
beads = handles.beadImage{cI}; 
imshow(axon) 
hold on; 
[xp yp] = find(beads); 
plot(yp, xp,'o','MarkerFaceColor','g') 
  
[yd,xd] = ginput(1); %lets user click on points that are not beads 
%find the point that it is closest to.  Make sure that the distance is 
not 
%too far 
d = []; 
  
for i = 1:length(xp)  
d(i) = sqrt((xd-xp(i))^2 + (yd - yp(i))^2)  ; 
end 
  
minI = find(d == min(d)); %return index of the smallest distance, so the 
point corresponding to the clicked point 
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%now remove that point 
  
beads(xp(minI), yp(minI)) = 0; 
  
[xp yp] = find(beads); 
imshow(axon) 
hold on; 
plot(yp, xp,'o','MarkerFaceColor','g') 
  
beadIdx = find(beads); 
sumB = 0; 
for i = 1:length(beadIdx) 
    sumB = sumB + beads(beadIdx(i));  
end 
beadingIndex = sumB/(handles.Length{cI}*handles.AxonWidth{cI}); 
handles.BeadingIndex{cI} = beadingIndex; 
handles.numBeads{cI} = length(find(beads)); 
  
handles.beadImage{cI} = beads; 
  
  
guidata(hObject, handles); 
  
function traced = traceSpine(skel, soma) 
stats= regionprops(soma, 'centroid'); 
centr = stats.Centroid; 
[xp yp] = find(skel); 
%find the point on the skeleton that is closest to the centroid 
yd= centr(1); 
xd = centr(2); 
d = []; 
  
for i = 1:length(xp) 
    d(i) = sqrt((xd-xp(i))^2 + (yd - yp(i))^2)  ; 
end 
  
  
minI = find(d == min(d)); 
  
P = [xp(minI) yp(minI)]; 
%b = bwtraceboundary(skel, P, 'E'); 
b = bwtraceboundary(skel,P,'E',8,length(find(skel)),'clockwise'); 
traced = b; 
handles.boundary = traced; 
%plot(b(:,2),b(:,1),'g','LineWidth',2); 
%plot(P(2),P(1),'gx','LineWidth',2); 
%plot 25th point from the beginning: 
%plot(b(25,2),b(25,1),'.'); 
  
function tort = calcTort(skel, b) 
x1=b(1,1); 
y1 = b(1,2); 
x2 = b(length(b), 1); 
y2 = b(length(b),2); 
176 
 
 
 
enddist = sqrt((x2-x1)^2 + (y2-y1)^2); 
skelLength = length(find(skel)); 
  
%tortuousity is the length between endpoints divided by the total length. 
A 
%tortuousity of 1 implies a perfectly straight line 
tort = enddist/skelLength; 
  
  
% --- Executes on button press in FreehandDraw_push. 
function FreehandDraw_push_Callback(hObject, eventdata, handles) 
% hObject    handle to FreehandDraw_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
cI = handles.currentIndex; 
handles.cF = 4; 
axes(handles.EditedImage); 
%plot the original image, with the points on the axon over it 
orig = handles.originalImages{cI}; 
h = imshow(orig); 
hold on; 
  
%get all the points on the axon, and plot on top. 
  
axon = handles.finalAxon{cI}; 
[x y] = find(axon); 
  
plot(y, x, '.'); 
  
imf = imfreehand(gca); 
M = imf. getPosition; 
addX = M(:, 1); 
addY = M(:, 2); 
plot(addX, addY, '.'); 
mask = createMask(imf,h); 
axon = axon + mask; 
  
imshow(orig); 
[x y] = find(axon); 
hold on; 
plot(y, x, 'y.'); 
  
handles.finalAxon{cI} = axon; 
% Update handles structure 
guidata(hObject, handles); 
  
  
  
% --- Executes on button press in FreehandRemove_push. 
function FreehandRemove_push_Callback(hObject, eventdata, handles) 
% hObject    handle to FreehandRemove_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
cI = handles.currentIndex; 
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handles.cF = 4; 
axes(handles.EditedImage); 
%plot the original image, with the points on the axon over it 
orig = handles.originalImages{cI}; 
h = imshow(orig); 
hold on; 
  
%get all the points on the axon, and plot on top. 
  
axon = handles.finalAxon{cI}; 
[x y] = find(axon); 
  
plot(y, x, 'r.'); 
  
imf = imfreehand(gca); 
M = imf. getPosition; 
addX = M(:, 1); 
addY = M(:, 2); 
mask = createMask(imf,h); 
mIdx = find(mask); 
axon(mIdx) = 0; 
  
imshow(orig); 
[x y] = find(axon); 
hold on; 
plot(y, x, 'y.'); 
  
handles.finalAxon{cI} = axon; 
% Update handles structure 
guidata(hObject, handles); 
  
  
% --- Executes on button press in Overlay_push. 
function Overlay_push_Callback(hObject, eventdata, handles) 
% hObject    handle to Overlay_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
cI = handles.currentIndex; 
handles.cF = 4; 
axes(handles.EditedImage); 
%plot the original image, with the points on the axon over it 
orig = handles.originalImages{cI}; 
h = imshow(orig); 
hold on; 
  
%get all the points on the axon, and plot on top. 
  
axon = handles.finalAxon{cI}; 
[x y] = find(axon); 
plot(y, x, 'y.'); 
guidata(hObject, handles); 
  
  
% --- Executes on slider movement. 
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function scroll_slider_Callback(hObject, eventdata, handles) 
% hObject    handle to scroll_slider (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hints: get(hObject,'Value') returns position of slider 
%        get(hObject,'Min') and get(hObject,'Max') to determine range of 
slider 
  
%change the original Image axes to be the current image. Also change the 
title 
  
sliderValue = round(get(hObject,'Value')); 
handles.currentIndex = sliderValue; 
cI = sliderValue; 
  
axes(handles.OriginalImage); 
imshow(handles.originalImages{cI}); 
  
  
%now change the second image depending on what you had been looking at 
  
axes(handles.EditedImage); 
cla; 
cF = handles.cF; 
  
if(cF == 1) 
    imshow(handles.finalAxon{cI})  % show segmented axon 
end 
  
if(cF == 2) 
    imshow(handles.finalAxon{cI})  % show segmented axon with bead 
overlay 
    hold on 
    beads = handles.beadImage{cI}; 
    [xp yp] = find(beads); 
    plot(yp, xp,'o','MarkerFaceColor','b') 
     
end 
  
if(cF == 3) 
    imshow(handles.finalAxon{cI})  % show segmented axon with spine 
overlay 
    hold on 
    spine = handles.Skeleton{cI}; 
    [xp yp] = find(spine); 
    plot(yp, xp,'.') 
     
end 
  
if(cF == 4) 
    imshow(handles.img{cI})  % show original axon with segmented overlay 
    hold on 
    overlay = handles.finalAxon{cI}; 
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    [xp yp] = find(overlay); 
    plot(yp, xp,'y.') 
     
end 
 
guidata(hObject, handles) 
% --- Executes on button press in SegmentAll_push. 
function SegmentAll_push_Callback(hObject, eventdata, handles) 
% hObject    handle to SegmentAll_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA)v 
set(hObject,'string','running','enable','off'); 
handles.cF = 1; 
  
for i = 1:handles.numImages 
    cI = i; 
    handles.currentIndex = i; 
    set(handles.scroll_slider,'Value', i); 
    scroll_slider_Callback(hObject, eventdata, handles) 
    img = handles.img{cI}; 
    blocksize = get(handles.MaxBlockSize_Slider, 'Value'); 
    stdFF= get(handles.StdThresh_Slider, 'Value'); 
    meanFF= get(handles.MeanFF_slider, 'Value'); 
    threshFF= get(handles.threshFF_slider, 'Value'); 
    img = AdaptOtsu(img, blocksize, stdFF, meanFF, threshFF); 
    img = Cleanup(img); 
    handles.blocksegment{cI} = img; 
    handles.finalAxon{cI} = img; 
end 
  
cI = 1; 
set(handles.scroll_slider,'Value', i); 
axes(handles.OriginalImage); 
imshow(handles.originalImages{cI}); 
axes(handles.EditedImage) 
imshow(handles.finalAxon{cI})  % show segmented axon 
  
set(hObject,'string','Preliminary Segmentation','enable','on'); 
disp('Done Segmenting');  
guidata(hObject, handles); 
% --- Executes during object creation, after setting all properties. 
function LoadImage_button_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to LoadImage_button (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% --- Executes on button press in IsolateAll_push. 
function IsolateAll_push_Callback(hObject, eventdata, handles) 
% hObject    handle to IsolateAll_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
set(hObject,'string','running','enable','off'); 
handles.cF = 1; 
for i = 1:handles.numImages 
    handles.currentIndex = i; 
    cI = i; 
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    set(handles.scroll_slider,'Value', i); 
    img = handles.img{cI}; 
    block = handles.blocksegment{cI}; 
    [axon, soma] = RemoveSoma(img, block); 
    handles.finalAxon{cI} = axon; 
    handles.Soma{cI} = soma; 
end 
cI = 1; 
set(handles.scroll_slider,'Value', i); 
axes(handles.OriginalImage); 
imshow(handles.originalImages{cI}); 
axes(handles.EditedImage) 
imshow(handles.finalAxon{cI})  % show segmented axon 
  
set(hObject,'string','Isolate All Axons','enable','on'); 
disp('Done Isolating Axons');  
guidata(hObject, handles); 
  
% --- Executes on button press in AllEdges_push. 
function AllEdges_push_Callback(hObject, eventdata, handles) 
% hObject    handle to AllEdges_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
set(hObject,'string','running','enable','off'); 
handles.cF = 1; 
for i = 1:handles.numImages 
    handles.currentIndex = i; 
    cI = i; 
    set(handles.scroll_slider,'Value', i); 
   scroll_slider_Callback(hObject, eventdata, handles) 
    img = handles.img{cI}; 
    axon = handles.finalAxon{cI}; 
    edges = Edges(img, axon); 
    axonEdges = subtractEdges(axon, edges); 
    [xc xr] = find(edges); 
    handles.Edges{cI} = edges; 
    handles.finalAxon{cI} = axonEdges; 
   
end 
  
cI = 1; 
set(handles.scroll_slider,'Value', i); 
axes(handles.OriginalImage); 
imshow(handles.originalImages{cI}); 
axes(handles.EditedImage) 
imshow(handles.finalAxon{cI})  % show segmented axon 
  
disp('Done Incorporating Edges');  
set(hObject,'string','Incorporate All Edges','enable','on'); 
guidata(hObject, handles); 
  
% --- Executes on button press in SpineAll_push. 
function SpineAll_push_Callback(hObject, eventdata, handles) 
% hObject    handle to SpineAll_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
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handles.cF = 3; 
set(hObject,'string','running','enable','off'); 
for i = 1:handles.numImages 
    handles.currentIndex = i; 
    cI = i; 
    set(handles.scroll_slider,'Value', i); 
    %find skeleton 
    axon = handles.finalAxon{cI}; 
    skel = skeleton(axon); 
    spineThresh= get(handles.SpineThresh_slider, 'Value'); 
    %prune skeleton 
    skel = prune(skel, spineThresh); 
    handles.Skeleton{cI} = skel; 
    [skel1 skel2] = find(skel); 
end 
  
cI = 1; 
set(handles.scroll_slider,'Value', i); 
axes(handles.OriginalImage); 
imshow(handles.originalImages{cI}); 
axes(handles.EditedImage) 
imshow(handles.finalAxon{cI})  % show segmented axon 
hold on; 
spine = handles.Skeleton{cI}; 
[xp yp] = find(spine); 
plot(yp, xp,'.') 
  
set(hObject,'string','Find All Spines','enable','on'); 
disp('Done Finding Spines');  
guidata(hObject, handles); 
  
% --- Executes on button press in CalcAllBeads_push. 
function CalcAllBeads_push_Callback(hObject, eventdata, handles) 
% hObject    handle to CalcAllBeads_push (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
handles.cF = 2; 
set(hObject,'string','running','enable','off'); 
for i = 1:handles.numImages 
    handles.currentIndex = i; 
    cI = i; 
    set(handles.scroll_slider,'Value', i); 
    skel = handles.Skeleton{cI}; 
    axon = handles.finalAxon{cI}; 
    %find slope 
    slope = slopeArray(skel); 
    slopeImg = slopeimg(axon,skel); 
    %find width 
    widthAxon = widthaxon(axon,skel, slope); 
    %find possible beads 
    widthI = widthImg(axon, skel, slope); 
    %find nonbead properties 
    [meanAxonWidth, stdAxonWidth] = nonBeadProps(widthI); 
    %filter beads 
    beadImg = filterbeads(widthI, 1); 
    nb1 = 0; 
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    %find close beads and combine them. Repeat until there are no more 
changes 
    distthresh= meanAxonWidth*2; 
    beads = beadImg; 
    c=0; 
    while(nb1 ~= length(find(beads))) 
     nb1 = length(find(beads)); 
beads = combinedBeads(beads, distthresh); 
    end 
  
    [beadx beady] = find(beads); 
    b = traceSpine(skel, handles.Soma{cI}); 
    %will update all of the following in another function that can also 
be run after removing beads 
    tort = calcTort(skel, b); 
    handles.Tortuosity{cI} = tort; 
    len = length(find(skel)); 
    handles.AxonLength{cI} = len; 
    handles.AxonWidth{cI} = meanAxonWidth; 
    beadIdx = find(beads); 
    sumB = 0; 
    for j = 1:length(beadIdx) 
  sumB = sumB + beads(beadIdx(j)); 
    end 
  
    beadingIndex = sumB/(len*handles.AxonWidth{cI}); 
    handles.stdAxonWidth{cI} = stdAxonWidth; 
    handles.widthImg{cI} = widthI; 
    handles.BeadingIndex{cI} = beadingIndex; 
    handles.numBeads{cI} = length(find(beads)); 
    handles.Length{cI} = len; 
    handles.beadImage{cI} = beads; 
end 
  
cI = 1; 
set(handles.scroll_slider,'Value', i); 
axes(handles.OriginalImage); 
imshow(handles.originalImages{cI}); 
axes(handles.EditedImage) 
imshow(handles.finalAxon{cI})  % show segmented axon 
beads = handles.beadImage{cI}; 
[xp yp] = find(beads); 
plot(yp, xp,'o','MarkerFaceColor','b') 
  
  
set(hObject,'string','Calculate Beads','enable','on'); 
disp('Done Calculating Beads');  
guidata(hObject, handles); 
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Appendix B: Quantification of Focal Disruptions in Microtubules 
The quantification of focal disruptions in microtubules involved manual segmentation 
in ImageJ, the automatic creation of a profile plot in Matlab, and further filtering analysis 
and thresholding in Matlab to identify focal disruptions in microtubule intensity. 
ImageJ was used for the segmentation part of the analysis due to the ease and speed 
of the user interface, which could then be integrated into the Matlab code (Figure 76). 
The image was imported into ImageJ and rotated so that the soma would be oriented 
towards the left of the screen. This was important because the Matlab code used later 
would identify the left-most point of the axon in order to find the anterograde-retrograde 
direction. The image was then cropped so that only the axon was included, background 
subtracted using a 50-pixel rolling ball radius, and converted to an 8-bit image using a 
custom macro with build-in ImageJ functions. The image was then thresholded so that 
the axon could be segmented out of the original image. This axon was then imported into 
Matlab for further processing 
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Figure 76. Axon rotation and segmentation in ImageJ before creation of the plot profile. 
 
 The java package MIJ was used to exchange images between Matlab and ImageJ. 
Creating the plot profile in Matlab was very similar to the beading program and consisted 
of finding and pruning the spine, finding the slope at every point on the spine, and using 
the overlapping line perpendicular to the slope to find the width of the axon at that point 
(Figure 77). The average fluorescence intensity of all pixels along that overlapping line 
was used to find the average intensity at that point. The values were oriented from 
proximal to distal and were used to create the plot profile of tubulin intensity along the 
axon.  
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Figure 77. Matlab processing to create plot profile of microtubule intensity 
 The values for the plot profile were then analyzed in a separate program to find 
focal disruptions by finding local minima in fluorescence intensity. The intensity of the 
values along the axon was smoothed and filtered using a low-pass filter. All local minima 
and maxima were identified, and areas of microtubule disruption were chosen from the 
local minima based on a manual threshold. The final graphs are then presented to the 
user along with an image of the axon with the focal disruptions highlighted (Figure 78).  
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Figure 78. Plot profile filtering to identify focal disruptions in microtubules 
Code 
% javaaddpath 'C:\Program Files\MATLAB\R2014a\java\ij.jar' 
% javaaddpath 'C:\Program Files\MATLAB\R2014a\java\mij.jar' 
% MIJ.start 
% load image from imagej 
  
close all 
axon = MIJ.getCurrentImage; 
  
imagesc(axon) 
title(axon) 
%%this image is all black and white, except for where the data points are 
%% 
bw = logical(axon); 
imshow(bw) 
title('bw') 
figure() 
%get skeleton 
skel = skeleton(axon); 
  
%%plot overlay of skeleton and axon 
  
imagesc(axon) 
hold on 
[S1, S2] = findPoints(skel); 
plot(S1, S2, 'r') 
%get slope array 
slope = getSlope(skel); 
% plot slope array 
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plotSlope(axon, skel, slope); 
  
 %find the average intensity at each point on the axon 
 [intensityImage, widthImage, stdIntensityImage] = IntensityCalc(axon, 
bw,skel, slope); 
  
  
 %% 
 figure() 
 imagesc(intensityImage) 
 title('Intensity') 
  figure() 
 imagesc(widthImage) 
 title('width') 
  
%click on point closest to  
traced = traceSpine(skel); 
hold on; 
 plot(traced(1,2), traced(1,1), 'or'); %%plot starting point 
  
 %%make backup image of traced values, so you can correlate with location 
loc = zeros(size(axon)); 
for i = 1:length(traced) 
loc(traced(i,1), traced(i,2)) = i;    
end 
  
  
 %now get values for width and intensity from starting point  
  
 width = zeros(1, length(traced)); 
 Intensity = zeros(1, length(traced)); 
 stdIntensity = zeros(1, length(traced)); 
 x = 1:length(traced); 
  
 for i = 1:length(x) 
    width(i) = widthImage(traced(i, 1), traced(i, 2)) ; 
    Intensity(i) = intensityImage(traced(i, 1), traced(i, 2)) ; 
    stdIntensity(i) = stdIntensityImage(traced(i, 1), traced(i, 2)) ; 
 end 
%% 
  
%Save Images so that it can be added to cell 
Results = {axon, skel, traced, widthImage, intensityImage, 
stdIntensityImage, width, Intensity, stdIntensity}; 
  
subplot(2, 1, 1) 
plot(width) 
title('width') 
subplot(2,1,2) 
plot(Intensity); 
title('Intensity') 
  
clear S2 S1 loc i Cbw x 
 
189 
 
 
 
 
function skel = skeleton(axon) 
imshow(axon) 
  
% smooth the axon 
se = strel('disk',10); 
axon = imclose(axon,se); 
skel = bwmorph(axon, 'thin', Inf); 
skel = bwmorph(skel, 'spur'); 
%%now prune 
skel = prune(skel, 20); 
  
skel = bwmorph(skel, 'spur'); 
skelb = bwmorph(skel, 'fatten'); 
skel = bwmorph(skelb, 'skeleton', 'inf'); 
end 
  
function skel = prune(skel, lengthresh) 
branchpoints = bwmorph(skel, 'branchpoints'); 
branchpoints = bwmorph(branchpoints, 'thicken'); 
b = imsubtract(skel, branchpoints); 
b(b<0) = 0; 
  
l = bwlabel(b); 
figure() 
imshow(l) 
title('bwlabeled') 
f = []; 
for i = 1:max(max(l)) 
   if length(find(l==i))<lengthresh 
       f = [f i] 
   end 
end 
  
remove = ismember(l,f); 
skel = skel-remove; 
skel(skel<0) = 0; 
%remove anything that is not the longest segment 
  
l = bwlabel(skel); 
ll = zeros(max(max(l)),1); 
for i = 1:max(max(l)) 
   ll(i) = length(find(l==i));  
end 
skel = ismember(l, find(ll==max(ll))); 
end 
 
function [S1, S2] = findPoints(bw) 
[S2,S1]= find(bw==1); 
  
end 
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function slope = getSlope(skel) 
[S1, S2] = findPoints(skel); 
r = 1; 
slope = zeros(length(S1), 1); 
for k = 1:length(S1) 
   %draw a box around that point 
   sx = S2(k); %x and y coordinates 
   sy = S1(k); 
   disk = skel(sx-r:sx+r, sy-r:sy+r); 
   %find all the x and y points in the box 
    [x, y] = find(disk); 
  
   %calculate the slope 
   coeff = polyfit(x, y,1); 
    
   sk = coeff(1); 
   sk = -1/sk; 
   %%now figure out the ones that are extremes, so either 0 or inf (Nan) 
   nnn = isnan(sk); 
   slope(k) = sk; 
       if abs(slope(k))<0.000001 
        slope(k) = 100000; 
    end 
   if abs(slope(k))>1000000 
       slope(k) = 0; 
   end 
  
   if(nnn== 1) 
       slope(k) = 10000; 
   end 
    
end 
end 
 
function [intensityImage, widthImage, stdIntensityImg] = 
IntensityCalc(img, axon,skel, slope) 
[S1, S2] = findPoints(skel); 
%for each point on the spine, find the overlapping points of a line 
l = 50; 
m = slope; 
  
for i = 1:length(S1) 
     
    xCenter = S1(i); 
    yCenter = S2(i); 
    %use the pythagorean theorem to find the range of x values 
  
    lengthx = round(sqrt(((l/2)^2)/(1+m(i)^2))); %length on each side of 
centerpoint     
        if lengthx < 3 %in the case of a flat line 
           lengthx = round(l/2);  
        end 
    xp = 1:2*lengthx+1; 
    yp = xp*m(i); 
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    %center the middle point of the x axis at S1(i) 
     
    xd = S1(i) - xp(lengthx); 
    xp = xp+ xd; 
  
    %raise the middle point of the y-axis to match the center point of 
S2(i) 
  
    yd = S2(i) - yp(lengthx); 
    yp = yp+yd; 
     
    if (abs(m(i))==0) %%in case of a horizontal line  
        xp = -lengthx:lengthx; 
        xp = xp+S1(i); 
        %and there will only be one y-value 
        for j = 1:length(yp) 
         yp(j) = S2(i); 
        end 
     
    end 
     
   if (abs(m(i))>50) %%in case of a vertical line  
     
        yp = -lengthx:lengthx; 
        yp = yp+S2(i); 
        %and there will only be one x-value 
        for j = 1:length(yp) 
        xp(j) = S1(i); 
          end 
    end 
     
    %%also check the minimum and maximum ranges of yp 
        if(min(yp)<1 || max(yp) > length(axon)) 
            for j = 1:length(xp) 
               yp(j) = yd; 
            end 
        end 
        yp = round(yp); 
     C = improfile (axon, xp, yp); 
     intensityLine = improfile(img, xp, yp); 
      
    %the number of 1s in C will be the width at that point (in pixels); 
    %it is possible that the line will cross the axon at mutlipe 
locations, so 
    %look for the region that contains the center point  
  
    Cbw = bwlabel(C); 
    if max(max(Cbw)) > 1 
        np = max(xp == S1(i)); 
        Cbw = ismember(Cbw, np); 
    end 
    points = find(Cbw); 
     
    intensityValues = intensityLine(points); 
    Intensity(i) = mean(intensityValues); 
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    stdIntensity(i) = std(intensityValues); 
    Width(i) = length(points); 
    assignin( 'base', 'Cbw', Cbw); 
end 
intensityImage = zeros(size(img)); 
widthImage = zeros(size(img)); 
  for i = 1:length(S1) 
    intensityImage(S2(i),S1(i)) = Intensity(i); 
    widthImage(S2(i),S1(i)) = Width(i); 
    stdIntensityImg(S2(i),S1(i)) = stdIntensity(i); 
  end 
end 
function traced = traceSpine(skel) 
  
[xp yp] = findPoints(skel); 
%get endpoints 
endPoints = bwmorph(skel, 'endpoints'); 
[xEnd yEnd] = findPoints(endPoints); 
%have the starting point be the one with the smallest xValue 
minI = find(xEnd == min (xEnd)); 
P = [yp(minI) xp(minI)]; 
b = bwtraceboundary(skel,P(1,:),'E',8,length(find(skel)),'clockwise'); 
traced = b; 
end 
 
function [nfoc nfocnorm] = groupFilter(Data) 
close all; 
for k = 1:length(Data) 
    current = Data{k}; 
[B,A] = butter(1, .05, 'low'); 
[axon, ~, traced, ~, ~,~, ~, Intensity,~]=ExtractResults(current); 
  
%remove zero's from intensity values 
izeros = (Intensity <=1); 
Intensity(izeros) = nan; 
figure 
subplot(2,1,1) 
plot(Intensity) 
xlabel('Distance from Soma - Pixels') 
ylabel('Fluorescence Intensity') 
title('Plot Profile') 
  
   IntensitySmooth = filtfilt(B,A, smooth(Intensity)); 
   Intensitydet = detrend(IntensitySmooth); 
   dfIntensity = diff(IntensitySmooth); 
   aIntensity = diff(dfIntensity); 
   Intensity = smooth(IntensitySmooth); 
    
 hold on; 
 plot(Intensity, 'r')  
 xlocPeaks = filterIntensity(Intensity) 
plot(xlocPeaks, Intensity(xlocPeaks), 'y*') 
[~, xlocmax] = findpeaks(Intensity); 
plot(xlocmax, Intensity(xlocmax), 'k*') 
  
%%for each minima, find surrounding maxima and see if it is within the 
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%%tolerance 
xmin = []; 
for i = 1:length(xlocPeaks) 
   y1 = 0; 
   y2 = 0; 
   minx = xlocPeaks(i); 
   miny = Intensity(minx); 
   for j = 1:length(xlocmax)-1 
       if (xlocmax(j)<minx) 
          y1 = Intensity(xlocmax(j)); 
          y2 = Intensity(xlocmax(j+1)); 
       end 
   end 
        
   %%now filter based on percentage difference 
   tol1 = 15; 
   tol2 = 5; 
    
   percentageDifference1 = round((y1-miny)/y1*100); 
   percentageDifference2 = round((y2-miny)/y2*100); 
    
   %%make sure it is not near the last 20 points 
   if (minx > length(Intensity) - 20) 
       percentageDifference1 = 0; 
   end 
 
   if(percentageDifference1>tol1) 
       
       if(percentageDifference2>tol2) 
            xmin(end+1) = minx; 
       end 
   end 
   plot(xmin, Intensity(xmin), 'g*') 
   legend('Raw Intensity', 'Filtered Intensity', 'Local Min' ,'Local Max' 
,'Filtered Min') 
  
end 
  
subplot(2,1,2) 
imagesc(axon) 
colormap(gray) 
hold on; 
  
plot(traced(xmin,2),traced(xmin,1), 'or', 'MarkerSize',30); 
nfoc(k,1) = length(xmin); 
nfocnorm(k,1) = length(xmin)/length(traced); 
end 
  
%%change places where intensity=0 to intensity = NA; 
end 
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